Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,-0.115620756198601,0.00333255224099845,-0.122152558590958,-0.109088953806244,9.43803074773094e-253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,-0.103474418222912,0.00348150097264923,-0.110298160129304,-0.0966506763165195,4.02918500581838e-188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,-0.0817766012651071,0.00391934314420901,-0.0894585138277568,-0.0740946887024575,6.71877718056334e-95
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,0.118508728861993,0.00603425408193249,0.106681590861405,0.130335866862581,1.8026600236344e-84
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.243492814620163,0.0135568228375018,-0.270064187381667,-0.21692144185866,2.59225736860638e-71
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9,Complement component C9,39990,-0.107536440208561,0.00616569425217356,-0.119621200942821,-0.0954516794743009,2.9987215025028e-67
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,41843,0.221979396788556,0.0132871550408138,0.195936572908561,0.248022220668551,5.07981311299889e-62
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42080,0.0737007542849496,0.00446181310132379,0.064955600606355,0.0824459079635443,1.07191171110133e-60
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42137,0.0782277002987807,0.00485436371565694,0.0687131474160931,0.0877422531814683,6.92020666463343e-58
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,-0.0427819944275032,0.00273569384974869,-0.0481439543730106,-0.0374200344819958,1.18212263154786e-54
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,39958,0.142502996878591,0.00922887047934455,0.124414410739076,0.160591583018106,3.01063846193496e-53
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,-0.0511393137085172,0.00333769905469119,-0.0576812038557119,-0.0445974235613225,1.50848691826438e-52
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.041197879488585,0.00269625563159971,-0.0464825405265205,-0.0359132184506496,2.81518486576837e-52
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYY,Peptide YY,39575,0.15983686790818,0.0107348057233873,0.138796648690341,0.18087708712602,1.17412986193662e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,-0.0856890271383251,0.00578811088133297,-0.0970337244657378,-0.0743443298109125,3.37547772160392e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,0.0799203245222584,0.005436852889171,0.0692640928594832,0.0905765561850335,1.85576485158994e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.080270894539635,0.00547696389499686,-0.0910057437738288,-0.0695360453054411,2.87857299070968e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,39990,-0.0395810560652156,0.00278421483329597,-0.0450381171384757,-0.0341239949919555,1.77783028662209e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,-0.110630174210914,0.00785148149157824,-0.126019077934407,-0.0952412704874204,1.03631396271685e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42137,-0.0420015328400541,0.00301932097796076,-0.0479194019568572,-0.036083663723251,1.08640950131506e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0871811196691318,0.00640004364483526,-0.0997252052130089,-0.0746370341252547,5.57374453879705e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,39990,-0.0678688909065737,0.00504059676415321,-0.077748460564314,-0.0579893212488335,5.2102270545657e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42262,-0.0528050142305211,0.00394471380821155,-0.0605366532946157,-0.0450733751664264,1.31090504999459e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42070,0.12631857097544,0.00944124082240888,0.107813738963518,0.144823402987361,1.44729865735261e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42158,-0.0275761466396398,0.00206152270388539,-0.0316167311392552,-0.0235355621400244,1.49744954540225e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42262,-0.0660001010317524,0.00497885389195307,-0.0757586546599804,-0.0562415474035243,7.33235917250628e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,0.0554632978943484,0.0042030361575782,0.0472253470254952,0.0637012487632017,1.80389866874031e-39
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,39735,-0.0428818769526089,0.00333762316114454,-0.0494236183484522,-0.0363401355567656,1.62892305048249e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,-0.0527397242160643,0.00410772930289999,-0.0607908736497483,-0.0446885747823803,1.63525353439063e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42145,0.0848882784892625,0.00676008964757494,0.0716385027800156,0.0981380541985094,5.75093810377936e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,-0.0321589038554631,0.00263572187967703,-0.0373249187396301,-0.0269928889712962,4.99682019382904e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42163,0.109313062887956,0.00913319865247374,0.0914119935291071,0.127214132246804,7.5805875931442e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0491517748270752,0.00415112351098304,-0.057287976908602,-0.0410155727455485,3.46271723711235e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,0.0670508035060451,0.00570165029661983,0.0558755689246702,0.07822603808742,8.97043667491359e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASN,Vasorin,41975,-0.0343373433909822,0.00294505591301546,-0.0401096529804925,-0.0285650338014719,2.91332822729414e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,-0.0509603661279228,0.00449896779853737,-0.059778343013056,-0.0421423892427895,1.39196278858337e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0541410076847618,0.00479449038130662,-0.0635382088321227,-0.0447438065374008,1.93742044467209e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42089,0.124419524464965,0.0110821863968759,0.102698439127089,0.146140609802842,4.04611181298274e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0349684726057416,0.00312948435763006,-0.0411022619466966,-0.0288346832647867,7.3109533772395e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELL,L-selectin,39979,-0.0280203965326088,0.00250847748231438,-0.032937012397945,-0.0231037806672727,8.04848010233442e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,-0.0289864256002105,0.00260452393671928,-0.0340912925161803,-0.0238815586842407,1.20494593785543e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.0420415173078134,0.00378102206625797,0.0346307140579478,0.049452320557679,1.34598991725597e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42195,0.0400931392026971,0.00365992102295868,0.0329196939976981,0.0472665844076961,8.24970756504344e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0478016716029452,0.00437581009325804,-0.056378259385731,-0.0392250838201595,1.15521249606559e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0345395474773644,0.00319408840301498,-0.0407999607472737,-0.028279134207455,3.81968304990351e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,39966,-0.066604875604424,0.00619019955047436,-0.0787376667233537,-0.0544720844854942,7.18294482026066e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42123,0.0652267740356886,0.0060693240826934,0.0533308988336096,0.0771226492377677,7.86006956369228e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.0441770145922376,0.00411301530920058,-0.0522385245982707,-0.0361155045862044,8.39612706431646e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,0.167591581135058,0.0156089819451608,0.136997976522543,0.198185185747574,8.73993166444859e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,39736,-0.0601839365031592,0.00562951751003755,-0.0712177908228328,-0.0491500821834856,1.51199364127905e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.0690955414466128,0.00650863299123061,-0.0818524621094248,-0.0563386207838008,3.17607991384807e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42249,-0.042773256940201,0.00403830464798166,-0.050688334050245,-0.0348581798301569,4.10396088432877e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0360993914565252,0.00345209402723409,-0.0428654957499041,-0.0293332871631464,1.69588254797429e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,0.0941850235538084,0.00901019025393258,0.0765250506561005,0.111844996451516,1.77853828929303e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42016,-0.0388074951469212,0.00371646885049487,-0.0460917740938911,-0.0315232161999512,1.99444558066821e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0551351491701755,0.00534481462060294,-0.0656109858265573,-0.0446593125137938,7.7096059301845e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,0.0600940383627842,0.00588171869682249,0.0485658697170121,0.0716222070085563,2.04631694741362e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.0163710074241227,0.00160346137341611,-0.0195137917160183,-0.0132282231322271,2.28419557655568e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,0.137786292959087,0.0135112284921853,0.111304285114404,0.16426830080377,2.59520192354326e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,-0.0304219111312673,0.00300415189823811,-0.036310048851814,-0.0245337734107206,5.11428676241638e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,39958,0.0980986804167041,0.00977511621010519,0.078939452644898,0.11725790818851,1.33379884681635e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,41994,-0.0291499103096055,0.00295200921645326,-0.0349358483738538,-0.0233639722453571,6.42404456939018e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0461583698231411,0.00468493928910161,-0.0553408508297803,-0.0369758888165019,8.28661401515855e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.0170867215621589,0.00173858927798889,-0.0204943565470171,-0.0136790865773007,1.01464217030455e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42129,-0.0327590180710532,0.00338117673275222,-0.0393861244672475,-0.0261319116748588,3.97628689583739e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0320543744435389,0.00330953830799877,-0.0385410695272165,-0.0255676793598613,4.09902091534283e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,-0.0316858862072769,0.00327679096329104,-0.0381083964953273,-0.0252633759192264,4.92916624071029e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0447292705422473,0.00462967770112716,-0.0538034388364565,-0.0356551022480381,5.17374387374813e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.0902517879560174,0.00934454824612068,0.0719364733936209,0.108567102518414,5.51517291125272e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42145,-0.0362718169887477,0.0037751062372756,-0.0436710252138079,-0.0288726087636875,8.66706896648888e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFP,Properdin,39979,-0.0244512432541373,0.00255410380538969,-0.0294572867127011,-0.0194451997955735,1.24887095880274e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42137,0.0408845651855526,0.0042823514471259,0.0324911563491858,0.0492779740219193,1.55723691154019e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42181,0.0413371264740104,0.00434690057600493,0.0328172013450407,0.0498570516029801,2.23157605926776e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42153,-0.0515663905517786,0.00547252480859188,-0.0622925391766187,-0.0408402419269386,5.09397593172067e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.0284490688318385,0.0030193079025905,-0.0343669123209159,-0.0225312253427611,5.26079207103979e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,39930,0.0773077691280224,0.00820585792451108,0.0612242875959807,0.0933912506600641,5.32986879121858e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FST,Follistatin,42166,-0.0492459248713892,0.00524550061016593,-0.0595271060673144,-0.0389647436754639,7.05972254326121e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42247,0.12130625211146,0.0129400368462958,0.09594377989272,0.146668724330199,8.02822262186652e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,0.0371310365119078,0.00396279743226844,0.0293639535446617,0.044898119479154,8.38110841161951e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42181,-0.0278071307867515,0.0029682306013116,-0.0336248627653222,-0.0219893988081807,8.51985614934386e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0422109474861032,0.0045137011889026,-0.0510578018163522,-0.0333640931558541,1.02678230673232e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0359402665854583,0.00385600116882853,-0.0434980288763622,-0.0283825042945543,1.33323230742787e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42296,0.0291230409920742,0.00314202550441882,0.0229646710034133,0.035281410980735,2.1580078696508e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42185,-0.040898770515385,0.00441884808672742,-0.0495597127653708,-0.0322378282653993,2.44623743590035e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MME,Neprilysin,42070,0.0774432431118256,0.00839122144105174,0.0609964490873642,0.093890037136287,3.13117958233046e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,-0.0295540276067587,0.003229114327079,-0.0358830916878335,-0.0232249635256839,6.53965062390265e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0322098173785372,0.00352234010724703,-0.0391136039887414,-0.025306030768333,6.83575990316913e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,39966,-0.0251172314546898,0.00275486964764009,-0.0305167759640644,-0.0197176869453153,8.98431522488011e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0314511889633155,0.00345775443500325,-0.0382283876559219,-0.0246739902707091,1.06598771088782e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,-0.0265077305865008,0.00291514370099481,-0.0322214122404506,-0.0207940489325509,1.12183452633528e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELE,E-selectin,42310,0.049300283153844,0.00544144424527207,0.0386350524331107,0.0599655138745772,1.47672722592714e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0407735459688417,0.00450674845372826,-0.049606772938149,-0.0319403189995343,1.66239837635959e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,41913,0.0805053161496919,0.0089045116437335,0.0630524733279742,0.0979581589714096,1.76511425567733e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,41654,-0.0305456468918407,0.00338746512390481,-0.0371850785346942,-0.0239062152489873,2.19450093613906e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.020515304243716,0.00227695446109732,-0.0249781349874668,-0.0160524734999653,2.38891424295555e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42129,-0.172302476081334,0.0191625459919747,-0.209861066225605,-0.134743885937064,2.75553961790068e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.039659256944332,0.00444221484733672,-0.048365998045112,-0.0309525158435521,4.9071402763909e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0446459337606733,0.00502721537913657,-0.054499275903781,-0.0347925916175656,7.45409044428434e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42249,-0.0277377954231766,0.00313494085788582,-0.0338822795046328,-0.0215933113417204,9.99740224526011e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0761841079041843,0.00866390165749338,0.0592028606554973,0.0931653551528713,1.62696578191487e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),39775,-0.172261922153168,0.0196625375366634,-0.210800495725028,-0.133723348581307,2.21564432025993e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,39966,-0.0303853733527129,0.00346857177399661,-0.0371837740297463,-0.0235869726756796,2.22478718507954e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.0250043108471272,0.00285661324101216,-0.0306032727995111,-0.0194053488947434,2.36700806375363e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.0770162946590699,0.00881570625738248,0.0597375103946002,0.0942950789235396,2.6949198303187e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0266941314224365,0.0030608689616965,-0.0326934345873617,-0.0206948282575114,3.07049649076717e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,39954,-0.0334191567719151,0.00383607610285929,-0.0409378659335193,-0.0259004476103108,3.40442907323962e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42205,0.0623278230439239,0.00717577700015141,0.0482633001236272,0.0763923459642207,4.1830434941083e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.0311674956960678,0.00360357122904958,-0.038230495305005,-0.0241044960871306,5.77239692382781e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0247891442724194,0.00287249018204541,-0.0304192250292284,-0.0191590635156104,6.95853402068976e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0188839023163993,0.00219484574259172,-0.0231857999718791,-0.0145820046609195,8.55389540392598e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,-0.0270997152651599,0.0031607243945702,-0.0332947350785175,-0.0209046954518024,1.10761441216825e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42070,-0.0257424451024682,0.00300345640111793,-0.0316292196486594,-0.0198556705562771,1.13722433149629e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42171,-0.0359680556946547,0.00420494890881898,-0.0442097555559399,-0.0277263558333695,1.31814641694957e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0319542230759724,0.00375074990061268,-0.0393056928811733,-0.0246027532707716,1.77134888003852e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42113,-0.0270587971399122,0.00317647559068796,-0.0332846892976606,-0.0208329049821638,1.78589205913236e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42137,-0.0247871670539986,0.00291664546199953,-0.0305037921595177,-0.0190705419484796,2.11931527093432e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0305202084939425,0.00359133634513839,-0.0375592277304138,-0.0234811892574713,2.12383407852472e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0444445470727035,0.00523026713115823,-0.0546958706497736,-0.0341932234956333,2.13696077023452e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0315365971464514,0.00371678416338928,-0.0388214941066944,-0.0242517001862084,2.38108432466686e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42145,-0.0370554097630141,0.00436937219830302,-0.045619379271688,-0.0284914402543402,2.46797443478903e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,-0.0260044091614147,0.00307981261963928,-0.0320408418959077,-0.0199679764269217,3.39044925451819e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.0351373509303281,0.00416179649180458,-0.0432944720542651,-0.0269802298063912,3.48108339577632e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0417098403221506,0.00494511512038551,-0.0514022659581062,-0.032017414686195,3.65854224845796e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.0301748490212432,0.00358706609875504,-0.0372054985748031,-0.0231441994676833,4.42281336383717e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0406242180632814,0.00484598049207861,-0.0501223398277555,-0.0311260962988073,5.65710577419573e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.0197585014371653,0.00237546511113596,-0.0244144130549918,-0.0151025898193388,9.98685723416284e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,39970,-0.0318239492017412,0.00383598584296433,-0.0393424814539513,-0.0243054169495312,1.19643841725234e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42016,-0.0232953164290478,0.00281615591345833,-0.0288149820194261,-0.0177756508386695,1.44029108319732e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,-0.0351829416216357,0.00425392324662536,-0.0435206311850214,-0.02684525205825,1.45727745817196e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0984829934553757,0.0119586614120614,0.0750440170877354,0.121921969823016,2.00027934289616e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42016,-0.0300582380864546,0.00367516851847414,-0.0372615683826639,-0.0228549077902453,3.12459860803035e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,0.0418084727845502,0.00513300237528131,0.0317477881289989,0.0518691574401016,4.12197275774789e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,39925,-0.0422019650958171,0.00518432707552809,-0.0523632461638522,-0.0320406840277821,4.35538511697865e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,41638,-0.020767515066672,0.00255314044042326,-0.0257716703299016,-0.0157633598034424,4.52335111711754e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFD,Complement factor D,39979,-0.017764296394389,0.002186108652044,-0.0220490693523952,-0.0134795234363827,4.89560449199055e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.0226146603219845,0.00278964427853763,-0.0280823631079183,-0.0171469575360508,5.64747375768612e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD248,Endosialin,39966,-0.0352013691756321,0.00437351283195978,-0.0437734543262733,-0.026629284024991,9.19498786498909e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42310,-0.0220276669586953,0.00273914208078649,-0.0273963854370369,-0.0166589484803538,9.57348113942541e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,0.0504200373292813,0.00627584188395306,0.0381193872367333,0.0627206874218293,1.02189283014245e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42134,-0.0338936913345522,0.00421906073684941,-0.042163050378777,-0.0256243322903273,1.02549820931944e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.0171060810338521,0.00212940545245798,-0.0212797157206697,-0.0129324463470344,1.04279690673776e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POSTN,Periostin,39966,-0.0327164052743023,0.00408794322216717,-0.04072877398975,-0.0247040365588546,1.33058898805267e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42119,-0.029581927829123,0.00372002655825766,-0.036873179883308,-0.022290675774938,1.97903580873882e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,-0.0278117619662383,0.00350921813311705,-0.0346898295071477,-0.0209336944253289,2.49359179652995e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42070,-0.0256461954234391,0.0032458802947384,-0.0320081208011263,-0.0192842700457518,2.97681318462059e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,0.0851486272399446,0.0108270952903882,0.0639275204707837,0.106369734009105,3.99703177817827e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.0331325356846718,0.0042450887795849,-0.0414529096926582,-0.0248121616766854,6.39192909011523e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,-0.0240635050719829,0.00308415757321986,-0.0301084539154938,-0.0180185562284719,6.52148548785837e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0434645561130359,0.00558881780900682,-0.0544186390186893,-0.0325104732073826,7.96393832494714e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42070,-0.0250918633090435,0.00323327782479192,-0.0314290878456356,-0.0187546387724513,9.066611315228e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42070,-0.0237804343511118,0.00310320708097565,-0.0298627202298241,-0.0176981484723996,1.9375583038597e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,-0.0286528807149906,0.00374184736061553,-0.035986901541797,-0.0213188598881841,2.02559108970944e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,-0.0375370837444967,0.00491066170412627,-0.0471619806845842,-0.0279121868044092,2.25074020254582e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,39859,-0.0252837607891723,0.00330754363790397,-0.0317665463194641,-0.0188009752588805,2.27207448133271e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0253428082951523,0.00332889727287318,-0.0318674469499837,-0.0188181696403208,2.89509620496249e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.022083725282027,0.00290978468785658,-0.0277869032702259,-0.0163805472938281,3.42096996549603e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,0.0693901246636247,0.00914660087491172,0.0514627869487977,0.0873174623784517,3.50267110337887e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42145,0.0558029638127519,0.0073678621280689,0.0413619540417369,0.0702439735837669,3.85799709632026e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42193,0.0269356719947768,0.00356084902474571,0.0199564079062752,0.0339149360832784,4.14650526125556e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0299311198831115,0.00396511899991318,-0.0377027531229413,-0.0221594866432816,4.68169604626064e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0432505605281152,0.00574137095677788,-0.0545036476033998,-0.0319974734528305,5.26696342978473e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,39870,-0.0264005066661543,0.00351896348830769,-0.0332976751032374,-0.0195033382290712,6.73964536332128e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42310,-0.0158641063219154,0.00212404858509116,-0.0200272415486941,-0.0117009710951368,8.58101214357897e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42138,-0.032785145929449,0.00441396831652875,-0.0414365238298453,-0.0241337680290526,1.17206706681158e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0244545285685794,0.00330482493119147,-0.0309319854337147,-0.0179770717034441,1.46380461867967e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,-0.0214663172759606,0.00290736668563358,-0.0271647559798024,-0.0157678785721188,1.63276166424971e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,39929,-0.0239874981464328,0.00326957216072296,-0.0303958595814498,-0.0175791367114158,2.34079000522791e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,-0.0214316444475276,0.00292226225365046,-0.0271592784646825,-0.0157040104303727,2.36045674986914e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-0.0322542882302266,0.00440021747195127,-0.0408787144752511,-0.0236298619852021,2.42745497278966e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.0192595398611408,0.00262963614385937,-0.0244136267031051,-0.0141054530191764,2.5429357244367e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,-0.0213411651849152,0.00291758654574667,-0.0270596348145787,-0.0156226955552517,2.72520761401593e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,-0.0206361082252299,0.00282058205496736,-0.0261644490529659,-0.0151077673974938,2.72640330419475e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,-0.0251926687627273,0.00345227387920042,-0.0319591255659601,-0.0184262119594945,3.0958741333694e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,-0.0241204617194846,0.00330828917365957,-0.0306047084998573,-0.0176362149391118,3.28357653593098e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42137,-0.0298338602642527,0.00409644083812871,-0.037862884306985,-0.0218048362215204,3.4483209154641e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,39966,-0.0403522501174634,0.00554127202647743,-0.0512131432893592,-0.0294913569455676,3.50303243417977e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0319175194492254,0.00439808342687059,-0.0405377629658918,-0.0232972759325591,4.17036069478467e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,-0.0188482917511185,0.00259884702779793,-0.0239420319256025,-0.0137545515766346,4.31180742305918e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.0380715598840745,0.00525200421896894,-0.0483654881532536,-0.0277776316148954,4.42680921543768e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0260016158801682,0.00359300407127012,-0.0330439038598576,-0.0189593279004788,4.84345516610614e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0327200672053067,0.00453008450344777,-0.0415990328320643,-0.0238411015785491,5.3613975279193e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41225,0.0322855533408734,0.00447081324907837,0.0235227593726798,0.041048347309067,5.440297528569e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.0231258212162107,0.00320379078564016,-0.0294052511560654,-0.016846391276356,5.54751542686775e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0425629048413223,0.00590048191455125,-0.0541278493938427,-0.0309979602888019,5.74434587982674e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0265790167063414,0.0036872122773234,-0.0338059527698953,-0.0193520806427876,5.95885826964829e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.0291231681264431,0.00405929468375121,-0.0370793857065954,-0.0211669505462907,7.63976449691378e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0219732066247078,0.00306327104168661,-0.0279772178664136,-0.015969195383002,7.70678749872492e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42230,0.0535665730127088,0.00746809801962049,0.0389291008942527,0.068204045131165,7.73147205819803e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42249,-0.0216574478151205,0.00302825662021716,-0.0275928307907462,-0.0157220648394949,9.00154809102426e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,-0.0190934951571729,0.00267135540637575,-0.0243293517536694,-0.0138576385606764,9.28878225672725e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPN,Asporin,39958,-0.0214360693892449,0.00300794022377593,-0.0273316322278457,-0.0155405065506441,1.09194543207484e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0294458850604202,0.00413993001961384,-0.0375601478988633,-0.0213316222219771,1.19487013046861e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.040701055085376,0.00572746002252593,-0.0519268767295268,-0.0294752334412252,1.25159370384805e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,39979,0.0264174966823484,0.00371743930424147,0.0191313156460351,0.0337036777186616,1.26257176269146e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42119,0.0252294097733663,0.00355188295515467,0.0182677191812631,0.0321911003654694,1.28082564439781e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.0289646012890427,0.00408686893920419,-0.0369748644098829,-0.0209543381682025,1.4494484236613e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0232954119949921,0.00328880766044737,-0.0297414750094689,-0.0168493489805152,1.4913144275316e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,39713,-0.0221693143756538,0.00313084891945588,-0.0283057782577873,-0.0160328504935203,1.51837112763485e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTR,Transthyretin,39862,0.0189336925301965,0.00268638428316476,0.0136683793351936,0.0241990057251995,1.92086343493895e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0186385480560997,0.00264557841158338,-0.0238238817428032,-0.0134532143693963,1.94073471673131e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.0195573280004481,0.00277787074743004,-0.025001954665411,-0.0141127013354852,2.01026951865661e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0414118896333407,0.00588474936718202,-0.0529459983930175,-0.029877780873664,2.07530752850156e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0325261641155407,0.00462981661750914,-0.0416006046858586,-0.0234517235452228,2.23800368837661e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,-0.0210792291322074,0.00300124606431213,-0.0269616714182592,-0.0151967868461557,2.26685685119976e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFM,Afamin,39979,0.0153465668196643,0.00218539667972212,0.0110631893274089,0.0196299443119196,2.30638918089676e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42310,-0.018349835626035,0.00261864879209659,-0.0234823872585443,-0.0132172839935257,2.54181603027797e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.0211366997666164,0.00301888968847014,-0.0270537235560178,-0.0152196759772149,2.65109627441985e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.070490357467695,0.0100930609209244,0.0507079580626831,0.0902727568727069,3.00205065334878e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPS,Colipase,42115,-0.0555880307588919,0.00795968671825148,-0.0711890167266648,-0.039987044791119,3.00952774519496e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSN,Gelsolin,39943,-0.0143168222857587,0.00205008303811632,-0.0183349850404667,-0.0102986595310507,3.03940249000032e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0320861886133968,0.00460387104999305,-0.0411097758713832,-0.0230626013554104,3.32867689170432e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.016644070085549,0.0023985721062464,-0.021345271413792,-0.0119428687573061,4.12399675166526e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.0258577593053897,0.00373560237687992,-0.0331795399640743,-0.0185359786467051,4.65269250963897e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,-0.0278350331279068,0.00402679021456414,-0.0357275419484525,-0.0199425243073611,4.9764664295346e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0319787975757162,0.00464028456412611,-0.0410737553214033,-0.022883839830029,5.76675658970297e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,-0.0250288463270315,0.00363414174676276,-0.0321517641506865,-0.0179059285033765,5.94136438733568e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.0204065014811399,0.00298288316862693,-0.0262529524916487,-0.0145600504706311,8.25791083955007e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,0.0388804831627982,0.00569687660160315,0.027714605023656,0.0500463613019404,9.1780170586632e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0141392261713557,0.00207459745095881,-0.0182054371752349,-0.0100730151674764,9.79478265486563e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42224,0.0357545537595728,0.00525346078344031,0.0254577706240298,0.0460513368951158,1.04614951300326e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.0222921436744583,0.0032817029553025,-0.0287242814668512,-0.0158600058820654,1.14586718178463e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0240514163785256,0.00355284979147749,-0.0310150019698214,-0.0170878307872297,1.34444859612767e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.0646298155515572,0.00955521650435686,-0.0833580399000967,-0.0459015912030178,1.41011124342269e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0345259294323788,0.00510872580763718,-0.0445390320153477,-0.0245128268494099,1.45359184745398e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,41839,0.0384733033990944,0.00569683208357362,0.0273075125152901,0.0496390942828987,1.50390734389509e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0672418380673239,0.00996074396778865,-0.0867648962441896,-0.0477187798904581,1.54531451953944e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0260753279939419,0.00386524214211177,-0.0336512025924809,-0.0184994533954028,1.59396760300072e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0374108752159486,0.00556795269457567,-0.0483240624973169,-0.0264976879345803,1.91971845205969e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAST,Gastrin,39929,0.0945032373123052,0.0141494215911129,0.0667703709937239,0.122236103630887,2.51929535907253e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,39934,-0.035344003689455,0.00529216691371144,-0.0457166508403294,-0.0249713565385805,2.52604332622743e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.0177740246995184,0.00266477878640811,-0.0229969911208783,-0.0125510582781585,2.65894664449378e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,0.0233006449070011,0.00349289909614977,0.0164545626785476,0.0301467271354546,2.66650116864962e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.023017408258269,0.00345308228005536,-0.0297854495271776,-0.0162493669893605,2.75860169657814e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,39966,-0.0344977870294701,0.0051780538746493,-0.0446467726237827,-0.0243488014351575,2.82011490155776e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0235235808709369,0.00353902919550218,-0.0304600780941212,-0.0165870836477526,3.1084788485371e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0274500636481073,0.00413654930569574,-0.0355577002872709,-0.0193424270089436,3.34654942046976e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0216042728906395,0.0032573468565559,-0.0279886727294891,-0.0152198730517899,3.42637263564983e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42286,-0.0314904695639416,0.00474822473809514,-0.040796990050608,-0.0221839490772751,3.43481416506318e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,-0.0170982774522812,0.00257866891666176,-0.0221524685289382,-0.0120440863756241,3.46857187113707e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,-0.0194146596559037,0.00293322757179913,-0.02516378569663,-0.0136655336151774,3.75598132030251e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0276182464953731,0.00418186468466417,-0.0358147012773149,-0.0194217917134314,4.14329449600306e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.0660240087381951,0.0100246517515239,-0.0856723261711819,-0.0463756913052084,4.71299803642591e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0255871625700857,0.00389381700457522,-0.0332190438990532,-0.0179552812411183,5.17277361508567e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.0286281915648335,0.00435688653713713,-0.0371676891776223,-0.0200886939520448,5.18963198549793e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0240719140435978,0.00366354974048792,0.0168913565522415,0.0312524715349541,5.19264590376414e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0567206752899436,0.00864134579881162,-0.0736577130556144,-0.0397836375242728,5.43375450517163e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0201781931075057,0.00307548408617412,-0.026206141916407,-0.0141502442986044,5.57721684739901e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.0152858857392328,0.00233265451876488,-0.019857888596012,-0.0107138828824536,5.84259502921531e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,0.0141496477808963,0.00215944012433082,0.00991714513720795,0.0183821504245847,5.86496808122209e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42137,-0.0173140214884745,0.00265017341942171,-0.022508361390541,-0.0121196815864079,6.66964435693902e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,39736,-0.0331380955097835,0.00507195878662835,-0.043079134731575,-0.0231970562879919,6.70130373902183e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNC,Tenascin,42217,-0.0340149708992154,0.00520895562761516,-0.0442245239293411,-0.0238054178690897,6.80601858855894e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,39826,-0.0775637028504859,0.0119100527230662,-0.100907406187696,-0.0542199995132762,7.7089253002742e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42016,-0.0234625668732415,0.00360670314597575,-0.030531705039354,-0.016393428707129,8.03068307008094e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42137,0.0198834990057553,0.00305845312750871,0.0138889308758382,0.0258780671356723,8.24967660535402e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0259629303190127,0.00399362769149869,-0.0337904405943501,-0.0181354200436753,8.2527276226581e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,-0.014878090403347,0.00229218305015516,-0.0193707691816511,-0.0103854116250429,8.83348985959585e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42310,-0.01117258942292,0.00172378170668982,-0.0145512015680321,-0.00779397727780798,9.39578713983936e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.0209328610713709,0.00324991120536541,-0.0273026870338871,-0.0145630351088547,1.22621063852735e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.027218163800442,0.00422935491692056,-0.0355076994376063,-0.0189286281632777,1.27307489372155e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42262,-0.0195264211732067,0.00303509429425205,-0.0254752059899407,-0.0135776363564726,1.28814690599366e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0504566349245812,0.00784996102041548,-0.0658425585245956,-0.0350707113245669,1.33913534471997e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREH,Trehalase,39966,0.0522968080039881,0.00814179602174178,0.0363388878013742,0.068254728206602,1.38718482984523e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,0.0239847221043036,0.00375123378422189,0.0166323038872287,0.0313371403213785,1.68131222934172e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0286192938845312,0.004484152901426,-0.0374082335713262,-0.0198303541977363,1.80090116194408e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0264816414854768,0.00416945986184795,-0.0346537828146988,-0.0183095001562548,2.20308532669045e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0350988711093667,0.00553632339358418,-0.0459500649607917,-0.0242476772579417,2.37518220526219e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42230,-0.0186303873106077,0.00294602463384573,-0.0244045955929453,-0.01285617902827,2.62988464096228e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42119,-0.0301295363239303,0.00476859256701637,-0.0394759777552824,-0.0207830948925782,2.72697043153735e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,39468,-0.0289819319471054,0.00458619496495815,-0.0379708740784234,-0.0199929898157874,2.72889167274588e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-0.0330330408694633,0.00523088984495119,-0.0432855849655677,-0.022780496773359,2.78624283572543e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42145,-0.0322870658196563,0.005116072320735,-0.0423145675682969,-0.0222595640710157,2.86042093040749e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.0522018641855127,0.00828422258116917,-0.0684389404446042,-0.0359647879264211,3.06290233625257e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,39929,-0.0613198963826179,0.00973916585415231,-0.0804086614567564,-0.0422311313084794,3.16281626085077e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.0197708873634199,0.00314295007576701,-0.0259310695119232,-0.0136107052149165,3.26241172675235e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42249,0.0254101387770667,0.00404030377636685,0.0174911433753877,0.0333291341787458,3.28908187774298e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,39638,0.0428450498307403,0.00682383325387632,0.0294703366531428,0.0562197630083379,3.54159292072265e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0250202476475421,0.0039868297861399,-0.0328344340283764,-0.0172060612667079,3.58617286391124e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0309377208810071,0.00493049319440569,-0.0406014875420422,-0.0212739542199719,3.60688853659446e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPTC,Opticin,42070,-0.0306679799800226,0.0049010767866367,-0.0402740904818306,-0.0210618694782147,4.03312824374562e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0315364716275092,0.00505084537089571,-0.0414361285544647,-0.0216368147005536,4.42756694271616e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.0123598380501319,0.00198455238499291,-0.016249560724718,-0.00847011537554575,4.89018079671571e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.023333966992985,0.00374921351208077,-0.0306824254766633,-0.0159855085093067,4.99890868582131e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42199,0.0122807567646531,0.0019776378157452,0.00840458664579254,0.0161569268835137,5.4592185716639e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.0200201279080144,0.00322915609279617,-0.0263492738498949,-0.0136909819661339,5.8170261058664e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42261,-0.0231284979148389,0.00374048884582103,-0.0304598560526481,-0.0157971397770297,6.45704665093698e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42137,-0.0360127434132715,0.00582550709453006,-0.0474307373185504,-0.0245947495079925,6.51506998923406e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0164571175277614,0.0026650639857252,-0.0216806429397827,-0.01123359211574,6.79771187936903e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,-0.0227695129434255,0.0036898572900756,-0.0300016332319737,-0.0155373926548773,6.98648178129064e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,39966,-0.0173211015269951,0.00280683248543582,-0.0228224931984493,-0.0118197098555409,7.01480673549577e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,41881,-0.0378781832062107,0.0061393349321689,-0.0499112796732618,-0.0258450867391597,7.03836975971335e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,0.0682928982438204,0.0110754152165064,0.0465850844194679,0.0900007120681729,7.23460107422958e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.0209782889367225,0.00340294897943608,-0.0276480689364172,-0.0143085089370278,7.26415653808475e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0234710512117848,0.00380755776279646,-0.0309338644268659,-0.0160082379967038,7.27745623670101e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.0693142600310586,0.011247178754292,-0.0913587303894709,-0.0472697896726463,7.38920491364212e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0242101117039487,0.00392978289292143,-0.0319124861740747,-0.0165077372338227,7.4528387358445e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.0177802122516693,0.00288646243571105,-0.023437678625663,-0.0121227458776756,7.48784386418863e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,-0.0389239181838649,0.0063238962114051,-0.0513187547582189,-0.0265290816095109,7.71583771027986e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42169,-0.0181025811057444,0.00294886474926158,-0.0238823560142971,-0.0123228061971917,8.54480614133927e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,-0.0175502787907746,0.00286642202145285,-0.0231684659528221,-0.011932091628727,9.45154077697563e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0228220039344143,0.0037287432831339,-0.0301303407693567,-0.0155136670994718,9.58239624976031e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FURIN,Furin,42181,0.0217692498914359,0.0035683678072196,0.0147752489892855,0.0287632507935863,1.08529400306076e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,0.0507319132398126,0.00832510467976031,0.0344147080674824,0.0670491184121428,1.13287592752551e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.0163464228692822,0.00268456292688355,-0.021608166205974,-0.0110846795325904,1.16659446866191e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,39657,-0.0197046966101142,0.00324382436320482,-0.0260625923619956,-0.0133468008582327,1.28444756228749e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42262,0.041530538491943,0.00685713785154785,0.0280905483029092,0.0549705286809768,1.42729205212804e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,-0.0182134074439528,0.00301376248290822,-0.0241203819104529,-0.0123064329774527,1.54908273455471e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.0226159387996524,0.00374298918033575,-0.0299521975931104,-0.0152796800061943,1.56071234684551e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.036918263525399,0.00612114717442896,-0.0489157119872797,-0.0249208150635182,1.67891846259708e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39418,-0.0152824423896326,0.0025399505256591,-0.0202607454199244,-0.0103041393593408,1.83629501556963e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42296,-0.0314183671700725,0.00523270591677584,-0.0416744707669531,-0.0211622635731918,1.97105579648847e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42299,-0.0288424402054858,0.00481134008863612,-0.0382726667792126,-0.019412213631759,2.0901168038775e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42199,-0.0183393626948598,0.00305996799073367,-0.0243368999566978,-0.0123418254330218,2.10802587803986e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0363048892594208,0.00606205374255821,-0.0481865145948349,-0.0244232639240067,2.16657212288587e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,41984,-0.0227239575168842,0.00379606337282398,-0.0301642417276192,-0.0152836733061492,2.20309461162654e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0223529941255534,0.00373733376220506,-0.0296781682994753,-0.0150278199516315,2.27390089756284e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0452705871522002,0.00757202427957372,-0.0601117547401647,-0.0304294195642357,2.30687749647463e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.042445779368226,0.00710745724735691,-0.0563763955730455,-0.0285151631634065,2.40205193331703e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,-0.0140013748362221,0.00234901678413851,-0.0186054477331336,-0.00939730193931065,2.57725407790693e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42070,-0.0501272792698476,0.00841576555891362,-0.0666221797653183,-0.0336323787743769,2.64356307167554e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,-0.0368017185653443,0.00618220287836878,-0.0489188362069471,-0.0246846009237415,2.70113011247317e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.024281946762822,0.00408070556675289,0.0162837638519864,0.0322801296736577,2.73984775822962e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,39979,-0.0442763638185459,0.00744885877399211,-0.0588761270155705,-0.0296766006215214,2.86224435798197e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,-0.00861597722239999,0.0014495653365443,-0.0114571252820268,-0.00577482916277315,2.86735822302396e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2,Brorin,41973,-0.0262484388937647,0.00441671646613692,-0.0349052031673931,-0.0175916746201363,2.86859599892826e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42145,-0.0308385158358306,0.00519484595933086,-0.0410204139161191,-0.0206566177555421,2.98533736463421e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRN,Agrin,42185,-0.0229478498100671,0.00386603619345113,-0.0305252807492313,-0.0153704188709029,2.99623815163555e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42119,-0.0430788072331112,0.00726079942637156,-0.0573099741087995,-0.028847640357423,3.04598953543699e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,41913,0.0283644092026757,0.00479130297847727,0.0189734553648602,0.0377553630404911,3.29912055246377e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.035814354735365,0.00605180457474588,0.0239528177688631,0.0476758917018669,3.35697318837702e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,39934,0.0330674885074932,0.00560536398940743,0.0220809750882546,0.0440540019267317,3.75573914398515e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0236551545434448,0.00401652536115848,-0.0315275442513154,-0.0157827648355742,3.9686369929948e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.0207911248430366,0.00353711480881759,-0.0277238698683191,-0.0138583798177542,4.25157750719445e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42145,-0.0186882255158608,0.00319476156173564,-0.0249499581768626,-0.0124264928548589,5.03990661935592e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0226330549440778,0.00386948279575004,-0.0302172412237479,-0.0150488686644077,5.05534360051371e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.0224018476100531,0.00384769065792052,-0.0299433212995773,-0.0148603739205289,5.96667786736263e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.0173692645095889,0.00298538348395936,-0.0232206161381492,-0.0115179128810285,6.08611575013831e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42170,-0.0232469010267871,0.00400002361095885,-0.0310869473042665,-0.0154068547493078,6.32338943720237e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,41976,-0.035000885385629,0.00603236815550553,-0.0468243269704198,-0.0231774438008381,6.69403319137786e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0182117423281324,0.00314113107447586,-0.024368359234105,-0.0120551254221597,6.86782726961355e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.0323945439233902,0.00559643834388726,-0.0433635630774093,-0.0214255247693712,7.26608576448923e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0168747020759322,0.00291653946791781,-0.0225911194330511,-0.0111582847188133,7.3732434105305e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0333513056955507,0.00577158719483467,-0.0446636165974267,-0.0220389947936748,7.70462270050123e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0159983155574803,0.00277023979498495,-0.0214279855556508,-0.0105686455593098,7.89994520717607e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0281808308303541,0.00488276366369876,-0.0377510476112037,-0.0186106140495046,8.02964525209395e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0273933565862097,0.00474941916153498,-0.0367022181428183,-0.0180844950296011,8.21112645493759e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.016014818414447,0.00277939893917296,-0.021462440335226,-0.010567196493668,8.53020809952363e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_E,,42119,-0.0182424386592766,0.00316647383128151,-0.0244487273685884,-0.0120361499499648,8.53772933522794e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42144,-0.0206870658878095,0.00359283252560814,-0.0277290176380014,-0.0136451141376175,8.70294283240438e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.0444520423898342,0.00772661778533584,-0.0595962132490925,-0.029307871530576,8.99487556355492e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42123,-0.0145237077645556,0.00252656185062225,-0.0194757689917752,-0.00957164653733595,9.20326409397844e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.019659912396086,0.00342377661037155,-0.0263705145524143,-0.0129493102397578,9.54761167952691e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGN,Mimecan,42137,-0.0267868560254319,0.00467046603040729,-0.0359409694450302,-0.0176327426058337,9.93787938352582e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,0.076534056625938,0.0133511926178379,0.0503657190949758,0.1027023941569,1.01126387798761e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0193980076538653,0.00338647062740497,-0.0260354900835791,-0.0127605252241516,1.03715219945106e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,39979,-0.0187275890617754,0.00326927503445648,-0.0251353681293101,-0.0123198099942407,1.03975915826296e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,0.038972216885233,0.00680461667202762,0.0256351682080589,0.0523092655624071,1.04694914030019e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42158,-0.0190927989321554,0.00333702863447283,-0.0256333750557222,-0.0125522228085886,1.07821697013726e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42016,-0.0262488195677824,0.00459183644264825,-0.035248818995373,-0.0172488201401919,1.11114465142381e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0369491887530108,0.0064881092406076,-0.0496658828646017,-0.02423249464142,1.25980543759401e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0167162999784689,0.00293986875239842,-0.0224784427331698,-0.010954157223768,1.32666164865686e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42274,-0.0330321080736365,0.00581318028975621,-0.0444259414415587,-0.0216382747057143,1.35623640037401e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42119,-0.0304740362371009,0.00536501722746241,-0.0409894700029272,-0.0199586024712746,1.37359680434635e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42310,-0.0186285026903233,0.00328101983954123,-0.0250593015758241,-0.0121977038048225,1.39322316725293e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0170356639622086,0.00300258108810759,0.0111506050295177,0.0229207228948995,1.42634827470758e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,39638,0.0386178916544918,0.00681193859743255,0.025266492003524,0.0519692913054596,1.47110266500272e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.0464757887054835,0.00820631554431985,-0.0625601671723504,-0.0303914102386165,1.51406246415634e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,0.0196867593567814,0.00347764399164613,0.012870577133155,0.0265029415804078,1.53590983095665e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C3,Complement C3,39445,-0.0282090179088148,0.00498703414763312,-0.0379836048381757,-0.0184344309794539,1.58429116173694e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,-0.0210744817483142,0.00372739493844864,-0.0283801758276735,-0.0137687876689549,1.60680993296376e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.0281246115414836,0.00498169492615613,0.0183604894862176,0.0378887335967496,1.67902693507739e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0204053417865633,0.00361595507715104,-0.0274926137377793,-0.0133180698353472,1.70282724579993e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0276325867485182,0.00489716817624916,-0.0372310363739665,-0.0180341371230698,1.70911741406055e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0199728147724441,0.00354133176988123,-0.0269138250414113,-0.0130318045034768,1.73554762762413e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42181,-0.0203732824107003,0.00363302784957264,-0.0274940169958626,-0.0132525478255379,2.08915391876056e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42249,-0.0181803969854184,0.0032521224683126,-0.024554557023311,-0.0118062369475257,2.31000316433246e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,39930,0.0674215823116433,0.0120634379701899,0.0437772438900712,0.0910659207332155,2.33767656359459e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,39979,-0.0200372143942988,0.00358908542832817,-0.027071821833822,-0.0130026069547756,2.42073264098546e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.0166462557189059,0.00299276319874298,-0.0225120715884421,-0.0107804398493697,2.71468391973662e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0173966218382814,0.00313197031363591,-0.0235352836530078,-0.011257960023555,2.83622471808197e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.0164857077288439,0.00296851791094664,-0.0223040028342994,-0.0106674126233885,2.85189550622499e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0251579368666042,0.00453700441255601,-0.034050465515214,-0.0162654082179945,2.99671314262117e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,0.0457248551527513,0.00825634697558099,0.0295424150806126,0.0619072952248901,3.12626807539997e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,41697,0.0240103098490838,0.00433967824097182,0.0155045404967791,0.0325160792013886,3.21318147425584e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.0185270883975474,0.0033493180482947,-0.025091751772205,-0.0119624250228898,3.24348231032635e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0317329745582594,0.00575279442298873,-0.0430084516273173,-0.0204574974892014,3.53111572935611e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,41714,-0.015721739182825,0.00285109594812284,-0.0213098872411457,-0.0101335911245042,3.56837765829963e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0205146701537547,0.00372835011210224,-0.027822236373475,-0.0132071039340343,3.81664944120952e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42204,0.0408178379749338,0.00742646423158118,0.0262619680810347,0.0553737078688329,3.94895327893549e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,-0.040832968169872,0.0074361177532885,-0.0554077589663175,-0.0262581773734265,4.06518440724803e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.0156886827378864,0.0028583360565334,-0.0212910214086918,-0.0100863440670809,4.13464352764775e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0512962672685472,0.00934734701730858,-0.069617067422472,-0.0329754671146224,4.14228715496659e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.0256549262796149,0.00467462030673583,-0.0348171820808171,-0.0164926704784127,4.14960272201286e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0115740240451402,0.00211223714131739,-0.0157140088421223,-0.00743403924815811,4.34168070363697e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0158632644284952,0.00289643605849436,-0.0215402791031441,-0.0101862497538462,4.4077171302644e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0252383897658746,0.00461466949741163,-0.0342831419808014,-0.0161936375509478,4.60223451559642e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42123,-0.0161549889840526,0.00295478598074325,-0.0219463695063093,-0.0103636084617958,4.6479323763733e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0137233384076361,0.00251027512144699,-0.0186434776456722,-0.00880319916959999,4.67739257274241e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0562339668902664,0.0102896112215069,-0.0764016048844198,-0.0360663288961129,4.70781361796289e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2,Complement C2,42199,-0.013323878398244,0.00243818150079497,-0.0181027141398022,-0.0085450426566859,4.71910738766136e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0172480594149547,0.00315971654443326,-0.0234411038420438,-0.0110550149878655,4.8791108683964e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0528020313859836,0.00969023583189625,-0.0717948936165003,-0.033809169155467,5.15428121354759e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0197334203959012,0.00362257062697079,-0.0268336588247639,-0.0126331819670384,5.20098484209274e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0371614002625105,0.00683543351455893,-0.050558849951046,-0.023763950573975,5.5241606496738e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,39657,-0.0245947913836925,0.00452576508922352,-0.0334652909585706,-0.0157242918088144,5.61498220185268e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0257213835850408,0.00473493231856615,-0.0350018509294305,-0.0164409162406511,5.66092700797798e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0154792379544086,0.00285454688717765,-0.0210741498532768,-0.00988432605554039,5.97262330652931e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42145,-0.0143308985686377,0.00264546104111364,-0.0195160022092204,-0.00914579492805495,6.15859436219188e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.0255943054973981,0.00472849083949183,-0.0348621475428021,-0.0163264634519941,6.33484478989812e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,39736,-0.0690654732153229,0.0127617011907773,-0.0940784075492465,-0.0440525388813993,6.36406067942077e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0200549485234124,0.00371924447883707,-0.027344667701933,-0.0127652293448917,7.07704906625566e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,39736,0.0199739643331387,0.00370602691068907,0.0127101515881881,0.0272377770780893,7.20593422355856e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.0225865774534395,0.00419090539147509,-0.0308007520207306,-0.0143724028861483,7.21374457068847e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42167,-0.0122409175709588,0.00227726432142785,-0.0167043556409574,-0.00777747950096022,7.77319645183693e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0493780271635306,0.00919556514083719,-0.0674013348395715,-0.0313547194874897,8.01478777005815e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0276704968521607,0.00515427116697138,-0.0377728683394246,-0.0175681253648968,8.0725984870939e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,41843,-0.0219321531325092,0.00408800814513515,-0.0299446490969741,-0.0139196571680443,8.23126145797951e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0417046893937807,0.00778383825994376,-0.0569610123832705,-0.0264483664042909,8.56173890174011e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,0.0136630967453645,0.00255119527282365,0.00866275401063015,0.0186634394800988,8.69513259871989e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,0.048412639905883,0.00905114157494597,0.0306724024189889,0.0661528773927771,9.02639427472251e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,-0.0222750046713096,0.00416842938807928,-0.030445126271945,-0.0141048830706742,9.2508556170582e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.0138425489564833,0.00259590042395916,-0.0189305137874432,-0.00875458412552336,9.84693106917679e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0262007420591167,0.00492578592916699,-0.0358552824802841,-0.0165462016379494,1.06303160206032e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,39886,-0.0164212831709555,0.0030916439791493,-0.0224809053700881,-0.0103616609718228,1.10790386309867e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42129,-0.0222042192711192,0.00418589236609114,-0.0304085683086578,-0.0139998702335806,1.14739568080007e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0378836520772771,0.00715797750788518,-0.051913287992732,-0.0238540161618221,1.22897671764714e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0180813142578942,0.00341676689693965,-0.0247781773758959,-0.0113844511398925,1.22923783374663e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0394913408552377,0.00747799669911453,-0.0541482143855021,-0.0248344673249732,1.30475417112495e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,39736,-0.0177109857875352,0.00335564008741222,-0.0242880403588631,-0.0111339312162072,1.33074460644211e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RETN,Resistin,42105,-0.0244346444100354,0.00463172078390148,-0.0335128171464823,-0.0153564716735885,1.34440132118927e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.0244923300258709,0.00464471765872923,-0.0335959766369802,-0.0153886834147617,1.36185816298835e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0244916175629565,0.0046628379524946,-0.0336307799498459,-0.015352455176067,1.52298165355437e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0187411191679275,0.00356910956592886,-0.0257365739171481,-0.0117456644187069,1.54070674078884e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0350761932174708,0.00672214285490976,-0.0482515932130939,-0.0219007932218476,1.83504837964234e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0128597049030766,0.00247412081014291,-0.0177089816909567,-0.00801042811519648,2.04682213518114e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0236824873144665,0.00456929664621016,-0.0326383087410384,-0.0147266658878946,2.21496165093453e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0174417139495867,0.00337471365461647,-0.0240561527126349,-0.0108272751865384,2.39528047183652e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42310,-0.0164594086934627,0.00318488399215011,-0.0227017813180769,-0.0102170360688485,2.39964981651536e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.040412776459929,0.00782371277365307,-0.0557472534962891,-0.025078299423569,2.43321009971579e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0180143969383315,0.00349034013703561,-0.0248554636069213,-0.0111733302697417,2.4886270264072e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.0179712896642789,0.0034852123189054,-0.0248023058093335,-0.0111402735192243,2.55236394980819e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.020201034735257,0.00391833556713805,0.0125210970236664,0.0278809724468476,2.57313731134716e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0286968285059492,0.00556766249115685,-0.0396094469886166,-0.0177842100232818,2.58277849615223e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.0189574601183701,0.00368274721845972,-0.0261756446665511,-0.011739275570189,2.67485160554738e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42145,0.0350872495129124,0.00681869966920156,0.0217225981612773,0.0484519008645474,2.70195571434299e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42145,0.0212189770424922,0.00412655614086761,0.0131309270063917,0.0293070270785928,2.7553938083844e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,-0.00454050747273553,0.000884146191812098,-0.00627343400868725,-0.00280758093678382,2.86167848806427e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,-0.0265805688279795,0.0051787267617237,-0.0367308732809579,-0.016430264375001,2.89722487774242e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0269550226206847,0.00525378860953835,0.0166575969459895,0.0372524482953798,2.93705051653799e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0150569190372659,0.00293753026448018,-0.020814478355647,-0.00929935971888475,3.00493912562485e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0239860825192448,0.00468393535587457,0.0148055692217306,0.033166595816759,3.08212508290564e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42070,-0.0172246058604006,0.00336427440267484,-0.0238185836896433,-0.0106306280311579,3.09982461197265e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0168078031986627,0.00328309260631799,-0.0232426647070459,-0.0103729416902794,3.10516329345385e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0157961147331854,0.00309162927287619,-0.0218557081080227,-0.00973652135834808,3.27735454408992e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42262,-0.0345262999378101,0.00676503672759913,-0.0477857719239044,-0.0212668279517159,3.3765863131674e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.0170378408515087,0.00333840571931139,-0.023581116061359,-0.0104945656416584,3.37735832073162e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,39979,-0.0103482374854099,0.00203403714262472,-0.0143349502849544,-0.00636152468586548,3.68527907210847e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0652651480304282,0.012832105187734,-0.0904160741983868,-0.0401142218624696,3.70422476325704e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0185236465766709,0.00364470654861289,-0.0256672714119522,-0.0113800217413897,3.77824483762961e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,41900,-0.027304273875479,0.00538280881936289,-0.0378545791614303,-0.0167539685895277,3.97921200879183e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,-0.079595900664868,0.015701463623737,-0.110370769367392,-0.0488210319623436,4.05488428590251e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0180524538043675,0.00356188998995698,-0.0250337581846832,-0.0110711494240518,4.06988115152056e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.0292390240250664,0.00577629970168096,-0.0405605714403611,-0.0179174766097717,4.21799553017923e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0230605293976514,0.00455859378655375,-0.0319953732192968,-0.0141256855760061,4.27646322617476e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42249,-0.0123704803791384,0.00244697833069542,-0.0171665579073014,-0.00757440285097536,4.35028642618188e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42166,-0.0167211702490062,0.00331748809898923,-0.0232234469230251,-0.0102188935749873,4.70764600774678e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0168819153580309,0.00334956538306751,-0.0234470635088432,-0.0103167672072186,4.71462919919619e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0184694663685651,0.00366955658449039,-0.0256617972741663,-0.011277135462964,4.88749279858307e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0424694547181834,0.00843935936480728,-0.0590105990732057,-0.0259283103631611,4.90776913045437e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.0399469711440949,0.00793957286922432,-0.0555085339677745,-0.0243854083204152,4.94401779890521e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,41843,-0.0293989244532355,0.00586583445111244,-0.0408959599774159,-0.0179018889290551,5.45935944588067e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,39713,0.0212434050134175,0.00424212155929999,0.0129288467571895,0.0295579632696455,5.59208968526621e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0355590836243607,0.00710277521705107,-0.0494805230497808,-0.0216376441989406,5.63018834655302e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42310,-0.0144314810978831,0.00288534249199969,-0.0200867523822025,-0.00877620981356368,5.75441324186628e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0196527629879066,0.00393021176336982,-0.0273559780441115,-0.0119495479317018,5.79241046722987e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0129190912003272,0.00258657537531461,-0.0179887789359439,-0.00784940346471057,5.96705008704376e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,-0.033126459786021,0.00663290288421677,-0.0461269494390858,-0.0201259701329561,5.99412075429987e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42069,-0.0238803660563133,0.00478224072821925,-0.0332535578836231,-0.0145071742290036,6.0020814531353e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,39726,-0.0113160229778964,0.00227036598036378,-0.0157659402994094,-0.00686610565638341,6.3146207925563e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0201541872042516,0.00404803209247704,-0.0280883301055066,-0.0122200443029966,6.47746376166992e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0198723043906669,0.0039949191568556,-0.0277023459381039,-0.0120422628432299,6.64090810288135e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,-0.0206889222545452,0.00417147370858138,-0.0288650107233647,-0.0125128337857257,7.16567874992991e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.027764568839645,0.00560271695610843,0.0167832436056725,0.0387458940736176,7.29977846096821e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,39636,-0.0239680647106642,0.00484215611421625,-0.0334586906945281,-0.0144774387268004,7.53588759267989e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0429283189499484,0.00869742140825743,0.0258813729897638,0.059975264910133,8.07942360354461e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0180527034839718,0.003663694538999,-0.0252335447804098,-0.0108718621875337,8.44841501885752e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42119,0.0387448583121152,0.00787121586170722,0.0233172752231691,0.0541724414010614,8.65207971453809e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.014228003453199,0.00289092371809249,-0.0198942139406603,-0.00856179296573776,8.68499063734263e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0467690952821789,0.0095085792606406,-0.0654059106330345,-0.0281322799313233,8.84127333084e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0676780553356179,0.0137810418250136,-0.0946888973126444,-0.0406672133585913,9.16888077789208e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0377831787171408,0.00769626447732746,-0.0528678570927026,-0.022698500341579,9.26820941782261e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0283675267227727,0.00578410188404767,-0.0397043664155061,-0.0170306870300393,9.48012438502732e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0511620635902836,0.0104376086655337,-0.0716197765747297,-0.0307043506058376,9.63257455942047e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.021585408782909,0.00442062736517076,-0.0302498384186437,-0.0129209791471743,1.05965384909535e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0144242805585565,0.00295552805274869,-0.0202171155419439,-0.00863144557516906,1.07296434097262e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,39575,-0.0369093907246785,0.00756374910407023,-0.0517343389686562,-0.0220844424807009,1.0770065920144e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,39575,0.0407835940876283,0.00837116792744062,0.0243761049498447,0.057191083225412,1.12067882108158e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,39990,0.015284400077127,0.00314047063500069,0.00912907763252562,0.0214397225217283,1.14874412572053e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.0419352885792913,0.00863991355035075,0.0250010580206039,0.0588695191379788,1.22556101214247e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0251020552474825,0.0051726157267589,-0.0352403820719299,-0.014963728423035,1.23071864770039e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0151779658136458,0.00313188107544815,-0.0213164527215242,-0.00903947890576746,1.27496741780725e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.0287153213065175,0.00592724467054126,0.0170979217522566,0.0403327208607783,1.28289034009278e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.0128798536585403,0.00266038650735332,-0.0180942112129528,-0.00766549610412775,1.30695347442242e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.0307960052938157,0.00636482919361544,-0.0432710705133019,-0.0183209400743294,1.3230067187099e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,41825,-0.029424646962605,0.0060899688339086,-0.0413609858770658,-0.0174883080481441,1.36919910369649e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0216636999553295,0.00448583977231193,-0.0304559459090609,-0.0128714540015981,1.38462804902014e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.0273761998056798,0.0056851046936651,-0.0385190050052634,-0.0162333946060962,1.48781934186515e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.0322335479173936,0.00669940750815777,-0.0453643866333828,-0.0191027092014044,1.51493064109194e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0153438369574464,0.00319481519857956,-0.0216056747466623,-0.00908199916823043,1.58570411545891e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0163576155883522,0.00340744796620663,-0.0230362136021172,-0.0096790175745872,1.59923189887814e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,39736,0.0146847900305232,0.00306161930904922,0.0086840161847867,0.0206855638762596,1.63626322521242e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,39959,-0.0116401133645713,0.00243196388400223,-0.0164067625772157,-0.00687346415192695,1.72023807661537e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,39966,-0.0257651707907402,0.00538410545948753,-0.0363180174913357,-0.0152123240901446,1.7278366345395e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,39934,0.0218075726009028,0.00456128672859125,0.012867450612864,0.0307476945889417,1.76607753989877e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0211635489204671,0.00443074638463616,-0.029847811834354,-0.0124792860065802,1.80231008215161e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0146614126635708,0.00307511965071406,-0.0206886471789703,-0.0086341781481712,1.88245033410195e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,39958,0.0143988329371895,0.00302057524966448,0.00847850544784714,0.0203191604265319,1.89387351672369e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,-0.0123219948685055,0.00259242824009984,-0.0174031542191012,-0.00724083551790985,2.02400137930751e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0468904180557433,0.00987792839637205,-0.0662511577126325,-0.027529678398854,2.08585488375882e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLU,Clusterin,39979,-0.0154557614860448,0.0032563199095803,-0.0218381485088222,-0.00907337446326741,2.09602793459188e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0201941389130307,0.00426458031496493,-0.028552716330362,-0.0118355614956995,2.20930533344991e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.0154672596369536,0.003273500095212,-0.0218833198235692,-0.00905119945033812,2.3296068232911e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,39875,-0.0372949333076004,0.00789729461707958,-0.0527736307570763,-0.0218162358581244,2.35778040837805e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42181,-0.0218009515238796,0.00461700289159921,-0.0308502771914141,-0.0127516258563452,2.36006175234976e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.0326401037013321,0.00691683006993446,-0.0461970906384037,-0.0190831167642606,2.39963183032478e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0360843150450566,0.00764946279196975,0.0210913679727959,0.0510772621173173,2.41500416092584e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0213493124561287,0.00453279287144655,-0.030233586484164,-0.0124650384280935,2.50195654996706e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42194,0.0157593616832737,0.00334787601649992,0.0091975246909339,0.0223211986756136,2.53532006561062e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,-0.0124889040771598,0.00265667670088308,-0.0176959904108906,-0.00728181774342894,2.61507232459e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0168063753061212,0.00358187153758867,-0.023826843519795,-0.0097859070924474,2.73657161912006e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0579790563531781,0.0124075795126314,-0.0822979121979357,-0.0336602005084206,3.00435437945122e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0172150731407704,0.00368495816420447,-0.0244375911426111,-0.00999255513892962,3.0162217770169e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.0117926463672049,0.0025391622183711,-0.0167694043152123,-0.00681588841919756,3.44435599117883e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0234956966468612,0.00505906031642205,-0.0334114548670484,-0.0135799384266739,3.44531710880617e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0414311583302009,0.00892642606029429,-0.0589269534083777,-0.0239353632520241,3.4930086843393e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.0277212588785963,0.00597456279542016,-0.0394314019576198,-0.0160111157995728,3.52644946994837e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0297848057171053,0.00642912222604663,-0.0423858852801566,-0.0171837261540539,3.64084812976838e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0161892232049793,0.00350184401417328,-0.0230528374727589,-0.00932560893719962,3.81763217144137e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0268873889619276,0.00581663734216906,-0.0382879981525789,-0.0154867797712762,3.82729860469946e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0187796002728849,0.00406408607281625,-0.0267452089756047,-0.010813991570165,3.85726131845495e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,39929,-0.0200037618063659,0.00433463356696653,-0.0284996435976203,-0.0115078800151115,3.97663857814562e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.034255231523627,0.0074369406990941,-0.0488316352938514,-0.0196788277534025,4.14016527518863e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0235689955884089,0.00511763144748505,-0.0335995532254796,-0.0135384379513383,4.15408016708106e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.0152410409624966,0.00331035647709909,-0.0217293396576108,-0.00875274226738242,4.18096354012401e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0127413504987848,0.00276796412708181,-0.0181665601878651,-0.00731614080970445,4.20661785414465e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0204512697859771,0.00444320759077869,0.0117425829080508,0.0291599566639033,4.21424531722041e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.0116438098527871,0.00253067434278861,-0.0166039315646528,-0.0066836881409214,4.24160406258329e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0252945681716859,0.00551354901677659,-0.036101124244568,-0.0144880120988038,4.52122227502076e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C5,Complement C5,39979,-0.00745639160182995,0.00162574931908221,-0.0106428602672311,-0.00426992293642882,4.55693931367869e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0195272728740555,0.00426119398333666,-0.0278792130813953,-0.0111753326667157,4.64295404895716e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,-0.0182235164250768,0.00397987710428595,-0.0260240755494772,-0.0104229573006763,4.7246161122582e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.0494253301621067,0.0107981002624593,0.0282610536476864,0.0705896066765269,4.75383381090424e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42184,-0.014145209506755,0.00309468794303376,-0.0202107978751012,-0.00807962113840888,4.9014307629937e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.0113262261596931,0.00248520429196346,-0.0161972265719415,-0.00645522574744472,5.23160102316351e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0340155983528707,0.00749275859715332,0.0193297915024502,0.0487014052032912,5.69033284751511e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0430348982072019,0.00948909174214942,-0.0616335180218147,-0.024436278392589,5.81414402934251e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.011204872642532,0.00247163129617967,-0.0160492699830442,-0.00636047530201987,5.85409254004034e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.0102219503802774,0.00225606392614499,-0.0146438356755215,-0.00580006508503318,5.9244137427972e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0588426461324258,0.0129875445542678,-0.0842982334587906,-0.0333870588060609,5.93903131932636e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0172628590279515,0.00381084566977909,-0.0247321165407185,-0.00979360151518448,5.9504803156668e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.0292972799582246,0.00647212386691659,0.0166119171790681,0.0419826427373812,6.04377349356156e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGMN,Legumain,42185,-0.017736160717261,0.00391891544944564,-0.0254172349981744,-0.0100550864363475,6.06831110360914e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42189,-0.0175887694826026,0.00388808679317543,-0.0252094195972264,-0.00996811936797874,6.12654297534907e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,0.0446104889146631,0.00986493250816412,0.0252752211986614,0.0639457566306648,6.17416034155127e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,-0.0159532613881424,0.0035329055108053,-0.0228777561893207,-0.00902876658696397,6.36616227848705e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,41900,-0.0190240862317459,0.00421482547004862,-0.0272851441530412,-0.0107630283104506,6.42797766681792e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0134189881765494,0.00297428857866814,-0.0192485937907389,-0.00758938256235982,6.4856397902854e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.0279915971448723,0.00621164041231704,-0.0401664123530137,-0.0158167819367309,6.65118785263394e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0252504154262461,0.00561253691647767,-0.0362509877825423,-0.0142498430699498,6.88586174373133e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0204273963031411,0.0045411664169257,-0.0293280824803155,-0.0115267101259668,6.91897575135908e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,41839,-0.0221259600162511,0.00491921488901565,-0.0317676211987218,-0.0124842988337804,6.92234604844783e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0137270614315455,0.00305582500129083,-0.0197164784340756,-0.0077376444290155,7.11045268271463e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0220571983838993,0.00491168785054574,-0.0316841065709689,-0.0124302901968296,7.15604754970739e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42027,-0.0224692419780497,0.00500628193050737,-0.0322815545618441,-0.0126569293942552,7.24217611659525e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0313787898132565,0.00699706670763266,-0.0450930405602165,-0.0176645390662964,7.37830104237054e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.00974200123420549,0.00217273857853131,-0.0140005688481269,-0.00548343362028413,7.4066236067839e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0172116696407863,0.00384537976120145,-0.0247486139727412,-0.00967472530883148,7.66941233183554e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42262,0.0162994681183024,0.00364385700603098,0.0091575083864817,0.0234414278501231,7.77027531095032e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0231079497950111,0.00516871967432121,-0.0332386403566807,-0.0129772592333415,7.85950644455675e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB2,Calretinin,41839,-0.0142359064755153,0.0031850310263619,-0.0204785672871847,-0.00799324566384601,7.90061007430529e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42070,0.0645689229468673,0.0144528534180564,0.0362413302474768,0.0928965156462579,7.97630675568205e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,39657,-0.00826264451708531,0.00185405044255037,-0.011896583384484,-0.00462870564968658,8.41135888681909e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,-0.0207427114583957,0.00465868785676926,-0.0298737396576635,-0.011611683259128,8.57165199649834e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.0221618499416968,0.00497824099828576,-0.0319192022983369,-0.0124044975850567,8.59900115179496e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42122,-0.0314041966057781,0.00705853468117381,-0.0452389245808788,-0.0175694686306774,8.69155977479515e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0179056623542533,0.00402515975801274,0.0100163492285483,0.0257949754799583,8.73234856968136e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.0475727747862018,0.010698658359896,-0.068542145171598,-0.0266034044008056,8.80637052336033e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42145,-0.0244151301686733,0.00549658866385337,-0.0351884439498259,-0.0136418163875207,8.98872608055934e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,-0.0164843982805158,0.00371502993504793,-0.0237658569532097,-0.00920293960782184,9.18457966474549e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,-0.0184687274152516,0.00416227528947322,-0.0266267869826192,-0.0103106678478841,9.18789566922726e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,39919,-0.0502958263377214,0.0113425936562685,-0.0725273099040077,-0.0280643427714351,9.32668775378502e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0189925046061135,0.00428630982498692,-0.0273936718630878,-0.0105913373491391,9.45528118965249e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRN,Progranulin,42077,-0.0120199820603895,0.00271523366613366,-0.0173418400460115,-0.00669812407476754,9.6362673439739e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0131126767615164,0.00296344276431331,-0.0189210245795705,-0.0073043289434623,9.72780274168735e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,39736,0.0254130770130389,0.00574427255310406,0.0141543028089549,0.0366718512171228,9.77774414960615e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42137,0.0184564237538993,0.00417365950684971,0.0102760511204738,0.0266367963873247,9.84988824222132e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0345703712869784,0.00782291967576084,-0.0499032938514697,-0.0192374487224872,1.0002758202786e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0239954327539691,0.00543653119226278,-0.0346510338908042,-0.0133398316171341,1.02376403519099e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,-0.00733483410744637,0.00166789734134358,-0.0106039128964798,-0.00406575531841296,1.10421506047941e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,39575,-0.0278225458045592,0.00633547095987278,-0.0402400688859098,-0.0154050227232085,1.13599084959531e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0130341451905818,0.00296820874698225,0.00721645604649664,0.018851834334667,1.13719026170356e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42310,0.0243223627359523,0.00554102796792157,0.013461947918826,0.0351827775530786,1.14459509266396e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42296,-0.00436068781253846,0.000994166478281064,-0.00630925410996934,-0.00241212151510757,1.16169215093869e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0186883774307913,0.00426743973808886,-0.0270525593174454,-0.0103241955441371,1.19959137645867e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,-0.0193061090738549,0.00441173764982821,-0.0279531148675181,-0.0106591032801916,1.2174939401901e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.010975559379763,0.00252006820660704,-0.0159148930647128,-0.00603622569481317,1.33873265420661e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,0.0298839656825031,0.00688591793915518,0.016387566521759,0.0433803648432472,1.43607347436907e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,41913,-0.0159615417308074,0.00367906553296448,-0.0231725101754178,-0.00875057328619701,1.4453037322125e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0125912424319647,0.00290478096495032,-0.0182846131232673,-0.00689787174066207,1.4704370498534e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42224,-0.0284170854985613,0.00660447532518421,-0.0413618571359224,-0.0154723138612003,1.69904865564974e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.0134260671530997,0.00312558771134616,-0.0195522190673382,-0.00729991523886123,1.75484757049018e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0215836465455406,0.0050267834953176,-0.0314361421963631,-0.0117311508947181,1.77155685771602e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.026746288708955,0.0062313068664654,0.0145329272506828,0.0389596501672272,1.78385881674598e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.0480975512138406,0.011258990037065,-0.0701651716864881,-0.0260299307411931,1.95375521230033e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0197516583885264,0.00463426156278783,-0.0288348110515905,-0.0106685057254622,2.0389296061682e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0164980422364175,0.00387251949349595,-0.0240881804436695,-0.00890790402916543,2.05527448576904e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.0175974788692686,0.00413123028839702,-0.0256946902345268,-0.00950026750401048,2.06151225298427e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42016,-0.0192644031015426,0.00452353264553448,-0.0281305270867902,-0.010398279116295,2.07012334126236e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,-0.0119272366160335,0.00280460682181086,-0.0174242659867828,-0.0064302072452842,2.1260241910496e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42310,0.028351769183271,0.0067038727535719,0.0152121785862701,0.0414913597802719,2.36084573321837e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0295764055839898,0.00699591521778941,0.0158644117571226,0.0432883994108571,2.37680219650172e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0382887278101686,0.00906110450861529,0.0205289629732826,0.0560484926470546,2.39895249938509e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0091465174245649,0.00216487254676475,-0.0133896676162238,-0.004903367232906,2.40545357253232e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0147258551209758,0.00349591431451866,-0.0215778471774323,-0.0078738630645192,2.54733095406043e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42187,-0.0123995702908074,0.00294507518479031,-0.0181719176529964,-0.00662722292861837,2.56704134760952e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0155940704942938,0.00370743636436884,-0.0228606457684567,-0.00832749522013088,2.61739877135393e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.02790438867914,0.00666343941782755,-0.040964729938082,-0.014844047420198,2.8394049018383e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42286,-0.0136829638029943,0.00326860818046645,-0.0200894358367086,-0.0072764917692801,2.85469007565909e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,-0.0171801521317277,0.00410661875640804,-0.0252291248942874,-0.00913117936916791,2.88870523773674e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0126444576023244,0.00302281025721035,-0.0185691657064567,-0.00671974949819211,2.89461746073919e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42079,-0.0129704514904833,0.00310249331755891,-0.0190513383928987,-0.00688956458806779,2.92507611870763e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,39736,-0.0177929309968729,0.00425977667077101,-0.0261420932715841,-0.00944376872216173,2.97678635665925e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0282195526430792,0.0067657563150021,0.0149586702656751,0.0414804350204833,3.05243565269995e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0225147430808433,0.00540919395819692,-0.0331167632389093,-0.0119127229227774,3.16979192751268e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0256543517863529,0.00617218559225953,-0.0377518355471816,-0.0135568680255242,3.25619684807541e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0162883782151678,0.00391881151485531,-0.0239692487842842,-0.00860750764605136,3.25657519856741e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPL,Periplakin,39657,-0.0145146077744836,0.0034939218641475,-0.0213626946282127,-0.00766652092075448,3.28817327107654e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,41913,-0.0208894252850352,0.00503565658399225,-0.03075931218966,-0.0110195383804104,3.37029607482629e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42310,0.0289854814450923,0.00699095829749713,0.015283203181998,0.0426877597081867,3.40163634506061e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0190786306263044,0.00460217654033821,-0.0280988966453673,-0.0100583646072415,3.4150276339753e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,0.0387347693830261,0.00936980739258921,0.0203699468935513,0.0570995918725009,3.58656946059991e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0172400374507799,0.00417202095426623,-0.0254171985211418,-0.00906287638041813,3.61729420220174e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0486817580195688,0.0117880096250969,-0.0717862568847587,-0.0255772591543789,3.65778532163766e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39358,-0.010840508551655,0.00263042350470494,-0.0159961386208767,-0.00568487848243333,3.79725397488055e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0178015744406126,0.00432268177590862,-0.0262740307213935,-0.00932911815983166,3.84149941900737e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.0472810702932725,0.0114832722990846,0.0247738565870668,0.0697882839994783,3.85470103329781e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0189322219149893,0.00460799640610748,-0.02796389487096,-0.00990054895901866,4.00480078074247e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,-0.0180191477280909,0.00439650860486881,-0.0266363045936338,-0.00940199086254804,4.18711370802939e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.0268249262409698,0.00654600891941995,-0.0396551037230329,-0.0139947487589067,4.19376039975412e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0188135813312021,0.0046024002992552,-0.0278342859177423,-0.00979287674466194,4.38013688346529e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42070,-0.0329785347936615,0.00807164780776983,-0.0487989644968903,-0.0171581050904326,4.41938202981754e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42070,0.0172519630269047,0.00423229088611943,0.00895667289011061,0.0255472531636988,4.60264559476462e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0260339097100001,0.00639002133480722,-0.0385583515262222,-0.0135094678937779,4.64458466062088e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0408351038736703,0.0100372432249576,-0.0605081005945872,-0.0211621071527534,4.76187345570172e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAX,Protein max,41839,-0.046680251074731,0.0114919974473325,-0.0692045660715027,-0.0241559360779593,4.89389115629453e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42144,-0.0129860507327231,0.00320092718779811,-0.0192598680208074,-0.00671223344463881,4.99931950387919e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.026911665706733,0.00663510229917148,-0.0399164662131091,-0.0139068652003569,5.02636265765053e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FN1,Fibronectin,39979,-0.0119561465163482,0.00294940483983545,-0.0177369800024256,-0.00617531303027068,5.07388171203914e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0153801227784764,0.00380232489892915,-0.0228326795803775,-0.00792756597657525,5.2635160770947e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.00966582867269686,0.00239056836549921,-0.0143513426690753,-0.00498031467631842,5.2997101913894e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0258819906749129,0.00640680293927877,-0.0384393244358993,-0.0133246569139265,5.38000811492823e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0327882946418277,0.00812045380272066,-0.0487043840951602,-0.0168722051884952,5.42670578179468e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REN,Renin,42145,0.0354216803766948,0.00877868836883169,0.0182154511737847,0.0526279095796049,5.49108822254219e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,0.0326694189853513,0.00809705235091427,0.0167991963775594,0.0485396415931433,5.49658772385595e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,41913,-0.0210222393682952,0.00521109975576573,-0.031235994889596,-0.0108084838469944,5.51116212599105e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0234374486418344,0.00581445478315551,-0.0348337800168192,-0.0120411172668496,5.5868375011436e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0328984571849055,0.00817333776184679,-0.0489181991981252,-0.0168787151716858,5.72702105600641e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.0231211827912834,0.00574831930424311,-0.0343878886275999,-0.0118544769549669,5.79591448490439e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,41959,-0.0188378679930467,0.00468531434970052,-0.0280210841184598,-0.00965465186763372,5.8364087179261e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0163542871172389,0.004072508938175,-0.0243364046360619,-0.00837216959841593,5.95754395981542e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.01853863544935,0.00462133959487363,-0.0275964610553023,-0.0094808098433977,6.06492416490974e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.0128292579543683,0.003205890684776,-0.0191128036965293,-0.00654571221220734,6.32075235499523e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0146639688452522,0.00366484117050091,-0.021847057539434,-0.00748088015107038,6.34185528236899e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0287915289891019,0.00719841173822136,-0.0429004159960158,-0.0146826419821881,6.37563657412206e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.0281792577266519,0.00704533140275813,0.014370408177246,0.0419881072760578,6.37656800294273e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,0.0205778205488351,0.00515486779116351,0.0104742796781547,0.0306813614195156,6.59524324999516e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0115589295215447,0.00289687296105809,-0.0172368005252185,-0.0058810585178708,6.64477383784869e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0140273158129808,0.0035168112596041,-0.0209202658818048,-0.00713436574415678,6.67965370987458e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,39930,-0.0498614274761775,0.0125249923034112,-0.0744104123908636,-0.0253124425614915,6.90673637354951e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0156325231469545,0.00393002101668424,-0.0233353643396557,-0.00792968195425343,6.99418956413657e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0245057165264321,0.00616752141355082,-0.0365940584969917,-0.0124173745558725,7.13201773882604e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.0244041986907071,0.00614464037269287,-0.0364476938211851,-0.0123607035602291,7.17620795292451e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFB,Complement factor B,39794,-0.0140630296176136,0.00354307972772527,-0.0210074658839551,-0.00711859335127205,7.25787101648535e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42070,-0.00648655685889168,0.00163582910242915,-0.00969278189965282,-0.00328033181813055,7.36819337091797e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0122405117310015,0.00308730953584604,-0.0182916384212597,-0.00618938504074323,7.38367667538775e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42116,-0.0173328541012051,0.00437463480326038,-0.0259071383155954,-0.00875856988681475,7.46668779032307e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42249,-0.0157748041403131,0.00398366922502112,-0.0235827958213544,-0.00796681245927167,7.53718039446713e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0351806677247336,0.00888961992838119,-0.0526043227843607,-0.0177570126651065,7.61242617142492e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,-0.0149202922651412,0.00376997750813011,-0.0223094481810763,-0.00753113634920623,7.61564434498791e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,-0.0215207201565031,0.00544126842712801,-0.032185606273674,-0.0108558340393322,7.69708126238726e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0463476335209745,0.0117391597801829,-0.069356386690133,-0.023338880351816,7.92653766681384e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42249,-0.00969015893477222,0.00245934752311672,-0.014510480080081,-0.00486983778946346,8.18416388852057e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0408029212929762,0.0103596708925455,-0.0611078762423654,-0.0204979663435869,8.23581763973191e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0118490234557063,0.00300991944516906,-0.0177484655682377,-0.00594958134317493,8.30362582216863e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0183678679690882,0.00467068760568505,-0.0275224156762309,-0.00921332026194547,8.44575193576907e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.011659780482585,0.00296704261486908,0.00584437695744161,0.0174751840077284,8.55464293984748e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.0295917280537019,0.0075425257287856,-0.0443750784821217,-0.0148083776252822,8.7770285459662e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.021746180019148,0.00554540997299428,-0.0326151835662168,-0.0108771764720792,8.84422236600335e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,41913,-0.0203948650033423,0.00520092202637304,-0.0305886721750335,-0.0102010578316512,8.84796074485649e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDK,Midkine,42129,-0.0216360443969467,0.00553120420407877,-0.0324772046369411,-0.0107948841569523,9.21220136559645e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0220230222037418,0.0056335144032866,0.0109813339733001,0.0330647104341836,9.30303213335168e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,-0.0172815362305799,0.00442145223292907,-0.0259475826071208,-0.00861548985403891,9.33867413385479e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,39518,-0.018604391539465,0.00476707345924735,-0.0279478555195898,-0.00926092755934022,9.57024937908548e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0224656097650221,0.00576766608747094,0.0111609842335791,0.0337702352964652,9.872463695019e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.017106328520721,0.00439551530072487,0.00849111853130025,0.0257215385101418,0.000100085880487031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.00901209560409481,0.00231688022199313,-0.0135531808392013,-0.00447101036898829,0.000100827927863781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,39657,-0.0149578297136534,0.00385361243543364,-0.0225109100871034,-0.00740474934020351,0.000104413695917579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,41800,-0.0201814433673747,0.00520043704188795,-0.0303742999694751,-0.00998858676527431,0.000104653774830203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0272466571114973,0.00702436848912991,-0.0410144193501919,-0.0134788948728027,0.00010553044746779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0152441570012962,0.0039355410994761,-0.0229578175562694,-0.00753049644632306,0.000107904941117009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0198101812588441,0.00512930529805849,-0.0298636196430387,-0.00975674287464945,0.000112927143133635
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.0151660988765528,0.00392805824793457,-0.0228650930425046,-0.00746710471060106,0.000113473713969725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,-0.00772980219884322,0.0020034051355153,-0.0116564762644532,-0.00380312813323323,0.000114794723000072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,-0.0143089131226608,0.00371113944785862,-0.0215827464404637,-0.00703507980485794,0.000116051662998469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42217,-0.019418902309251,0.00503767076775206,-0.029292737014045,-0.00954506760445695,0.000116385814139609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0275567369545162,0.00715100549342196,-0.0415727077216233,-0.0135407661874092,0.000116956987880625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42296,0.0127401789601644,0.00330690922933958,0.00625863687065883,0.01922172104967,0.000117405815908537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0252161742612205,0.00654941410601168,-0.0380530259090034,-0.0123793226134376,0.000118588457618132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.0249856859932125,0.00649400629405878,-0.0377139383295677,-0.0122574336568573,0.000119873962521445
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0361750947258178,0.00940664744785627,0.0177380657280195,0.0546121237236161,0.000120869568056737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,39736,0.0159220776609843,0.00414995845197929,0.00778815909510489,0.0240559962268637,0.000125395528447965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,-0.0128346107203721,0.0033464536742882,-0.019393659921977,-0.00627556151876724,0.000125979198615503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0246890605018381,0.00644317181649677,0.0120604437415045,0.0373176772621718,0.000127885216238199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,0.031429660751935,0.00825603677763371,0.015247828667773,0.0476114928360971,0.000141357401478631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,0.0115992468078439,0.00304919959416473,0.00562281560328106,0.0175756780124068,0.000143107099883821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,39929,-0.0117944838036513,0.00310464567634892,-0.0178795893292951,-0.00570937827800737,0.000146053078635263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,-0.011635344552611,0.00306433699559357,-0.0176414450639744,-0.0056292440412476,0.000147086202601184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0119557420705429,0.00314915152569052,-0.0181280790608963,-0.00578340508018952,0.000147395970747225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0340522944588323,0.00898469563393124,-0.0516622979013375,-0.016442291016327,0.000151279879665507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42070,-0.0173594675137246,0.00460310445490959,-0.0263815522453474,-0.00833738278210179,0.000163125098996188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0238858657983406,0.00634330614107619,-0.0363187458348499,-0.0114529857618312,0.000167055851601708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.011575749906714,0.00307631610157259,-0.0176053294657963,-0.00554617034763174,0.000168683598298062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.012412582022972,0.00330012403067222,-0.0188808251230896,-0.00594433892285448,0.000169774727131899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.0106764770910153,0.00283966927496109,0.00511072531209158,0.016242228869939,0.000170945924284228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.0152215662118739,0.00404968263692372,-0.0231589441802444,-0.00728418824350342,0.000171508826054846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42018,-0.0194680293048599,0.00518318512661719,-0.0296270721530296,-0.00930898645669017,0.000173382559783177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,0.0215957625239622,0.00575278107849871,0.0103203116101048,0.0328712134378197,0.000174784290867151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0128776100534973,0.00343060175344762,0.00615363061673998,0.0196015894902546,0.000174933958705703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0513116952673018,0.0136764777887638,-0.0781175917332788,-0.0245057988013247,0.000176445758311117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0177970295192999,0.00474758693457178,-0.0271022999110606,-0.0084917591275392,0.000178542915096097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0208612125002122,0.00556660623525671,0.00995066427910908,0.0317717607213154,0.000179444360944759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0223817873325761,0.00597403504154828,-0.0340908960140107,-0.0106726786511415,0.00018004692825208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42070,0.0287534924077311,0.00767770739326877,0.0137051859169243,0.0438017988985379,0.000181100326470098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.0246609915853563,0.00658617725828659,-0.037569899011598,-0.0117520841591146,0.000181619668259236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,-0.00861765780757371,0.00230140250247078,-0.0131284067124164,-0.00410690890273099,0.000181646308539162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0500939503740542,0.0133959060378157,-0.076349926208173,-0.0238379745399355,0.000185172620765131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,41839,0.0146308712386802,0.00392056954143664,0.00694655493746438,0.022315187539896,0.000190894210826778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0161392493143725,0.00432543595644559,-0.0246171037890059,-0.00766139483973915,0.000191469678902549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.0309902338632216,0.00832046557434483,-0.0472983463889375,-0.0146821213375057,0.000196439560130398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.0236317065972228,0.00636074205785005,-0.0360987610306089,-0.0111646521638367,0.000203825448240068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00864825186333655,0.00232775240470245,-0.0132106465765533,-0.00408585715011976,0.000203954609559496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0437534587355063,0.0117902922258707,-0.0668624314982128,-0.0206444859727997,0.00020729426493417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,39908,-0.0245324725644952,0.00661456132099744,-0.0374970127536502,-0.0115679323753402,0.000209191956352359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.0281799950642037,0.00759859348852445,-0.0430732383017116,-0.0132867518266958,0.000209421311165563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0115539574468167,0.00311857442737942,-0.0176663633244804,-0.00544155156915309,0.00021233662718572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.0245087773434512,0.00661594207996701,-0.0374760238201866,-0.0115415308667159,0.000212662516942454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0138346363276953,0.00374137807471511,-0.021167737354137,-0.00650153530125373,0.000218404040288899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.035210311888669,0.00952795763156989,-0.053885108846546,-0.016535514930792,0.000220537309776053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42262,0.0160485780433363,0.00434691814160866,0.00752861848578338,0.0245685376008893,0.000223412753600141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42048,-0.0231716124481037,0.00628292494678083,-0.0354861453437941,-0.0108570795524132,0.00022688757928966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,-0.0278347900540934,0.00757101903135267,-0.0426739873555446,-0.0129955927526422,0.000237404043408543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSPN,Claspin,41820,-0.0141403465429012,0.00384861836833016,-0.0216836385448283,-0.00659705454097409,0.000239598516536931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0194155138075815,0.00528727153512767,0.00905246159873128,0.0297785660164318,0.000241470663608092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.0262427592384127,0.00714738743764366,0.0122338798606311,0.0402516386161942,0.000242087836336896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0142664654818553,0.00389741901436076,0.00662752421370819,0.0219054067500024,0.000252914325361221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42119,0.0155802815214302,0.00426444255722433,0.00722197410927054,0.0239385889335899,0.000259634786380088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,0.0103667227019127,0.00284214815749803,0.00479611231321661,0.0159373330906089,0.000266009005291755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42070,0.013855427303084,0.00380263645192341,0.00640225985731413,0.0213085947488539,0.000269822363270484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.013680090919548,0.00375634058954427,-0.0210425184750548,-0.00631766336404125,0.000271875174766463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0227416617891673,0.00625030537033108,-0.0349922603150162,-0.0104910632633184,0.000275260014756608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,0.0119011061871922,0.00327779983497307,0.00547661851064502,0.0183255938637395,0.000283572313528482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0107267680622328,0.00295505218368413,-0.0165186703422537,-0.00493486578221188,0.000284484051576141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0109371876225671,0.00301302869211934,-0.016842723859121,-0.00503165138601319,0.000284741085258397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42296,-0.0228830088142168,0.00631837390564685,-0.0352670216692846,-0.0104989959591489,0.00029377485589747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,-0.0222333584409751,0.00614734958708838,-0.0342821636316683,-0.0101845532502819,0.00029966874477307
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0143248672269103,0.00396884899747295,-0.0221038112619573,-0.00654592319186331,0.000308318234427142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.02868768469592,0.00795749081943467,-0.0442843667020119,-0.013091002689828,0.000313120353976434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.0117659531079545,0.00327010672293556,-0.0181753622849082,-0.00535654393100077,0.00032199850471765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.0378892387490229,0.010559648282355,0.0171923281156072,0.0585861493824387,0.000334258078291387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0144532318194321,0.00402875674088205,-0.0223495950315609,-0.00655686860730325,0.000335271569979558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,0.0171784477373458,0.00478903133707535,0.00779194631667817,0.0265649491580135,0.000335633194786724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.0114028129502794,0.00317936451611929,-0.0176343674018733,-0.00517125849868563,0.000336319253114158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0140813695406021,0.00395532565518785,-0.0218338078247703,-0.00632893125643394,0.0003719904334205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,39802,0.00902174294413007,0.00253504754566405,0.00405304975462853,0.0139904361336316,0.000374085587348925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,0.0253782126151899,0.00716394130674659,0.0113368876539666,0.0394195375764133,0.000397998055591385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0108933105648265,0.00308290042585479,-0.0169357953995019,-0.00485082573015116,0.000411521573485503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42181,0.0207041915269646,0.00586478178705019,0.0092092192243462,0.0321991638295829,0.000416529327729767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0134296690934667,0.00380482885507364,-0.020887133649411,-0.00597220453752235,0.000417508727680287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.0187672349435266,0.0053175075389718,-0.0291895497199113,-0.00834492016714188,0.000418298673856843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.05561908140095,0.0157854487121933,0.0246796019250511,0.0865585608768488,0.000427410954033939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,39960,0.0142723771237168,0.00405357857169829,0.00632736312318812,0.0222173911242454,0.000431717387008859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0266915384754989,0.0075826970550022,-0.0415536247033033,-0.0118294522476946,0.000433144787350551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0317036865262419,0.00901202197961394,-0.0493672496062852,-0.0140401234461985,0.000436696091010272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42211,0.0231975159511756,0.00659579822975656,0.0102697514208528,0.0361252804814985,0.000437851959672939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.0120787572115688,0.00343523111096385,-0.018811810189058,-0.00534570423407967,0.000439332757190327
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,39929,0.0262171776897697,0.00745853812020311,0.0115984429741716,0.0408359124053678,0.000441378860806159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0138701003497823,0.00394862775259818,-0.0216094107448747,-0.00613078995468986,0.00044514068055531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0110925554915698,0.00316359717877202,0.00489190502117665,0.017293205961963,0.000456132767930866
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0139062146271058,0.00397714027399116,0.0061110196900831,0.0217014095641284,0.00047285850997851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0350815209496396,0.0100462283126003,-0.0547721284423362,-0.015390913456943,0.00048093286454772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTD,Biotinidase,39979,0.0077424658230079,0.00222082392264379,0.00338965093462607,0.0120952807113897,0.000491592293826444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42262,-0.041768451271046,0.0119832786783603,-0.0652556774806321,-0.0182812250614599,0.000492646906023917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0231854132826295,0.00666029938402485,0.0101312264899408,0.0362396000753182,0.000500890653930971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0458309887855381,0.013167143251277,-0.071638589558041,-0.0200233880130352,0.000501664763093884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,39757,-0.062618895166843,0.0179973878221575,-0.0978937752982716,-0.0273440150354143,0.000504583651238181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.0106593211168065,0.00306381365401491,-0.0166643958786757,-0.00465424635493729,0.000504677842336565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,-0.0229431008802489,0.00660537920529102,-0.0358896441226193,-0.00999655763787853,0.000515536507669701
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.0102095597996597,0.0029460507730065,-0.0159838193147524,-0.00443530028456694,0.000531186627372616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0334076820698143,0.00966370251173081,-0.0523485389928067,-0.0144668251468219,0.000548209336365596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,39990,-0.0199837583497665,0.00578858623358189,-0.031329387367587,-0.00863812933194603,0.000557911792171227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0184232266306082,0.00533725654752123,-0.0288842494637498,-0.00796220379746661,0.000558527247371652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0169965105507311,0.00492502197028961,-0.0266495536124988,-0.00734346748896349,0.000560146840858468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2,Prothrombin,39979,-0.00554437332820683,0.0016095777843861,-0.00869914578560359,-0.00238960087081008,0.000573938573009754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSG,Basigin,42284,-0.00777564693524748,0.00225819270407462,-0.0122017046352337,-0.00334958923526122,0.000576370427407613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0194344834390947,0.00564459778330274,-0.0304978950943681,-0.00837107178382133,0.000577027996486666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0119315883476785,0.00346950652907095,-0.0187318211446576,-0.00513135555069947,0.000585662406851549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.0380387933251739,0.0110656402691467,0.0163501383976464,0.0597274482527015,0.000588737947939323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,39736,0.0360695855475256,0.0105033349137676,0.0154830491165411,0.0566561219785102,0.00059667314802287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.0114997864847437,0.00335077203900323,-0.01806729968119,-0.00493227328829735,0.000601382483231713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42088,-0.0268329287843791,0.00783252761239929,-0.0421846829046817,-0.0114811746640765,0.000614744466076005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42210,-0.0156459636077488,0.00456911235823434,-0.0246014238298882,-0.00669050338560953,0.000618226540493568
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,0.0313487681918552,0.00917695650441452,0.0133619334432028,0.0493356029405077,0.000637286063499436
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0289787973298258,0.00848436435195256,-0.0456081514596528,-0.0123494431999988,0.000638436625467391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0166202176500668,0.00486878084318289,-0.0261630281027052,-0.0070774071974283,0.000643281828311506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0125346251372387,0.00367959662736013,-0.0197466345268645,-0.00532261574761282,0.000659870424579534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42262,0.0173379793377545,0.00509574232526322,0.00735032438023856,0.0273256342952704,0.000669775176685797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0340089063779465,0.0100239786699011,-0.0536559045709526,-0.0143619081849405,0.000693949385470973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0160057005385735,0.00472456192936532,-0.0252658419201295,-0.00674555915701748,0.000707047320615161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0153786303856051,0.00454842435667874,-0.0242935421246954,-0.00646371864651472,0.000724067803674474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.013386456907011,0.00396170781136692,-0.0211514042172902,-0.00562150959673182,0.000729658099836047
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,-0.0223636329960595,0.00662176365865507,-0.0353422897670235,-0.00938497622509559,0.000734095514011404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42087,-0.0241516026662343,0.00715224817613466,-0.0381700090914582,-0.0101331962410103,0.0007354557121532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.0278645870870232,0.00825339900236291,-0.0440412491316545,-0.0116879250423919,0.00073718518517873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0115475647904827,0.00342737473345252,-0.0182652192680496,-0.00482991031291577,0.000755938392819305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42062,-0.011740154945721,0.00348492709844615,-0.0185706120586754,-0.00490969783276653,0.000756975299365118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0232592605333927,0.00692118856897577,-0.0368247901285853,-0.00969373093820023,0.00078040595311391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,41864,-0.0180499574928454,0.00537835487776894,-0.0285915330532725,-0.00750838193241828,0.000792899747286739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.0202230898694027,0.00602738574205767,-0.0320367659238357,-0.00840941381496964,0.000795291989131472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.0184662524023123,0.00550388549808475,-0.0292538679785584,-0.00767863682606618,0.000795965527510012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAYN,Layilin,41997,-0.0129543019039723,0.00386599496402813,-0.0205316520334674,-0.00537695177447713,0.00080791634395276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,39638,0.0284973758699902,0.00851421206210867,0.0118095202282572,0.0451852315117232,0.00081953394739781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0203066438250526,0.00606934493693468,-0.0322025599014446,-0.00841072774866066,0.000823235369907414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,0.00867253077839245,0.0025929497631697,0.00359034924257985,0.0137547123142051,0.000826080796299791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0305418651511761,0.00914251845781895,-0.0484612013285012,-0.0126225289738509,0.000838154969723101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.0264177079956483,0.00791042060299409,0.0109132836137799,0.0419221323775167,0.000841281971754792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.0107181055437977,0.00320933683502833,-0.0170084057404532,-0.00442780534714215,0.000841573482042171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0211778967438558,0.00634429814342636,-0.0336127211049715,-0.00874307238274014,0.000845831035574092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.00964802798857348,0.00289645760520369,-0.0153250848947727,-0.00397097108237425,0.000868258464461554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,-0.0101983775986186,0.00306199376997827,-0.0161998853877761,-0.00419686980946125,0.000869304589465353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0169778573584059,0.00509974183914603,-0.0269733513631321,-0.00698236335367964,0.00087338146455426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.0237435676711584,0.00713848028174029,-0.0377349890233694,-0.00975214631894747,0.000882900210692149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,-0.0306299090074649,0.00921142053945331,-0.0486842932647934,-0.0125755247501364,0.000885920404872758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0142108942209238,0.00428421130342971,-0.022607948375646,-0.00581384006620154,0.000912169146532603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0168409444576313,0.00508757095890248,-0.0268125835370802,-0.00686930537818248,0.000934744569139928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42137,-0.00934891998268156,0.00282549228686459,-0.0148868848649362,-0.00381095510042696,0.000939494335096938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,-0.0122787613905908,0.00371687504827844,-0.0195638364852166,-0.0049936862959651,0.000957833529516257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0115317392357838,0.00349315022940714,-0.0183783136854218,-0.00468516478614578,0.000965041267609551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42145,-0.0251716722344651,0.00763450520889664,-0.0401353024439026,-0.0102080420250277,0.000979426792007731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,41900,-0.00829007050315662,0.002514976433548,-0.0132194243129107,-0.00336071669340254,0.000982303709353411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0401398723365057,0.0121810071048201,-0.0640146462619532,-0.0162650984110583,0.000985758153027521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,39959,0.0104014261081375,0.00315777350017392,0.00421219004779666,0.0165906621684784,0.000991058750590457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0216602991508739,0.00658745184600025,-0.0345717047690344,-0.00874889353271341,0.00101177891733522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.0130177368519681,0.00396198465619784,-0.0207832267781159,-0.00525224692582035,0.0010205805770518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,0.0117032396854615,0.00356651679945081,0.00471286675853793,0.0186936126123851,0.00103596790518599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42119,-0.0278896317792804,0.0085156714715389,-0.0445803478634966,-0.0111989156950641,0.00105892249570203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0118639843980354,0.00362337001892457,-0.0189657896351276,-0.00476217916094327,0.00106189222192094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,39934,-0.0122958521256797,0.00375888746063498,-0.0196632715485243,-0.00492843270283516,0.0010743442080792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0184269376612813,0.00563505173760108,-0.0294716390669794,-0.00738223625558316,0.00107794055008918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.0176762248608831,0.0054106939429629,-0.0282811849890904,-0.00707126473267579,0.00109006720667884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.00948082668319902,0.00290436933881094,-0.0151733905872685,-0.00378826277912958,0.00110047032560215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.0119247722513461,0.0036645165906009,-0.0191072247689239,-0.00474231973376835,0.00114086439808703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,-0.00929848844378697,0.00285840650263308,-0.0149009651889478,-0.00369601169862613,0.00114513140629246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,39919,-0.00933410322857953,0.00287625061009764,-0.0149715544243709,-0.00369665203278816,0.0011769552508974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0305168901670169,0.00941014790490935,-0.0489607800606392,-0.0120730002733946,0.00118575890633612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,39850,-0.0346186143265582,0.0106772491839807,-0.0555460227271603,-0.013691205925956,0.00118923575114135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0273715356197523,0.00845251810158178,-0.0439384710988526,-0.010804600140652,0.00120603103191785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42119,-0.0193570413803332,0.00597788959916157,-0.0310737049946899,-0.0076403777659765,0.00120616288344906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0357209548869712,0.011035817967814,-0.0573511581038866,-0.0140907516700559,0.00121163321432347
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,-0.0147100272932387,0.0045569612258148,-0.0236416712958357,-0.00577838329064165,0.00124939911241558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0268176805988178,0.00831598361516608,-0.0431170084845433,-0.0105183527130923,0.00126349430253498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0186231984287791,0.00578122760926776,-0.0299544045429439,-0.00729199231461425,0.00127907139302431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0127216597990684,0.00394959152991858,-0.0204628591977089,-0.00498046040042802,0.00128045795187807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0236251428654414,0.00736598413081055,-0.03806247176183,-0.00918781396905269,0.00134284561127024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42224,-0.0240791971445961,0.00751705233721887,-0.038812619725545,-0.00934577456364706,0.00136185985983328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0217543103915079,0.00679356314381903,-0.0350696941533932,-0.00843892662962259,0.00136771667146709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,39638,0.0179380977697896,0.00560528929466016,0.00695173075225565,0.0289244647873235,0.00137716485692678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0248332790865072,0.00776901494859474,-0.0400605483857529,-0.0096060097872615,0.00139511459337903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0254430143783204,0.00796121571276043,0.00983903158130998,0.0410469971753309,0.00139729464843109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,-0.0139190214522485,0.00436805674122151,-0.0224804126650427,-0.00535763023945435,0.00144314151607126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.0193595309510041,0.00608763294867597,-0.031291291530409,-0.00742777037159918,0.00147535647375311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,-0.0180219442268075,0.00567268210641371,-0.0291404011553784,-0.00690348729823666,0.0014915677164041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.029189972701186,0.00919396766375162,-0.0472101493221391,-0.0111697960802328,0.00150221861641917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0201811326591474,0.00635776055828834,-0.0326423433533925,-0.00771992196490224,0.001505600595677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0134983469562191,0.00425368183902155,-0.0218355633607013,-0.00516113055173684,0.00151039846141137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,-0.0170033428375818,0.00537012398098883,-0.0275287858403199,-0.0064778998348437,0.00154742359141999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42217,0.019521020144507,0.00617101897739831,0.00742582294880629,0.0316162173402077,0.00156313740599577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0129727460362245,0.00410566533364877,-0.0210198500901761,-0.00492564198227293,0.00158269783628194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,-0.0294421420583244,0.00933181007334366,-0.0477324898020779,-0.0111517943145708,0.00160834131128252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.0203086982181097,0.00644639668177507,-0.0329436357143888,-0.00767376072183058,0.00163405122653483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.01206545375618,0.00383442710581677,-0.0195809308835809,-0.00454997662877915,0.00165532112533989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,0.0235388257337523,0.00749202458696346,0.00885445754330389,0.0382231939242007,0.00168245758257082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.0356372804091759,0.0113811964973864,-0.0579444255440532,-0.0133301352742986,0.00174443961959992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.0157486217971276,0.0050311562875987,-0.0256096881208211,-0.00588755547343417,0.00175055615309119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,39638,0.0174647978654693,0.00558647532606059,0.00651530622639052,0.028414289504548,0.00177502030402067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0314392481774174,0.0100932216526143,-0.0512219626165415,-0.0116565337382934,0.00184474432474637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,41910,-0.0246440791730395,0.00793507481693028,-0.0401968258142229,-0.00909133253185614,0.0019021854676166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.0186401678286764,0.00600983007630224,-0.0304194347782288,-0.00686090087912402,0.0019295417778272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,41992,0.0173700283923877,0.00560299300748361,0.00638816209771985,0.0283518946870556,0.00193834477170206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,41647,0.0206055628946968,0.00664924293739637,0.00757304673739994,0.0336380790519937,0.00194631473162717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.00962618578029103,0.00310941022847718,-0.0157206298281063,-0.00353174173247576,0.0019667091833988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALLD,Palladin,39657,-0.0127646097069782,0.00412670923438398,-0.0208529598063708,-0.00467625960758556,0.00198524770807414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,0.0152482545930503,0.0049304315075927,0.00558460883816864,0.024911900347932,0.00198840511954419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.020757049396957,0.00671322249826162,-0.0339149654935498,-0.00759913330036423,0.00199334297397638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0091504961270886,0.00295992967546276,-0.0149519582909956,-0.00334903396318159,0.00199658899959369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00722119503924773,0.00234257487508633,-0.0118126417944169,-0.00262974828407853,0.00205714419598066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,-0.0248341534796382,0.00805843290448951,-0.0406286819724376,-0.00903962498683877,0.00206274490494834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.0345665000619071,0.0112368714608356,0.0125422319986693,0.0565907681251448,0.00210098741555824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNST,Consortin,42145,0.0362262971795877,0.0117787166871895,0.0131400124726963,0.0593125818864791,0.00210517376497847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.0122349698820856,0.00398041040762793,-0.0200365742810363,-0.0044333654831348,0.00211769362181707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0112548709882773,0.00366265823870465,0.00407606084041618,0.0184336811361384,0.00212436179278773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0274306046805245,0.00893761046402227,-0.0449483211900081,-0.00991288817104087,0.00215115101688757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0184090310397091,0.00600199851448151,-0.0301729481280928,-0.00664511395132532,0.00216538804889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,41992,-0.0109206690574096,0.00356549570354658,-0.0179090406363609,-0.00393229747845829,0.00219656377937764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.00935512401179647,0.00305887253635181,-0.015350514183046,-0.00335973384054691,0.00223073609647226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.0193504037277843,0.0063426880066509,-0.0317820722208201,-0.00691873523474857,0.00228757576475046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.0175700549940312,0.00577764857737415,-0.0288942462056846,-0.00624586378237788,0.00236300701612529
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.0113234540271247,0.00372729249768561,-0.0186289473225884,-0.00401796073166086,0.0023870960771948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,39966,-0.0142081104654728,0.00468064793578723,-0.0233821804196158,-0.00503404051132988,0.00240680005772218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,-0.0177486575484206,0.00584884391224737,-0.0292123916164254,-0.00628492348041573,0.00241355505485516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,41839,0.021926748106294,0.00722994430004787,0.00775605727820015,0.0360974389343878,0.0024279051269226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,39575,-0.0102189806597851,0.00337179086275528,-0.0168276907507855,-0.00361027056878475,0.00244533457057231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0159391860805698,0.00526115383724292,-0.0262510476015659,-0.00562732455957366,0.00245341217380027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,39990,0.0071455561569248,0.00236019428549764,0.00251957535734943,0.0117715369565002,0.00247113661518643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.0157810308191244,0.00521518651670861,-0.0260027963918733,-0.00555926524637553,0.00248405320438997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,0.0191240699391028,0.00632453549743239,0.00672798036413534,0.0315201595140703,0.00250187820222083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0141913828570413,0.00469517707869623,-0.0233939299312859,-0.00498883578279669,0.00251138236925883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42016,-0.0183864303405859,0.00608667469155373,-0.0303163127360312,-0.00645654794514061,0.00252609516099789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,-0.0173491428192688,0.00574508368196546,-0.0286095068359211,-0.00608877880261648,0.00253481846156205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0224974954831837,0.00745786982584042,-0.0371149203418309,-0.00788007062453649,0.00256194298276912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0159576318649937,0.00529243458454368,-0.0263308036506993,-0.00558446007928807,0.00257397481361605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0268730615631921,0.00892346110495813,-0.04436304532891,-0.00938307779747419,0.00260436919625891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.00740189015213868,0.00247005750993753,-0.0122432028716162,-0.00256057743266112,0.00273455180999185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0144539616406224,0.0048363600630165,-0.0239332273641348,-0.0049746959171101,0.00280758728530261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,0.0165047377785323,0.00553203804141721,0.00566194321735454,0.02734753233971,0.00285491749860703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.0133401386692468,0.00447607721166268,-0.0221132500041056,-0.0045670273343879,0.00288574590988351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.0062401185822649,0.0020963022476501,-0.0103488709876591,-0.0021313661768707,0.00291956856775266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,0.0246969392575317,0.00830298116688285,0.00842309617044129,0.0409707823446221,0.00294015920346329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0179819702119853,0.00605145983034873,-0.0298428314794688,-0.0061211089445018,0.00296865267330172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_DRA,,42060,-0.0116650032107647,0.00392667012075212,-0.0193612766474388,-0.0039687297740905,0.00297635625837122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.0218437961925737,0.00735953084099861,-0.036268476640931,-0.00741911574421647,0.00300297392954479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0102895104262145,0.00347205238200176,-0.017094733094938,-0.0034842877574911,0.00304667707720247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.0131457590327793,0.00443912927812178,-0.021846452417898,-0.00444506564766059,0.00306834606817965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,39638,0.0171521945962395,0.00579204099689127,0.00579979424233258,0.0285045949501464,0.00306957084892814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,0.0100338138775126,0.00338939455161721,0.00339060055634282,0.0166770271986823,0.00307818850195416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0181724451279782,0.00614669265379436,-0.0302199627294152,-0.00612492752654126,0.00311731179679994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.0154691988207279,0.00523676912692565,-0.0257332663095022,-0.00520513133195362,0.00314371576850443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0317985171752245,0.0107779031749274,-0.0529232073980821,-0.0106738269523669,0.00318068626773577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.0161176841123763,0.00547030774761095,-0.0268394872976938,-0.00539588092705885,0.00322177988557993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42025,0.0230051531476827,0.00781525750122941,0.00768724844527303,0.0383230578500923,0.00324952875196351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0159255407636404,0.0054105633509078,0.00532083659586109,0.0265302449314197,0.00325281515107857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,-0.00824198893316133,0.0028059442095702,-0.0137416395839189,-0.00274233828240374,0.0033161039137671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0363773903330396,0.0123844823212496,-0.0606509756826888,-0.0121038049833904,0.00331711129335182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,41997,-0.0254047166285474,0.00866469043111687,-0.0423875098735364,-0.00842192338355833,0.00337375909945221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0287067132989626,0.00979629628308654,-0.0479074540138122,-0.00950597258411295,0.00339241046639911
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,-0.0236836567407327,0.00809792211308864,-0.0395555840823864,-0.00781172939907893,0.00345539298814119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.0290006650232614,0.00991843070799305,0.009560540835595,0.0484407892109277,0.00346240290210682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,-0.0115596374706589,0.00395559839693294,-0.0193126103286474,-0.00380666461267033,0.00347977061031374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0306907155164346,0.0105062173639549,-0.0512829015497862,-0.010098529483083,0.0034939723099172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0183011713142403,0.00626524931318,-0.0305810599680732,-0.00602128266040754,0.00349423504989799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,39959,-0.00457061450815586,0.00156633314635871,-0.00764062747501893,-0.00150060154129278,0.00352935777198846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0170526966277604,0.00584462356431614,-0.02850815881382,-0.00559723444170073,0.00353359678012135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.0161391738524674,0.00553633816333539,0.00528795105233002,0.0269903966526047,0.00356115682061435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,-0.0123203278083966,0.00422761583659797,-0.0206064548481286,-0.00403420076866456,0.00357260930670873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCN,Decorin,41900,-0.00724831368703673,0.00248860904921563,-0.0121259874234994,-0.0023706399505741,0.00359033708275954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.0127658048146365,0.00438385993822981,-0.0213581702935669,-0.00417343933570605,0.00359714131692329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0264898403146186,0.00910216363245121,-0.0443300810342229,-0.00864959959501418,0.00361820916904603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42016,0.0167127092349801,0.00574800416458537,0.00544662107239279,0.0279787973975674,0.00364848699648068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.00876481949562913,0.00301913930597108,-0.0146823325353324,-0.0028473064559258,0.00370236292956504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,39930,0.0299623222117295,0.0103291836343144,0.00971712228847323,0.0502075221349858,0.00372993497109583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0228856858419497,0.00789220188575794,-0.0383544015380352,-0.00741697014586409,0.00374030301544937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42107,-0.0125862594299377,0.00434804570159961,-0.021108429005073,-0.00406408985480251,0.00380136733436811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0102532129022304,0.00354212210821776,-0.0171957722343372,-0.00331065357012356,0.00380185209173531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.0186726113695579,0.00645197285758459,-0.0313184781704237,-0.00602674456869211,0.00380980349702594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0179146464891254,0.00619293923187514,0.00577648559465008,0.0300528073836006,0.0038250044805426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0150744068398554,0.00521244049353837,-0.0252907902071906,-0.00485802347252015,0.00383414293918486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42196,-0.00925998923671498,0.00320249070346165,-0.0155368710154998,-0.00298310745793015,0.00384019927340666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0375117932176796,0.0129727804491375,-0.0629384428979891,-0.0120851435373702,0.00384055359202814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0175423169635892,0.00607016807597066,-0.0294398463924917,-0.00564478753468668,0.00385943474113541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0191544560847631,0.00662790547645486,-0.0321451508186146,-0.00616376135091159,0.00386027677417886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0178699672056536,0.00618715602383761,-0.0299967930123753,-0.00574314139893188,0.00388021694605359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,0.0202767839021717,0.00703325353049541,0.00649160698240074,0.0340619608219427,0.00394556740100222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,39876,-0.014753602383498,0.00512566777345906,-0.0247999112194778,-0.00470729354751829,0.00400478832252572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0198921360133247,0.00691130005453557,0.00634598790643496,0.0334382841202144,0.00400693559995759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0147626120386436,0.00513146699375275,-0.024820287346399,-0.0047049367308882,0.0040239862558912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0161225345833219,0.00560741426265652,-0.0271130665381287,-0.00513200262851515,0.00404390233217643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0152334477126946,0.00530461606223135,-0.025630495194668,-0.00483640023072112,0.00408983008177217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42216,-0.0181824648199512,0.00633324242106139,-0.0305956199652315,-0.00576930967467087,0.00409862515555101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42262,0.00761470953838808,0.00265690344151993,0.00240717879300902,0.0128222402837671,0.00416317005413738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42119,-0.0199762337915536,0.00697452576694597,-0.0336463042947677,-0.00630616328833952,0.00418746066953339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0275170509288853,0.00961177484318811,-0.046356129621534,-0.00867797223623657,0.00420621905868646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42016,-0.00374232788893208,0.00131630752476609,-0.00632229063747362,-0.00116236514039055,0.0044751573596145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0116906667220939,0.00411738588813411,-0.0197607430628367,-0.00362059038135103,0.00452871221989234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42310,-0.0226787772031272,0.00800463601480362,-0.0383678637921423,-0.00698969061411209,0.00461510398851102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0162305540346685,0.00573677932713396,-0.027474641515851,-0.00498646655348593,0.00467450543969746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42016,0.0131727573659043,0.00465793684148824,0.00404320115658736,0.0223023135752212,0.00469056870993845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42119,-0.0103308942551334,0.00365714035520446,-0.0174988893513341,-0.00316289915893261,0.00473711663425955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.0157667212274031,0.00559172010727304,-0.0267264926376582,-0.00480694981714793,0.00481600653178163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.0147553022760438,0.00523565159738393,-0.0250171794069163,-0.00449342514517129,0.00483747882580313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00621931331103731,0.00220883114868666,-0.0105486223624632,-0.00189000425961145,0.00487635849322795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42145,-0.011834862668651,0.00421149570594343,-0.0200893942523002,-0.00358033108500192,0.00495920744322588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARTN,Artemin,41913,-0.0136980487244611,0.00488068360811323,-0.0232641885963631,-0.00413190885255918,0.00501425851229701
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,39657,-0.0289652266820424,0.0103231167000217,-0.0491985354140849,-0.00873191794999996,0.0050270090040326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,-0.0105385705417914,0.00375645630600547,-0.0179012249015622,-0.00317591618202072,0.00503163113909731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00710454222606481,0.00253411013591541,-0.012071398092459,-0.00213768635967062,0.00506127508200842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0129593326625015,0.00462487529818432,0.00389457707806026,0.0220240882469428,0.00508438609616012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.0148148304740933,0.00528855803203059,-0.0251804042168732,-0.00444925673131333,0.00509864786223507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0146701222393058,0.00524356766452516,-0.0249475148617751,-0.00439272961683649,0.00515489643755819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42070,-0.0105602411497906,0.003778809625562,-0.0179667080158921,-0.00315377428368903,0.00520382909988443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.00897451239326005,0.00321131570024365,-0.0152686911657376,-0.0026803336207825,0.00520428184864541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,39979,-0.00682356792491027,0.00244795329122411,-0.0116215563757095,-0.00202557947411101,0.00532113684215281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.0108696067921405,0.00390080193600877,-0.0185151785867177,-0.00322403499756329,0.00533682750066079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.0158210826297369,0.00568002161290689,-0.0269539249910344,-0.00468824026843935,0.00535535148053641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,39979,-0.00778608982791497,0.00279585482538631,-0.0132659652856721,-0.00230621437015781,0.00536378299858323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,39806,-0.0107613632805295,0.00386533490162873,-0.0183374196877218,-0.00318530687333717,0.0053771428909251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.0132951595190636,0.00478640673399469,-0.0226765167176932,-0.00391380232043398,0.00548390439078091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,41774,-0.0190997882358953,0.00688355848458169,-0.0325915628656754,-0.00560801360611518,0.00553310164879865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.0121714747471519,0.00438706206519285,-0.0207701163949299,-0.00357283309937393,0.0055396049370826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.0116472573431821,0.00420630516896539,-0.0198916154743543,-0.00340289921200992,0.00563069440362532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0121265879851485,0.00438574933114883,-0.0207226566742002,-0.00353051929609677,0.00569995052105605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,-0.00995076392590671,0.00359900298375685,-0.0170048097740701,-0.00289671807774329,0.00570236633859796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,39958,0.00909090991376368,0.00329321924728525,0.00263620018908459,0.0155456196384428,0.00578067089357204
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.0237149250120154,0.00859417998151962,-0.0405595177757939,-0.00687033224823698,0.00579821898006066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0105356767353332,0.0038247366886297,-0.0180321606450474,-0.00303919282561896,0.00588400838341399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0140725689874661,0.0051150150564897,-0.0240979984981859,-0.00404713947674626,0.00594529416913902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00766190315698786,0.00279335872503576,-0.0131368862580579,-0.00218692005591777,0.00609973281657606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,39649,-0.0171695377814179,0.00627065354731009,-0.0294600187341456,-0.0048790568286901,0.00618983998416267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0192349597637763,0.00702874538777594,-0.0330113007238171,-0.00545861880373543,0.00621575049773198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0159831687272778,0.00584281307556299,-0.0274350823553813,-0.00453125509917436,0.00623776385877613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42137,-0.0146848203482919,0.00537128079302709,-0.025212530702625,-0.00415710999395879,0.00626606350578526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.016171751684682,0.00592534996117641,-0.0277854376085878,-0.00455806576077623,0.00635599274549104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,-0.00930743321766035,0.0034148708837825,-0.016000580149874,-0.00261428628544665,0.00642937514266049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42119,-0.0130814480781287,0.00480087398838322,-0.0224911610953598,-0.00367173506089754,0.00644221086464218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,39934,-0.0227042241425706,0.00833437642707302,-0.0390396019396338,-0.00636884634550753,0.00645629199769084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42185,0.0195794415502767,0.00719019552624054,0.00548665831884528,0.0336722247817082,0.00647599596940937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0175170133299416,0.00644997941656885,-0.0301589729864166,-0.00487505367346667,0.00662129183465329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,39586,-0.0311525690868102,0.0114830880729754,-0.0536594217098419,-0.00864571646377848,0.00667993962444393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LXN,Latexin,41960,-0.0200825105431853,0.00740522540282783,-0.0345967523327278,-0.00556826875364273,0.00669767272944171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBN1,Drebrin,39657,-0.0149697896660067,0.00552555955199131,-0.0257998863879097,-0.00413969294410375,0.00675516328176249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0182708290876086,0.00675682474707888,-0.0315142055918832,-0.00502745258333404,0.00686012180137156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0161940359786088,0.00598998218507845,-0.0279344010613626,-0.00445367089585507,0.00686947333640202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0165412361030084,0.00612094667396148,-0.0285382915839729,-0.00454418062204391,0.00689289706146637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42262,-0.00863086455079167,0.00319602867134395,-0.0148950807466258,-0.00236664835495754,0.00693213629469545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0157555883724001,0.00583460488960354,-0.027191413956023,-0.00431976278877715,0.00693487425393302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.00646248790699114,0.0023935969496009,-0.0111539379282089,-0.00177103788577337,0.00694443726549905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.00852277398911471,0.00315763590041186,-0.014711740353922,-0.00233380762430747,0.00696158500659299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,41839,-0.0135358128004126,0.00502678678787299,-0.0233883149046437,-0.00368331069618154,0.00709574258788876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,41976,-0.0189623021103232,0.007044067305426,-0.0327686740289582,-0.00515593019168823,0.00711232309132555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,39822,-0.00916641964802854,0.00340548282142431,-0.0158411659780202,-0.00249167331803689,0.00712016943444984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.0111607548385365,0.00414759385368619,-0.0192900387917614,-0.00303147088531153,0.00713646029532255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.00873820809300596,0.0032532199304855,-0.0151145191567575,-0.00236189702925437,0.00724145397883818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0166277677778751,0.00619367268013954,-0.0287673662309486,-0.00448816932480158,0.00726961334943259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.01085121448332,0.00404296944967764,-0.0187754346046882,-0.00292699436195184,0.00728609248928236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42070,-0.0170984169623637,0.00637722735123983,-0.0295977825707938,-0.00459905135393363,0.00734550709991182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,41830,0.0143354547063937,0.00534969806532199,0.00385004649836256,0.0248208629144248,0.00737847781323549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.010975294845615,0.00409576586435906,0.0029475937514712,0.0190029959397587,0.00738044301409905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42255,0.00707124738369613,0.00264511423627437,0.00188682348059837,0.0122556712867939,0.00751929737909146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0166604119921062,0.00623717657234615,-0.0288852780739046,-0.00443554591030772,0.00756838781206147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.0182193242915383,0.00682363577799958,-0.0315936504164175,-0.00484499816665916,0.00759519428078435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0251964180097256,0.00944766226376339,-0.0437138360467018,-0.00667899997274931,0.00766541068316882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0131687110504805,0.00494164753939443,-0.0228543402276936,-0.0034830818732674,0.00771338367740372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,-0.018232346115845,0.00684555901393349,-0.0316496417831547,-0.0048150504485354,0.00774722343551277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0166290026082593,0.00624607623259317,-0.028871312024142,-0.00438669319237672,0.00776976102423962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0345810655232012,0.0129993488791853,-0.0600597893264044,-0.00910234171999796,0.00781824421799861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0208021934505373,0.00782150224044168,-0.036132337841803,-0.00547204905927156,0.00783239510198731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0103628995150233,0.00389941191091007,-0.0180057468604071,-0.00272005216963959,0.00788022590642082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,41843,-0.0210410307980087,0.00792492873934717,-0.0365738911271291,-0.0055081704688882,0.00793930395769587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0109181510620412,0.00411666932572305,-0.0189868229404584,-0.00284947918362403,0.0080066956465396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,0.0220426201693469,0.00834719486293967,0.00568211823798515,0.0384031221007086,0.00828427917657725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.0148175619267561,0.00561590412932465,-0.0258247340202324,-0.00381038983327977,0.00833914700904891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42262,0.00746046946384054,0.0028295350614247,0.00191458074344813,0.013006358184233,0.00838259927461225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42145,-0.00896119719274855,0.00340084037467609,-0.0156268443271137,-0.00229555005838341,0.00842343188097051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0321641599046165,0.0122154018181115,-0.056106347468115,-0.00822197234111809,0.0084709150952495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,0.0163341391048594,0.00620644201459087,0.00416951275626133,0.0284987654534575,0.00850476490458687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00699740101963399,0.00266385676427988,-0.0122185602776225,-0.00177624176164543,0.00863096945875249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0174409088338967,0.00664743565133529,-0.0304698827105139,-0.00441193495727957,0.00870789001015358
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0160925689449845,0.0061399042093979,-0.0281267811954044,-0.00405835669456461,0.00877757630610744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,-0.00753149967091843,0.00287748564928239,-0.0131713715435119,-0.00189162779832494,0.0088727196402902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0283952482730797,0.0108901261226973,-0.0497398954735664,-0.00705060107259302,0.00913240543632382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0263890620555103,0.0101380115520631,-0.046259564697554,-0.00651855941346665,0.00925180741026855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.00697458452365812,0.00267961661037316,-0.0122266330799895,-0.00172253596732674,0.0092577795818022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TF,Serotransferrin,39979,0.00603003692835448,0.0023204815643334,0.00148189306226101,0.010578180794448,0.00937215457869537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,41883,-0.0248930892604614,0.00958586286161722,-0.0436813804692312,-0.00610479805169169,0.00941855040701293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.018431563941846,0.00710479542277392,0.00450616491320913,0.0323569629704829,0.0094901489265257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0184183767402186,0.00710592096323875,-0.0323459818281665,-0.00449077165227064,0.00955528615906281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.0237740616695783,0.0091727085222105,-0.0417525703731109,-0.00579555296604571,0.00955711644549484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,-0.0158351626063528,0.00611734682080765,-0.0278251623751358,-0.00384516283756977,0.00964797265637978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0147882233077431,0.00571295931265476,0.00359082305493972,0.0259856235605464,0.00964891360433268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0118806329562578,0.00459230887454316,-0.0208815583503624,-0.00287970756215318,0.00968973824098795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,0.00849287844499483,0.00328846661825306,0.00204748387321883,0.0149382730167708,0.00981758706941049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.013503628495325,0.00523932837902729,-0.0237727121182185,-0.00323454487243156,0.00996659084091139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.00742371776437267,0.00288359719660501,-0.0130755682697185,-0.00177186725902685,0.0100500685191095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-0.0136234578899247,0.00529248571992741,-0.0239967299009824,-0.00325018587886697,0.0100627150345123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0126767167190951,0.0049282011156856,-0.0223359909058388,-0.00301744253235128,0.0101138195262382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0194960220421794,0.00758668384416405,-0.034365922376741,-0.00462612170761788,0.0101895347067614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.0195019528446325,0.00759053155331834,-0.0343793946891364,-0.00462451100012851,0.010202492275603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00799510632494059,0.00311344003770288,0.00189276385104295,0.0140974487988382,0.0102433556699916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.00656830357236016,0.00255887575736743,-0.0115837000568003,-0.00155290708791999,0.0102726864903564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.0225953334841784,0.00881214528891026,-0.0398671382504425,-0.0053235287179143,0.010354592596909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0128412843855421,0.00500882095926867,0.00302399530537554,0.0226585734657087,0.010368387144021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,-0.0123409577541962,0.00481611565965642,-0.0217805444471228,-0.00290137106126962,0.0104049968048171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42119,-0.0132376679052674,0.00516716640266728,-0.0233653140544953,-0.00311002175603957,0.0104214263793357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42264,-0.00570491808149697,0.00222808487733925,-0.0100719644410819,-0.00133787172191203,0.0104640763586274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0106891786401806,0.00417645495887014,-0.0188750303595661,-0.00250332692079514,0.0104963600990816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,39930,-0.0217437915213095,0.00852001978065018,-0.0384430302913838,-0.00504455275123511,0.0107211292910554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0188303133981681,0.00738290827021417,-0.0333008136077878,-0.0043598131885483,0.0107690296960455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,39990,-0.00667278365329897,0.00261706972935704,-0.0118022403228388,-0.00154332698375917,0.0107940644834806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0209482833122994,0.00821932503144998,0.00483840625065743,0.0370581603739413,0.0108246150661444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0153552827812339,0.00602814958691705,-0.0271704559715913,-0.00354010959087649,0.0108681187920059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.00970161078642419,0.00381044445809211,-0.0171700819242847,-0.00223313964856365,0.0109078588687513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.00942416166168518,0.0037055936727746,-0.0166871252603234,-0.00216119806304697,0.0109944135912941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,0.0199528129429744,0.00785740332897578,0.00455230241818184,0.0353533234677669,0.0111190789908304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.008097104208101,0.00319021118893188,-0.0143499181384075,-0.00184429027779451,0.0111564557186269
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0173080831119069,0.00682144108431365,-0.0306781076371616,-0.00393805858665214,0.0111846500023282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0125618121502827,0.00495703199388485,-0.022277594858297,-0.00284602944226845,0.0112857235575431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0134233196025847,0.00530237931332748,-0.0238159830567066,-0.00303065614846288,0.011369224929575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0174201163915605,0.00688300532171552,0.00392942596099804,0.0309108068221229,0.0113908256553278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0135887174453776,0.00537322656318628,-0.0241202415092228,-0.00305719338153252,0.0114539511265345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42137,-0.0122260039834329,0.00483465041192355,-0.021701918790803,-0.00275008917606275,0.0114556410573631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.00697048021680553,0.00275736793772959,-0.0123749213747555,-0.00156603905885553,0.0114866057091318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0203755789429053,0.0080636192900292,-0.0361802727513625,-0.00457088513444802,0.0115203861938028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0131193474264166,0.00519187798244284,-0.0232954282720046,-0.00294326658082867,0.0115209735384745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,0.016630125342805,0.00658444970225729,0.00372460392638075,0.0295356467592293,0.0115618544217403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.023788600131411,0.00942159483965598,-0.0422549260171367,-0.00532227424568527,0.0115868377223551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,-0.0230964204700818,0.00915045333522677,-0.0410313090071263,-0.00516153193303734,0.0116143282850614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.00806287782006538,0.00320342562140851,-0.0143415920380261,-0.0017841636021047,0.011848787832405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,39930,-0.00842445902741631,0.00334707422964309,-0.0149847245175168,-0.00186419353731585,0.0118508449901818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0163191620230709,0.00648390427221029,-0.0290276143966031,-0.0036107096495387,0.0118517736425753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.00841398766621925,0.00334475888824144,-0.0149697150871725,-0.00185826024526603,0.011897598776991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0196324872800081,0.00780697710269169,-0.0349341624012838,-0.00433081215873241,0.0119239030838088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0231233598874696,0.00922045196088294,-0.0411954457308002,-0.00505127404413908,0.0121616176150847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0129053384524175,0.00514910947952522,-0.022997593032287,-0.0028130838725481,0.0122132370672789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.00606121289093183,0.00241866130652846,-0.0108017890517276,-0.00132063673013605,0.0122214392910901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0100098235197991,0.00399793310228804,-0.0178457724002836,-0.00217387463931452,0.0123004333905999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0190623302103059,0.00761406900552772,-0.0339859054611402,-0.00413875495947153,0.0123091554294802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42137,-0.00538999570799033,0.00215455322883371,-0.0096129200365044,-0.00116707137947625,0.0123723816364419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0196451957822721,0.00785920800642077,-0.0350492434748568,-0.00424114808968744,0.0124436922455846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0183636598781185,0.00735231332616578,-0.0327741939974035,-0.0039531257588336,0.0125129833166593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0104335615280288,0.0041789172366328,-0.0186242393118291,-0.00224288374422849,0.0125468046212534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0259997757932174,0.0104319869177374,-0.0464464701519828,-0.00555308143445211,0.0127059675440651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,-0.00793919004288645,0.00318605422164739,-0.0141838563173153,-0.00169452376845756,0.0127198186000398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,39657,-0.00798580618572807,0.00320637004766747,-0.0142702914791563,-0.00170132089229984,0.0127670861867217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0209472820955404,0.00841574434572368,-0.0374421410131588,-0.00445242317792195,0.0128201439735688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.00785070896179507,0.00315562652968504,-0.0140357369599778,-0.00166568096361239,0.0128662407623452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.0108067326194948,0.00435156731876841,-0.0193358045642809,-0.00227766067470874,0.0130278808578466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.0224830460430707,0.00905464401043101,-0.0402301483035155,-0.00473594378262595,0.013041244766819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0174015063150996,0.00701624681390548,-0.0311533500703544,-0.00364966255984489,0.0131438865311798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.012171545990686,0.00490962672906845,-0.0217944143796601,-0.00254867760171183,0.013185196873377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,41997,-0.0123003718375401,0.00496198858835028,-0.0220258694707067,-0.00257487420437358,0.0131903061391443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,39966,0.0305012804891974,0.0123057156482428,0.00638207781864163,0.0546204831597532,0.0132033126661492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESPL1,Separin,39560,-0.0142819379753035,0.00577612233084207,-0.0256031377437539,-0.00296073820685299,0.013429141950798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00822586376174349,0.00333302296782678,-0.014758588778684,-0.001693138744803,0.0136024749847816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.010692418772453,0.00433460701238865,-0.0191882485167347,-0.00219658902817122,0.0136492559348246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42070,0.0252951168385608,0.0102579279076665,0.00518957813953449,0.045400655537587,0.0136789706621896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,-0.0450007646986644,0.0182533203132071,-0.0807772725125503,-0.00922425688477843,0.0137005697251568
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,39930,-0.00931164924807913,0.00377879569684688,-0.016718088813899,-0.00190520968225925,0.0137472824654004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,39657,-0.0145841518250719,0.00591989839190683,-0.0261871526732093,-0.00298115097693452,0.0137707770908959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0135016202290455,0.00548142005641797,-0.0242452035396247,-0.00275803691846628,0.0137869268033566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.0123050869425491,0.00499686688574962,-0.0220989460386183,-0.00251122784647982,0.0138075257700363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.01159839416279,0.00471875046855075,-0.0208471450811495,-0.00234964324443053,0.0139864059095458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,39900,-0.0139866423551519,0.00569780597297064,-0.0251543420621743,-0.00281894264812941,0.0141135482161425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0133989890458341,0.00547177550999876,-0.0241236690454317,-0.00267430904623658,0.0143480389044278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,39929,0.0102836324638913,0.00419964282413621,0.00205233252858435,0.0185149323991983,0.0143526424219311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0321498336670489,0.0131333065334596,-0.0578911144726297,-0.00640855286146808,0.0143793093437023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,0.0105719062795056,0.00431890386109082,0.00210685471176759,0.0190369578472436,0.0143873592240053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42070,-0.0504903236984856,0.0206416230135074,-0.0909479048049601,-0.0100327425920111,0.0144560285545081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,-0.0160701639185279,0.00658389324841364,-0.0289745946854186,-0.00316573315163712,0.0146686793545191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0148596680159238,0.00610141028691271,0.00290090385357491,0.0268184321782727,0.0148886893529676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.00674132978445346,0.0027742919696046,-0.0121789420448785,-0.00130371752402843,0.0151172563288301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00727574953275356,0.002995657528382,-0.0131472382883823,-0.00140426077712484,0.0151661738902149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.00780851690905983,0.00321714924974148,-0.0141141294385531,-0.00150290437956653,0.0152310384656331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,41843,0.0168566848674478,0.00694794136523794,0.00323871979158143,0.0304746499433141,0.0152736078461462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0293623579608737,0.0121087048116433,-0.0530954193916945,-0.0056292965300529,0.0153259736665348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.0125446620359326,0.00517410969359483,-0.0226859170353785,-0.00240340703648676,0.0153424492653513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.014614187609527,0.00603750224497797,-0.0264476920096838,-0.00278068320937019,0.0155123774679979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0133292052689184,0.00550839446969226,0.00253275210832158,0.0241256584295152,0.015542422261767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42137,-0.0117582002066035,0.00486244108630346,-0.0212885847357583,-0.00222781567744876,0.0156119781484316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42299,-0.00888163277126646,0.00367336020598881,-0.0160814187750045,-0.00168184676752839,0.0156254874824201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.00649324780442587,0.00268578904294041,-0.0117573943285891,-0.00122910128026265,0.0156349691266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F3,Tissue factor,42174,-0.0068350277317856,0.00282738767139408,-0.012376707567718,-0.00129334789585321,0.0156433863428039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0193765798690595,0.00801861150501951,-0.0350930584188977,-0.0036601013192212,0.0156860787663967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0234342628598284,0.00970331928844572,-0.042452768665182,-0.00441575705447475,0.0157475758016017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42119,-0.0176891079607984,0.00732712755390765,-0.0320502779664574,-0.00332793795513938,0.0157832568608873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,-0.0117933191374624,0.00490425425451716,-0.021405657476316,-0.00218098079860877,0.0162015488277738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42070,-0.0144699146570431,0.00601803017436736,-0.0262652537988032,-0.00267457551528311,0.0162112503875337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00742923281698248,0.00309037744860076,-0.01348637261624,-0.001372093017725,0.0162331854181151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,39930,0.0150360485003219,0.00625836106515377,0.00276966081262052,0.0273024361880233,0.016297028684402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0121117435909823,0.00504313000389525,-0.021996278398617,-0.00222720878334766,0.0163386295932374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,39649,-0.0104487695995896,0.00435274715174652,-0.0189801540170128,-0.00191738518216641,0.016389124194283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,0.00839172539325587,0.00350891008714188,0.00151426162245778,0.015269189164054,0.0167941191929419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0121337309739113,0.00507392481347464,-0.0220786236083216,-0.00218883833950101,0.0168009455232766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39347,0.0320581301657015,0.0134177958295613,0.0057592503397614,0.0583570099916416,0.0169011080007965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00786775611800863,0.00329583628922435,-0.0143275952448883,-0.00140791699112891,0.0169950020952671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,41900,-0.020296478311629,0.00851443150553857,-0.0369847640624846,-0.0036081925607734,0.0171500776153999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0169837042364345,0.00712975634236089,-0.0309580266674619,-0.00300938180540717,0.0172285215229836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.00799771376079302,0.00336081008361106,-0.0145849015246707,-0.00141052599691534,0.0173404169521787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.0122282541684987,0.00514387560198315,-0.0223102503483857,-0.0021462579886117,0.0174595195050758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42208,-0.0287378353723804,0.0120892150790565,-0.0524326969273311,-0.00504297381742968,0.0174608977976575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,-0.016582123020496,0.00697808703938374,-0.0302591736176881,-0.0029050724233039,0.0175036736540118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.0088700881576984,0.00373734926501337,-0.0161952927171246,-0.00154488359827219,0.0176440115840355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42262,-0.00426097834867061,0.00179758718717134,-0.00778424923552644,-0.000737707461814777,0.0177832481335015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.00807572132983734,0.00340684554266639,-0.0147531385934635,-0.00139830406621122,0.0177840319730296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0256838556135453,0.0108500044546605,-0.0469498643446798,-0.00441784688241086,0.0179411740078178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,0.0212668680032509,0.00898727689576053,0.00365180528756029,0.0388819307189416,0.0179793486581951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,39757,0.0138165785592191,0.00584834486896848,0.00235382261604085,0.0252793345023973,0.0181703472937447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,41900,-0.0274635788557988,0.0116348229120982,-0.0502678317635112,-0.00465932594808639,0.0182664477503442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42119,0.0246026638194546,0.0104250382210654,0.00416958890616644,0.0450357387327427,0.0182910766592601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,-0.00757212136767856,0.00321123777731757,-0.013866147411221,-0.00127809532413612,0.0183874388464318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.028836838913891,0.0122339330710264,-0.0528153477331028,-0.00485833009467919,0.0184345417644476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0151396920880795,0.00642852374974265,-0.0277395986375751,-0.00253978553858389,0.0185356409530575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.0217168953008085,0.00924596642892991,-0.0398389895015112,-0.00359480110010591,0.018848728155907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0124390169573831,0.00530265456691515,0.00204581400622938,0.0228322199085368,0.0190029768124289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,0.0077307236440356,0.00330021693722983,0.00126229844706513,0.0141991488410061,0.0191730531359173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.022009601988253,0.0093987611387119,-0.0404311738201283,-0.00358803015637769,0.0192109318294393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0271555984527941,0.0116029146491339,-0.0498973111650965,-0.00441388574049175,0.0192797464516538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42144,-0.00824888173820557,0.00352463323168712,-0.0151571628723123,-0.00134060060409881,0.0192800200361843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.02245339686005,0.00960480812197798,-0.0412788207791268,-0.00362797294097314,0.01941634747129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,39919,0.0254570791159979,0.0108941660594464,0.00410451363948288,0.0468096445925129,0.0194688843503342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0182212699161809,0.0078004414196423,-0.0335101350986798,-0.00293240473368203,0.0195122988094172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42137,0.0147370277404018,0.00631381155463945,0.00236195709330847,0.0271120983874951,0.0196053687935506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0157840830401106,0.00676239247131144,-0.0290383722838811,-0.00252979379634019,0.019608007104474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0140150352928973,0.00600567204305339,-0.025786152497282,-0.00224391808851268,0.019632353772548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,-0.0133997602717857,0.00574309597169705,-0.0246562283763119,-0.00214329216725947,0.019652370863136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,-0.0225833283257697,0.00970303655585378,-0.0416012799752431,-0.00356537667629628,0.0199559850005306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42016,-0.0263294388300373,0.0113186074078872,-0.0485139093494962,-0.00414496831057843,0.0200222599888817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,39657,-0.00714646014020916,0.00307306670238004,-0.013169670876874,-0.00112324940354429,0.0200624809311916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.00637104283389692,0.00274223681236318,-0.0117458269861288,-0.000996258681665078,0.0201775145304843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42124,-0.0144558941209886,0.00622673041116735,-0.0266602857268766,-0.00225150251510055,0.0202699856739011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,-0.0198607619028533,0.0085676435116385,-0.0366533431856648,-0.00306818062004188,0.0204611957668773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.00766193463025595,0.00330619075798561,-0.0141420685159077,-0.00118180074460415,0.020493911804154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,-0.0241620092468455,0.0104401299432544,-0.0446246639356242,-0.00369935455806685,0.0206674353819229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,0.012734789269178,0.00551024620748431,0.0019347067025087,0.0235348718358472,0.0208416778097801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,-0.00905004753525445,0.00391911128081258,-0.0167315056456471,-0.00136858942486179,0.0209498952719909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0239619383968971,0.0103779629082052,-0.0443027456969792,-0.00362113109681497,0.0209659576089196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0189424321526432,0.00820464478734259,-0.0350235359358347,-0.00286132836945171,0.0209762076936583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.0285460393568732,0.0123736757839698,0.0042936348202923,0.052798443893454,0.0210729196057615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0228122070637742,0.00990058250339935,-0.0422173487704369,-0.00340706535711147,0.0212339514457715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0134786186311585,0.00585062724460538,-0.0249458480305851,-0.00201138923173198,0.0212528823935333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42070,-0.0133926746811597,0.00581449314261868,-0.0247890812406924,-0.00199626812162712,0.0212756499338928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0141599732536477,0.00614854261878872,-0.0262111167864736,-0.00210882972082177,0.0212985797344705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0282278374344752,0.0122886184999915,-0.0523135296944586,-0.00414214517449183,0.0216297973455217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00494762945125747,0.00215468884451831,-0.00917081958651336,-0.000724439316001592,0.0216788539699844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0180432650199461,0.00786806502932998,-0.0334646724774329,-0.00262185756245938,0.021853077856745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0111064349530549,0.0048483911324255,0.00160358833350091,0.0206092815726089,0.0219966407078099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,-0.00962313860072874,0.00420628036138054,-0.0178674481090346,-0.00137882909242289,0.0221647197720113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0216620385160864,0.00947428541018859,-0.0402316379200561,-0.0030924391121168,0.0222493546308811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,0.0162703455210298,0.00712586980098375,0.00230364071110167,0.030237050330958,0.0224294122714638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.00645514789661223,0.00283307958662458,-0.0120079838863964,-0.000902311906828053,0.0227158351545749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,0.0154812960301911,0.00680550990041463,0.00214249662537841,0.0288200954350038,0.0229325190819497
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,39649,-0.0106469847750646,0.00468133342987356,-0.0198223982976168,-0.00147157125251243,0.0229641127923082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42119,0.0197837155141186,0.00871794251165905,0.00269654819126681,0.0368708828369703,0.0232651557072285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.0186463069732777,0.00822407742251546,-0.034765498721408,-0.00252711522514738,0.023392316662965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRNN,Cornulin,41749,-0.0165043160692477,0.00728345844799258,-0.0307798946273131,-0.00222873751118221,0.0234675738975256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.00839358081456993,0.00370476352033175,-0.0156549173144202,-0.00113224431471971,0.0234905134871095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.0123965533514149,0.0054795968020059,-0.0231365630833464,-0.00165654361948331,0.0236943198693753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,39560,0.00980386050841441,0.00433412675493741,0.00130897206873709,0.0182987489480917,0.0237159663678349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,-0.00767673032411398,0.00339455902338558,-0.0143300660099497,-0.00102339463827824,0.0237488503728691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,41992,-0.0123216365719764,0.00545020516766374,-0.0230040387005973,-0.00163923444335545,0.0237897540745221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0221199606118167,0.00979094084206333,-0.0413102046622608,-0.00292971656137254,0.0238886389166317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42296,-0.00867310694748731,0.00383930011973016,-0.0161981351821584,-0.0011480787128162,0.023896966608395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0162464127627876,0.00720273723803338,0.00212904777624216,0.030363777749333,0.0241152959425094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00731095607515651,0.00324657027465365,-0.0136742338134777,-0.000947678336835366,0.0243442640787898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI3,Elafin,41966,-0.0136999221347306,0.00608421919226133,-0.0256249917515628,-0.00177485251789842,0.024356513014515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0178194329616238,0.00791879881404307,0.00229858728609942,0.0333402786371483,0.0244478389988883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0099493996490087,0.00442238471653637,-0.01861727369342,-0.00128152560459742,0.0244818665325266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,0.0211129300464595,0.00939660859776817,0.00269557719483387,0.0395302828980851,0.0246645629347569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,-0.00832703296318796,0.00370688639216867,-0.0155925302918385,-0.00106153563453738,0.0246995332223168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0239682788062352,0.0106724391318958,-0.0448862595047509,-0.00305029810771946,0.0247352769194232
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.0236861662874998,0.0105612274808052,0.0029861604251217,0.044386172149878,0.024929576933788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,39560,-0.00828804985004199,0.00370494327551845,-0.0155497386700581,-0.00102636103002582,0.0253047471636361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00673221794399191,0.00301018120671944,-0.012632173109162,-0.000832262778821803,0.0253367620119708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,-0.0102135879400417,0.00456928831609367,-0.0191693930395853,-0.00125778284049814,0.0254191281937526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42137,0.013449539970837,0.0060225957826572,0.00164525223682887,0.0252538277048451,0.0255533599498674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,39575,-0.0123089188620946,0.0055152212315514,-0.0231187524759354,-0.0014990852482539,0.025647714445358
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0179127602945849,0.00803348483789586,-0.0336583905768608,-0.00216713001230903,0.0257830967804644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,41843,-0.0157913880309686,0.00708710364906484,-0.0296821111831357,-0.00190066487880157,0.0258848126998246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.00532931581142704,0.00239458471574266,-0.0100227018542827,-0.000635929768571422,0.026059353593927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,39638,-0.0103585809528102,0.0046546557896878,-0.0194817063005982,-0.00123545560502208,0.0260729375818027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,41900,-0.00782228517128804,0.00351562463856463,-0.0147129094628747,-0.000931660879701364,0.026097558210584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0113290731007755,0.00510504864177875,0.00132317776288913,0.0213349684386618,0.0264940314723378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.00951389115772464,0.00428938777893884,-0.0179210912044448,-0.00110669111100452,0.0265744318018077
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,-0.00603524021165099,0.00272815523759606,-0.0113824244773393,-0.000688055945962705,0.0269690858544867
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42119,0.0220599918609913,0.00997372724749797,0.00251148645589527,0.0416084972660873,0.0269964409173565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.0173424414375391,0.00784090201578194,-0.0327106093884717,-0.00197427348660654,0.0270012539100338
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,-0.0199426017619688,0.00901882542021785,-0.0376194995855958,-0.00226570393834183,0.0270411615607467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0200896337233433,0.00908653677607129,-0.037899245804443,-0.00228002164224355,0.0270610818245993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00913666146064661,0.00413281959349707,0.00103633505739235,0.0172369878639009,0.0270699604772595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.0349625492961449,0.0158170216190067,-0.065963911669398,-0.00396118692289174,0.0270946698495423
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,39813,0.0263813695200171,0.0119411322487304,0.00297675031250546,0.0497859887275286,0.0271749318189833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42145,-0.00895470491298913,0.00405380727393296,-0.0169001671698977,-0.00100924265608052,0.0271939826534952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,0.00895968928366306,0.00405686857772852,0.00100822687131515,0.016911151696011,0.0272280995421784
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00676224162062005,0.00306204000044695,-0.0127638400214961,-0.000760643219744017,0.0272326390258927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.00888644955030243,0.00402539145110652,-0.0167762167944712,-0.000996682306133657,0.0272928587872269
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.0132848808287919,0.00602056115710851,-0.0250851806967245,-0.00148458096085918,0.0273601577818549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.0160397977184963,0.00727705409554913,-0.0303028237457726,-0.00177677169122006,0.0275297905977423
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0116808753159861,0.00530861906299077,-0.022085768679448,-0.00127598195252417,0.0278019735041967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.0117406369366725,0.00533978071996994,-0.0222066071478135,-0.00127466672553136,0.0279185814741707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00523081466394083,0.00237982354167421,-0.00989526880562228,-0.000566360522259379,0.0279708818156074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0095077599732365,0.00433432705846044,-0.018003041007819,-0.00101247893865403,0.0282817708783136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.00640297169768694,0.00291976384610906,-0.0121257088360607,-0.000680234559313194,0.0283260696799124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42296,-0.00804131536815666,0.00366821194879123,-0.0152310107877875,-0.000851619948525843,0.0283845703680254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.016192174598828,0.00738674975944261,-0.0306702041273355,-0.00171414507032045,0.0283963681609394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0211452354233586,0.00966339103399227,-0.0400854818499835,-0.00220498899673377,0.0286768908166203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,39990,-0.00540055545349681,0.00247213415876503,-0.0102459384046763,-0.000555172502317361,0.0289405459159585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,39966,-0.0270855478350213,0.0124002173277799,-0.05138997379747,-0.00278112187257271,0.0289620361556154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.0130493080279801,0.0059795409527409,-0.0247692082953522,-0.00132940776060789,0.0291029925802389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,-0.00705025056705075,0.00323381790985721,-0.0133885336703709,-0.000711967463730622,0.029266387693749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00769235764931856,0.00353484968659057,-0.0146206630350361,-0.000764052263601047,0.0295654172047045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,41865,-0.017549286921634,0.0080721987144931,-0.0333707964020405,-0.00172777744122754,0.0297197144892289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0222876493899974,0.0102655347089798,-0.0424080974195977,-0.00216720136039705,0.0299432399123022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.00831979554344974,0.00383275520196265,-0.0158319957392965,-0.000807595347602939,0.0299742063707117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.00843078508382981,0.00388486570052437,-0.0160451218568576,-0.000816448310802039,0.030015337495603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.00850101653462308,0.00391794788215825,0.000821838685592909,0.0161801943836532,0.030046224289196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0152859315724718,0.00704682249461491,-0.0290977036619171,-0.00147415948302661,0.0300856199457957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.0290017442173958,0.0133741711789071,-0.0552151197280537,-0.00278836870673798,0.0301392375316569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0100716502447065,0.00464696569156106,-0.0191797030001662,-0.000963597489246806,0.0302284940384655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0178650205546885,0.00825298622491278,0.00168916755385945,0.0340408735555176,0.0304334609763342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0145424257642317,0.00672212941658323,0.00136705210772855,0.0277177994207348,0.0305339058391602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,39649,-0.0157443101023872,0.00728215218687513,-0.0300173283886624,-0.00147129181611193,0.0306364283165238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0118088033902078,0.0054646751225781,-0.0225195666304609,-0.00109804014995476,0.0307213096124664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.00848856746546406,0.00392973579521375,-0.016190849624083,-0.000786285306845116,0.0307874289654015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0107596075257593,0.00498131350870941,-0.0205229820028297,-0.000996233048688821,0.0307906172167407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,0.0243006068866007,0.0112685962176624,0.00221415829998233,0.046387055473219,0.0310631220505532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0150127386441865,0.00696455653214165,0.00136220784118883,0.0286632694471841,0.0311365044251991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.00641642153348759,0.00298237829927093,-0.0122618830000586,-0.000570960066916573,0.0314587023922973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.00982290295664539,0.00456613026819395,0.000873287630985254,0.0187725182823055,0.0314737070031957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,0.0265423114186053,0.0123382481432831,0.00235934505777048,0.0507252777794402,0.0314764056236485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.0161247813432294,0.00750614593331759,-0.0308368273725319,-0.00141273531392696,0.0317181662842186
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.00945973787748558,0.00441981808151423,-0.0181225813172535,-0.000796894437717693,0.032348751718285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.00997420317542403,0.00466065425492519,-0.0191090855150774,-0.000839320835770662,0.0323697590890037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,41913,-0.0118156303064261,0.00552318238198033,-0.0226410677751075,-0.000990192837744611,0.0324311804534091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42152,0.00756843523035307,0.00354037245926002,0.00062930521020342,0.0145075652505027,0.0325547855938678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0143325250810434,0.00670889700612567,0.00118308694903706,0.0274819632130497,0.032673153845373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0166594712909125,0.00781881354441938,-0.0319843458379745,-0.00133459674385055,0.0331364997346539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,41827,0.0135756268316363,0.00639872175116004,0.00103413219936266,0.02611712146391,0.0338885864019337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42249,-0.0149171577557287,0.00704366923515081,-0.0287227494566243,-0.00111156605483311,0.0342091345452241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,41839,0.00947900436522958,0.00448215747112447,0.000693975721825618,0.0182640330086335,0.0344630111709655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42016,-0.015257252174998,0.00721940881836863,-0.0294072934590006,-0.00110721089099552,0.0345878772136197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42047,-0.0163609263459596,0.00774935582077819,-0.0315496637546848,-0.00117218893723432,0.0347681363080243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0199638044737729,0.00945615614385034,-0.0384978705157195,-0.0014297384318262,0.0347736900224703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0249624254093503,0.0118521777013612,-0.0481926937040183,-0.00173215711468233,0.0352100101468617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,39575,0.0127100730964485,0.00603671031592245,0.000878120877240464,0.0245420253156565,0.0352736444254927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,-0.0112710262970771,0.00535543213640888,-0.0217676732844385,-0.000774379309715661,0.0353483643989769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.00708681354914623,0.00336932934410959,-0.013690699063601,-0.000482928034691434,0.0354594134545643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0163315186510022,0.0077723926358644,-0.0315654082172965,-0.001097629084708,0.035639904255711
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.00983425869306149,0.00468197320967444,-0.0190109261840234,-0.000657591202099591,0.0357111681751903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,39736,0.0158525850006766,0.00755483150442315,0.00104511525200728,0.030660054749346,0.0358978259325151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.00831570757689613,0.00396990508985602,-0.0160967215530139,-0.000534693600778322,0.0362210221367614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0189458987337764,0.00904864050573238,0.00121056334254097,0.0366812341250119,0.0363013970745509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0177029076056263,0.00846383305026314,-0.0342920203841421,-0.00111379482711055,0.0364937963161842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,39586,-0.00933241673799319,0.00450655708635022,-0.0181652686272396,-0.000499564848746753,0.0383958445505266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0243631423773926,0.0117678843379352,-0.0474281956797457,-0.00129808907503957,0.0384428842693507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42137,-0.00706211917753853,0.00341414474998225,-0.0137538428875037,-0.000370395467573321,0.0386130536177631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,-0.00668499771926874,0.00323390352318434,-0.01302344862471,-0.000346546813827443,0.0387389578856703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0148509764681422,0.00719357689000382,-0.0289503871725497,-0.00075156576373467,0.0389915790989842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.00665063366087546,0.00322356657996994,0.000332443164134367,0.0129688241576165,0.0391230490696674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0187534094336789,0.00908997230461417,0.000937063716635142,0.0365697551507227,0.0391277461968812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEO1,Neogenin,39934,-0.00504988264546941,0.00244832104802131,-0.00984859189959117,-0.000251173391347644,0.0391743256573637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0136739788451843,0.00662988945170086,-0.026668562170518,-0.000679395519850636,0.0391815424878152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.00996795112722579,0.004833756849822,-0.0194421145528769,-0.000493787701574667,0.0392125364630229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.00371364703520976,0.00180413905933552,-0.00724975959150739,-0.000177534478912131,0.0395740864966621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.0155387527592064,0.00756643983973895,0.000708530673318043,0.0303689748450947,0.0400333320899957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,0.00549914065020133,0.00267935257913092,0.000247609595104722,0.0107506717052979,0.0401529775752444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,41913,-0.0209147418818532,0.0101922141810027,-0.0408914816766185,-0.000938002087087907,0.0401861405927931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.00967867935297591,0.00471734076765192,-0.0189246672575737,-0.000432691448378151,0.0402200741476229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00615169522437953,0.0030017558356286,-0.0120351366622116,-0.000268253786547479,0.0404499606827039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0112470601300769,0.00549203972734667,-0.0220114579956764,-0.00048266226447743,0.0405951170152818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,0.0169270659367904,0.00828350165677002,0.000691402689521194,0.0331627291840597,0.0410255224297201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42262,0.0140942601907796,0.00690838353585133,0.000553828460511014,0.0276346919210482,0.041352826054127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0065649076638926,0.00321844276783943,-0.0128730554888579,-0.000256759838927323,0.04139556482365
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42070,-0.00996390440486349,0.00489305105066028,-0.0195542844641576,-0.000373524345569339,0.0417359744445579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,41900,-0.0114558282117111,0.00562794589268853,-0.0224866021613807,-0.000425054262041626,0.0418177916137744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.0164761659722188,0.00809645196983443,-0.0323452118330943,-0.000607120111343371,0.0418762446669975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.00941059261857068,0.00463865138757825,-0.018502349338224,-0.000318835898917314,0.0425094224419176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42077,0.00505002544268598,0.0024900693056384,0.000169489603634707,0.00993056128173724,0.0425731204148472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0127130180747777,0.00627404974235958,-0.0250101555698025,-0.000415880579752942,0.0427555851921814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC1,Hamartin,39657,-0.0162286337072848,0.00801091290841304,-0.0319300230077743,-0.000527244406795239,0.0428076340840428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,39721,0.0127225746076447,0.00628269783247398,0.000408486855995692,0.0250366623592937,0.042889384950473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00613402454164395,0.00302991015456175,0.000195400638702922,0.012072648444585,0.0429436913811733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,39736,0.0141052710842122,0.00698433595986856,0.000415972602869867,0.0277945695655546,0.0434531688490544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,41830,0.0186930084848915,0.00926209245635648,0.00053930727043278,0.0368467096993502,0.0435877289124127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0125843492275529,0.00623962753926835,-0.0248140192045189,-0.000354679250586925,0.043731614776399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.0076875288067424,0.00381644750603992,-0.0151677659185806,-0.000207291694904156,0.0440000443950953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0154901019794793,0.00769449519366689,-0.0305713125590664,-0.000408891399892216,0.0441233704132202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,39586,-0.0101752926272701,0.00506524708143933,-0.0201031769068912,-0.000247408347649063,0.0445780712601071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0215056024957153,0.0107148365244479,-0.0425066820836332,-0.000504522907797348,0.0447641745642377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,39930,-0.0135279892737571,0.00675357567255206,-0.0267649975919591,-0.000290980955555034,0.0451918917081163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0168093966338146,0.008399407117062,-0.0332722345832561,-0.000346558684373076,0.045388825257233
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.00449721263354133,0.00224729420487492,9.25159919864822e-05,0.00890190927509618,0.0453943432508754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42262,-0.00993767963004339,0.00498968153603972,-0.0197174554406812,-0.000157903819405546,0.0464297796597222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,39919,0.00840961284475426,0.00422726181580281,0.000124179685780761,0.0166950460037278,0.046683752652881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,39948,-0.00952178499518412,0.0047894784919306,-0.0189091628393681,-0.000134407151000141,0.0468287091976636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.0128181937344856,0.00646146768279119,-0.0254826703927563,-0.000153717076214867,0.0473039842583481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.0122585349823831,0.00618159505377123,-0.0243744612877748,-0.000142608676991524,0.0473843256747206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.00500198182675943,0.00252403062926489,5.48817934002592e-05,0.00994908186011861,0.047527871543165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.00711895555571008,0.00359587164061436,-0.0141668639713142,-7.10471401059332e-05,0.0477507520685455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0195757458086519,0.00989924182122752,-0.0389782597782578,-0.000173231839045933,0.0480093332348168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0273966500501613,0.0138542161269385,-0.0545509136589608,-0.000242386441361774,0.0480098367305426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,-0.015281633699793,0.00773854011119533,-0.0304491723177358,-0.000114095081850136,0.0483220750378647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0116619122042754,0.00590729858779599,-0.0232402174363555,-8.36069721952444e-05,0.0483893393446139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0140752972466525,0.00713295294503358,-0.0280558850189183,-9.47094743867106e-05,0.0484881837516153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,39657,0.00970171963174484,0.00492004937175743,5.84228631002916e-05,0.0193450164003894,0.0486488275604013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.0186346536681851,0.00945921139784177,-0.037174708007955,-9.45993284152229e-05,0.0488632002726656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,39649,-0.00808442939077471,0.00411098665248251,-0.0161419632296404,-2.68955519089828e-05,0.0492609857554676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.012929561976027,0.00658039487767207,-0.0258271359362642,-3.198801578971e-05,0.0494553338305369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.00944794817827833,0.00480892756402792,-0.018873446203773,-2.24501527836176e-05,0.049477816476418
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00727136098950705,0.00370196730341307,-0.0145272169041967,-1.55050748174334e-05,0.049528786077126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.0119754914131347,0.00610514198782417,-0.0239415697092701,-9.41311699934055e-06,0.0498403003928952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,0.00860945151599186,0.00439055219486228,3.96921406178516e-06,0.0172149338179219,0.0499154702610281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,0.0143382949390671,0.00732220798050733,-1.32327027272307e-05,0.0286898225808615,0.0502326893519802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00556624448918953,0.00284727274336342,-0.0111468990661818,1.4410087802768e-05,0.0506156201443793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.0163057584805001,0.00834221792305543,-0.0326565056096887,4.4988648688557e-05,0.0506540221853979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,-0.0147078299179124,0.00752701906373231,-0.0294607872828278,4.51274470029111e-05,0.0507214205052887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,39958,-0.00636499388628885,0.00325781859663709,-0.0127503183356975,2.03305631198414e-05,0.0507541826102692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0101198374646268,0.00518382507604272,-0.0202801346136705,4.04596844169307e-05,0.0509359883479382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42016,0.0185621554155587,0.00951308372426788,-8.34886840063061e-05,0.0372077995151238,0.0510512127810808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,0.0127987895382711,0.00658317211214875,-0.000104227801540496,0.0257018068780826,0.0518963989857918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.011129046010655,0.00573512364866444,-0.0223698883620373,0.00011179634072735,0.0523433395591377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0506792417146545,0.0261291341391738,-0.101892344627435,0.000533861198126151,0.0524569610320764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,41881,-0.0108794599063698,0.00561303026800296,-0.0218809992316556,0.000122079418915996,0.0526138069477122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,39586,-0.00976486052792598,0.00504034850492542,-0.0196439435975798,0.00011422254172784,0.0527295954511469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.00685561349794913,0.00353946288263611,-0.0137929607479159,8.17337520176336e-05,0.0527774911338332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0081517094853338,0.00421961174107371,-0.0164221484978383,0.000118729527170675,0.053397809891427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0112335515765829,0.0058157387271514,-0.0226323994817996,0.000165296328633827,0.0534365431835362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,0.0129854127401811,0.00672760062200858,-0.000200684478955677,0.026171509959318,0.0536066361281004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.017950064075255,0.00930692035772147,-0.036191627976389,0.000291499825879126,0.0537920488710086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEXN,Nexilin,39990,-0.0145844707613732,0.00756420701606296,-0.0294103165128566,0.000241374990110186,0.053868780398164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.00459089747144366,0.00239003868031789,-9.35783419794009e-05,0.00927537328486671,0.0547765636353517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.00922929419226463,0.00480556322856379,-0.0186481981202497,0.000189609735720388,0.0548107079912642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.02188356100357,0.0114087387107605,-0.0442446888766607,0.00047756686952059,0.0551143683648731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.0111465330274512,0.00583181670671403,-0.0225768937726107,0.000283827717708343,0.055983646686655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0166380823145161,0.00871493273574104,-0.0337193504765686,0.000443185847536335,0.0562643189197172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.012793830110638,0.0067013148334737,-0.0259284071842465,0.000340746962970448,0.0562684826911828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.015842568473385,0.00830292628233172,-0.0321163039867552,0.000431167039985195,0.0564032420360144
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00748230384489631,0.00392453306488677,-0.0151743886520744,0.000209780962281764,0.0566052841695291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,0.0058257539946146,0.00305739810853883,-0.000166746298121504,0.0118182542873507,0.056741094849386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0216449866350795,0.0113612899062852,-0.0439131148513984,0.000623141581239495,0.056781646598486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,39657,-0.0114626438734239,0.00601886925194668,-0.0232596276072394,0.000334339860391596,0.0568773487444615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.00937267207776807,0.00492269941535448,-0.0190211629318629,0.000275818776326707,0.0569394828557595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0194967350031293,0.0102540750692063,-0.0395947221387738,0.000601252132515117,0.0572756811589467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,39929,-0.0195393331181151,0.0102869764957261,-0.0397018070497383,0.000623140813508165,0.057534085142376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,39929,-0.00785349491839778,0.00413636918807554,-0.0159607785270258,0.000253788690230289,0.0576366082948646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,39966,-0.0173141838804069,0.00912111185276662,-0.0351915631118295,0.000563195351015632,0.0576879839004524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,41839,-0.0141702690546213,0.00746643685169235,-0.0288044852839383,0.000463947174695717,0.0577359548344141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,39575,0.0080784460788884,0.00425890238921918,-0.000269002603981187,0.016425894761758,0.0578756079692155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,39638,-0.00603749596667318,0.00318491622807122,-0.0122799317736928,0.000204939840346407,0.0580320420977411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,-0.0125533273629055,0.00663507798500025,-0.025558080213506,0.000451425487694975,0.0585216737490976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,41913,-0.0149714889191117,0.00792527354976178,-0.0305050250766448,0.000562047238421367,0.058902600948177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,-0.0163081890381068,0.00863837144958417,-0.0332393970792918,0.000623019003078165,0.059068759798634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0124741202409181,0.00661092317407319,-0.0254315296621016,0.00048328918026534,0.0591958871492889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPSE,Heparanase,39866,-0.0195236229166888,0.0103473872204936,-0.0398045018688562,0.000757256035478594,0.0592106751200113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,-0.0101020545702324,0.00536008153798108,-0.0206078143846753,0.000403705244210533,0.059499049108716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.0103981856225897,0.00551909525889475,-0.0212156123300234,0.000419241084844016,0.0595817182805123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,39966,-0.0173614355385426,0.00922726135487361,-0.0354468677940949,0.000723996717009658,0.0599244136303265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0180956084053212,0.00962397935307069,-0.0369586079373397,0.000767391126697374,0.0600938584654237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,39990,0.00549952142165335,0.00292933181083281,-0.000241968927578956,0.0112410117708856,0.060489112947002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42083,-0.00713593677188266,0.003803728860199,-0.0145912453378727,0.000319371794107388,0.0606717608651819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERVV_1,,39575,-0.00884662030867993,0.00472018815063606,-0.0180981890839266,0.000404948466566748,0.0609281334957478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0134544095252678,0.00718054810605024,-0.00061946476259067,0.0275282838131263,0.0609888812996396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00952573929374409,0.0051072108771827,-0.0195358726130222,0.000484394025534005,0.0621855527985188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42137,0.00909376076731751,0.00487709384136456,-0.000465343161757028,0.018652864696392,0.0622610852068302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0170495168896161,0.00914426069574116,-0.0349722678532688,0.000873234074036576,0.0622766936228274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0116686573098438,0.00626746426793574,-0.0239528872749978,0.000615572655310285,0.0626558442121377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.015779136124987,0.00848480304651873,-0.0324093500961637,0.000851077846189683,0.0629547414753345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,39934,0.0105454859074381,0.00568475703026964,-0.000596637871890427,0.0216876096867666,0.0636156035608092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,41843,0.0197516272999176,0.0106479654517615,-0.00111838498553485,0.0406216395853701,0.0636231107711084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42296,0.00748445323306729,0.00404082352214085,-0.000435560870328781,0.0154044673364634,0.0640171937613763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,39575,-0.0116345077116411,0.00629094777420721,-0.0239647653490873,0.000695749925805005,0.0644262820174225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0151759683660348,0.00822397551150257,-0.0312949603685799,0.000943023636510195,0.0650115121021947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42148,-0.0187670789263214,0.0101994068982147,-0.0387579164468222,0.00122375859417938,0.065787648442253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.00657239149313867,0.00357252578080053,-0.00042975903723036,0.0135745420235077,0.0658336345369642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,0.00669838492685359,0.00364156584290502,-0.000439084125240258,0.0138358539789474,0.0658796069188088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COCH,Cochlin,39958,-0.00914766182945347,0.00497447286698946,-0.0188976286487528,0.000602304989845868,0.0659529197202962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0206584551685923,0.0112459595744679,-0.0427005359345494,0.00138362559736477,0.0662414749408618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.020653027859388,0.0112460689508358,-0.0426953230030261,0.00138926728425004,0.0663155550827721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSPN,Persephin,42119,-0.0171113981115534,0.00933798309961842,-0.0354138449868055,0.00119104876369874,0.0669062128587748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,-0.00537755754350832,0.00293905257554886,-0.0111381005915841,0.00038298550456744,0.0673223074774576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42119,0.0158968129523772,0.00869074060169708,-0.00113703862694913,0.0329306645317034,0.0673966608011376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.00784707557351289,0.00429538796655425,-0.0162660359879592,0.000571884840933443,0.0677424656370704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,39539,-0.00814985956012328,0.00446121699267681,-0.0168938448657698,0.000594125745523257,0.0677534284820365
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,41900,0.0106661042796583,0.00584165356272244,-0.000783536703277668,0.0221157452625943,0.0678921456303108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,41814,0.0120355456032985,0.00659472010266477,-0.000890105797924479,0.0249611970045214,0.0680194424750378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCIN,Adseverin,39586,-0.0145609039694234,0.00799493368804818,-0.0302309739979979,0.00110916605915102,0.0685935583043172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,39575,-0.00902985282735547,0.00496310844539606,-0.0187575453803317,0.000697839725620817,0.0688784797555687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,39586,-0.00944442632532876,0.00519519926273668,-0.0196270168802927,0.000738164229635133,0.0691044764626614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,0.0108734800913736,0.00598406110560571,-0.00085527967561359,0.0226022398583608,0.0692321507823697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.0135037466900748,0.00743961383561983,-0.0280853898078897,0.00107789642774005,0.069529020379405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0053660781847907,0.00295740674402051,-0.0111625954030709,0.00043043903348949,0.0696300230366676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.00961013184378706,0.00530225574995591,-0.0200025531137006,0.000782289426126521,0.0699374193125488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.00958231762009904,0.00529567180819945,-0.01996183436417,0.000797199123971885,0.0704058401178676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0120681038330191,0.00668562024868972,-0.025171919520451,0.00103571185441273,0.0710838325975722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,-0.0101046270437,0.00559826018355651,-0.0210772170034708,0.000867962916070747,0.0711085804844579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0124548209911664,0.0069105918084621,-0.0259995809357521,0.00108993895341932,0.0715236612400093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00934825265628207,0.00518702650088255,-0.0195148245980119,0.000818319285447722,0.071535504681071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0119800785545537,0.00665572052119812,-0.025025290776102,0.00106513366699464,0.0718880621874639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.00587744933217906,0.00326703131610582,-0.0122808307117465,0.000525932047388357,0.0720385345505429
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.0136305981150791,0.00757745879854706,-0.0284824173602313,0.00122122113007317,0.072066769698896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.0135137877725795,0.00752647424479976,-0.028265677292387,0.00123810174722807,0.0726015032573262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0192525514798411,0.0107266470771795,-0.0402767797511128,0.00177167679143073,0.0727076221968519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.0109197632855042,0.00608448503724051,-0.0228453539584956,0.00100582738748722,0.072725834660408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.00769468989046642,0.00428923290165269,-0.0161015863777057,0.000712206596772854,0.072843210167777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,41780,-0.00590752144586478,0.00329353133456721,-0.0123628428616165,0.000547799969886941,0.0728881363870195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,39958,-0.00630235620356734,0.00351562456667001,-0.0131929803542406,0.000588267947105879,0.0730522387165315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,-0.011908449131761,0.00664978482713391,-0.0249420273929435,0.00112512912942144,0.073347177087373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.00583913246527189,0.00326774478634521,-0.000565647315964722,0.0122439122465085,0.0739760551120698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,0.0212992089979839,0.0119221433069054,-0.0020681918835508,0.0446666098795185,0.0740410316108969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.00609273614376827,0.00341586060381253,-0.0127878229272408,0.000602350639704295,0.0745017164244323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00650271569416338,0.00364574681176602,-0.0136483794452248,0.000642948056898029,0.0745041124483177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_A,,39934,-0.00633423707081556,0.00355705819705142,-0.0133060711370364,0.000637596995405227,0.0749798165650775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,39978,0.0107601411248679,0.00604675703287907,-0.00109150265957503,0.0226117849093109,0.075186217548984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0124907804882908,0.00702077946477426,-0.00126994726266678,0.0262515082392483,0.0752482437912263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.00858654769173881,0.00483195641029378,-0.000884086872436997,0.0180571822559146,0.0755895657135839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00684864251316115,0.00385497611137329,-0.0144043956914528,0.000707110665130507,0.0756655434602451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42310,-0.00802115554923845,0.0045163010800231,-0.0168731056660837,0.000830794567606824,0.0757476161099625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.0141712164585507,0.00799697606082016,-0.0298452895377582,0.00150285662065682,0.0764103361106528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0147027152132879,0.0083029979391317,-0.030976591173986,0.00157116074741023,0.0766255175682445
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42137,-0.00449698516134581,0.0025409817838796,-0.00947730945774982,0.000483339135058198,0.0767858829221748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.00938760848904941,0.0053096232252381,-0.0197944700105161,0.00101925303241727,0.0770816835345817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0142038248412512,0.00805461216241965,-0.0299908646795937,0.00158321499709131,0.0778536852550575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0103592479001405,0.00589007991694795,-0.0219038045373585,0.00118530873707745,0.0786454280591754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,41913,-0.00598706740540056,0.0034067291895633,-0.0126642566169446,0.000690121806143503,0.0788685588935111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.0100874644325248,0.00574420603921355,-0.0213461082693834,0.00117117940433371,0.0790964687937366
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,39560,-0.0124150886294446,0.00707435146114184,-0.0262808174932826,0.00145064023439343,0.079296874137348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42070,0.0124840669641758,0.00711757671445469,-0.00146638339615539,0.026434517324507,0.0794571608781038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0137849522085327,0.00786073773768541,-0.00162209375733069,0.0291919981743961,0.0795139970550525
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42262,0.00708080447708109,0.00403847842234028,-0.000834613230705856,0.014996222184868,0.0795669917458115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,41839,-0.00849324277849345,0.00484837878980918,-0.0179960652065194,0.00100957964953255,0.0798365787966362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00909149263492908,0.00520358627003041,-0.0192905217241887,0.00110753645433052,0.0806329390805605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,39736,-0.0065451528235763,0.00374991675873802,-0.0138949896707028,0.000804684023550219,0.080940613871393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42296,-0.01488888406938,0.00856883830364756,-0.0316838071445293,0.00190603900576919,0.0823105759993524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.0158725856360447,0.00915126818474086,-0.0020639000060474,0.0338090712781368,0.0828577194355252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.00754722610802776,0.00435198438875912,-0.0160771155099956,0.000982663293940108,0.0829091998557535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.00953747488450589,0.0055005249129864,-0.0203185037139592,0.00124355394494746,0.0829602075858721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0185799081289907,0.0107212551078664,-0.0395935681404089,0.00243375188242741,0.0831233272045319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,0.00515290018026162,0.0029734581605037,-0.000675077814325632,0.0109808781748489,0.0831245138877159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,39979,0.00774055512443351,0.00446742550306898,-0.00101559886158168,0.0164967091104487,0.083182191148416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.00547769797952601,0.00316466367879095,-0.0116804387899563,0.00072504283090425,0.0834983374656969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.00760600373397836,0.00439467763827126,-0.01621957190499,0.00100756443703332,0.0835227910035471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.00456956111918935,0.00264066364671797,-0.000606139628377869,0.00974526186675656,0.0835709521778982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.0101390950359008,0.00586542489992411,-0.021635327839752,0.00135713776795049,0.0839049137460721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0146563333693134,0.00848179114171797,-0.0312806440070807,0.00196797726845378,0.0840197267471457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,0.00679299141881836,0.00393674222307388,-0.000923023338406445,0.0145090061760432,0.0844590636437939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,39757,-0.00995404278987392,0.00577195982616845,-0.0212670840491641,0.00135899846941623,0.084636001810652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,41913,-0.00768998080264868,0.00446048725768717,-0.0164325358277155,0.00105257422241819,0.0847269797439035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.00714869086858832,0.00414932095657027,-0.015281359943466,0.000983978206289407,0.0849415780714235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00725285551446307,0.00420999301235769,-0.0155044418186841,0.000998730789758003,0.0849580444929219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.020169493272229,0.0117277416042676,-0.00281688027213558,0.0431558668165936,0.0854942008605095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.0054650318920928,0.00318676648028347,-0.0117110941934484,0.000781030409262809,0.0863889325975743
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0147039074578517,0.0085751616472719,-0.0315112242865046,0.00210340937080125,0.0864216740846357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.00639604302236407,0.00373193808645262,-0.0137106416718112,0.000918555627083072,0.0865759056700894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0257013123120967,0.015013181348627,-0.0551271477554057,0.00372452313121221,0.0869393437288421
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0158316554157801,0.0092519967500991,-0.0339655690459743,0.00230225821441416,0.0870742357966753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,39929,0.0113111469082309,0.00661514574031619,-0.00165453874278887,0.0242768325592506,0.087314287609196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,0.00892927121208917,0.00522499784914636,-0.0013117245722377,0.019170266996416,0.0874872058641634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0150948480316729,0.00883338165826503,-0.0324082760818723,0.0022185800185266,0.087508648942493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0169646339293,0.00994014322682214,-0.0364473146538714,0.0025180467952714,0.0879052236784671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,0.00682763703933439,0.00400226591298794,-0.00101680415012197,0.0146720782287908,0.0880417680608265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.00819676641936047,0.00480722845303665,-0.0176189341873123,0.00122540134859137,0.0882053711868566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0130634242705001,0.00766499264826811,-0.0280868098611056,0.00195996132010536,0.0883538849005375
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.0104192255896507,0.0061145826911455,-0.0224038076642958,0.00156535648499452,0.088411415745631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,41751,0.0199802089739982,0.0117327204779604,-0.00301592316280424,0.0429763411108006,0.0886014918961097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.00642813141382029,0.00377697987324519,-0.0138310119653809,0.000974749137740288,0.0887980011988533
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0161922820288268,0.00952512933202077,-0.0348615355195875,0.0024769714619339,0.0891624631601076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.00795678404468911,0.00468248055344753,-0.0171344459294463,0.00122087784006804,0.089292275660885
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,39657,-0.00481950579235608,0.00283668208835345,-0.0103794026855288,0.000740391100816679,0.0893484489934707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.00846696719336545,0.00498651667100433,-0.0182405398685339,0.00130660548180304,0.0895362214121055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.00739017559034714,0.00435332675588852,-0.0159226960318886,0.00114234485119437,0.0896120619393876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.00870188176478249,0.00512958649191482,-0.0187558712889355,0.00135210775937055,0.0898357356592063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0170721506707421,0.0101144764479551,-0.0368965245087342,0.00275222316724997,0.0914550770086938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,0.0142112471514033,0.00842051542211197,-0.00229296307593617,0.0307154573787428,0.0914976495077927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,39934,0.0121399543292036,0.00719323995613512,-0.00195879598482121,0.0262387046432285,0.0914983950612747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0127978834938493,0.00758448426183398,-0.0276634726470439,0.0020677056593453,0.0915538995862905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.0107339618306456,0.0063655574471692,-0.0232104544270972,0.00174253076580602,0.09177482410515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.00508324123163567,0.00301821696055485,-0.0109989464743232,0.000832464011051843,0.09216913489008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00978086856360569,0.00581048998851464,-0.0211694289410944,0.001607691813883,0.0923426860215024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00850535973870847,0.005068763220655,-0.0184401356511923,0.00142941617377534,0.0933765708673772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,-0.0107747585038112,0.00642504199643814,-0.02336784081683,0.00181832380920754,0.0935711936656974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.011294984979164,0.0067370285074293,-0.0244995608537254,0.00190959089539746,0.0936528357021302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00873611356594952,0.00521815744146463,-0.00149147501932115,0.0189637021512202,0.0941245621645895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00656816772102997,0.00392706039248654,-0.0142652060903036,0.00112887064824365,0.0944453802070582
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.011835081901023,0.00708625588134949,-0.025724143428468,0.00205397962642198,0.0949139893851539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,-0.00722301743806778,0.00432604796482878,-0.0157020714491322,0.00125603657299662,0.0950157499793537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,39934,-0.00997258884736527,0.00597588250056596,-0.0216853185484745,0.00174014085374401,0.095183443872335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.00917923830502745,0.00550106369927229,-0.0199613231556011,0.00160284654554624,0.0952139443681474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,39757,-0.00696539248575728,0.00418387631429201,-0.0151657900617696,0.00123500509025506,0.0959771555844393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.00845475374018513,0.00508130721370513,-0.0184141158790472,0.00150460839867692,0.0961613708644938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,0.00787721766071946,0.00473562331691435,-0.00140460404043267,0.0171590393618716,0.0962617119303989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.00416217561298129,0.00250372620498818,-0.00906947897475812,0.000745127748795533,0.0964622496504946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.00844893876330229,0.0050852158810074,-0.0184159618900768,0.00151808436347222,0.0966422757088158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,39649,-0.00728538405541707,0.00438667590625208,-0.0158832688316711,0.00131250072083701,0.0967823283531889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,39736,0.00495550512113076,0.00298794557658104,-0.000900868208968075,0.0108118784512296,0.0972449270518373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.0134340991623245,0.00810306533201782,-0.00244790888843042,0.0293161072130795,0.0973655547094266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.015293288615995,0.00923615635936774,-0.0333961550803558,0.00280957784836578,0.0977886751625998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,39575,-0.00605453401875943,0.00365691425071895,-0.0132220859501686,0.00111301791264972,0.0978233062268268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0178913755495688,0.010810295898939,-0.0390795555114893,0.00329680441235161,0.0979415866992737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.0102474918185948,0.00619179994164126,-0.0223834197042117,0.00188843606702206,0.0979510009217745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,39586,-0.0086818920821232,0.00524882710009022,-0.0189695931983,0.00160580903405364,0.0981432279364443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.00975467363088644,0.00590676458960413,-0.00182258496473765,0.0213319322265105,0.0986721296633301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,41877,-0.00765042409323096,0.00463589716027119,-0.0167367825273625,0.00143593434090057,0.0989139327334756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.0116222251920865,0.0070429385184087,-0.0254263846881675,0.00218193430399457,0.098931550774461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,41913,-0.00844975202629428,0.00512282992889193,-0.0184904986869225,0.0015909946343339,0.0990830593205787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0131314306556885,0.00796145437130118,-0.0287358812234388,0.00247301991206177,0.0990991122931597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.01732134259061,0.010506475080724,-0.0379140337488291,0.00327134856760898,0.0992458805144254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.00695078646092667,0.00421695282967084,-0.0152160140070815,0.00131444108522819,0.0993150704457382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFI,Complement factor I,39979,-0.00346524196049536,0.00210298756339213,-0.00758709758474394,0.000656613663753213,0.099427277683262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.0109829636741979,0.00666684535724105,-0.0240499805743903,0.00208405322599457,0.0995043730365313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.00789308402025669,0.00480200890827367,-0.0173050214804731,0.00151885343995971,0.100264988440858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.00838459444373144,0.00510284896443612,-0.0183861784140262,0.00161698952656336,0.100385807504149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.0110975984299659,0.00675618041492435,-0.0243397120432177,0.00214451518328579,0.100492105527871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.00647157073867235,0.0039400071570221,-0.0141939847664357,0.00125084328909096,0.100508503202991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.024949364264323,0.0151957881770974,-0.0547331090914339,0.00483438056278794,0.100646672326326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0158474131144474,0.00968431657256833,-0.0348286735966813,0.00313384736778651,0.101779275871865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,39652,-0.0125763722785873,0.00768821812632242,-0.0276452798061793,0.00249253524900461,0.101910334117681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,0.0102538797564471,0.00628683578826703,-0.00206831838855633,0.0225760779014504,0.102912400910694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.0132343223143372,0.00812387744530204,-0.0291571221071292,0.00268847747845484,0.103323099142265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.0072571127544625,0.0044548072084308,-0.0159885348829869,0.00147430937406186,0.103330235623208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.0063036627221191,0.00387328140317475,-0.0138952942723416,0.00128796882810341,0.103665284612856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,39750,-0.0174872969814703,0.0107503050461456,-0.0385578948719157,0.00358330090897505,0.103833518941254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.00831027887710836,0.00511401266988716,-0.0183337437100872,0.00171318595587048,0.104185609058632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0138576304508676,0.00853376321467461,-0.0305838063516299,0.00286854544989461,0.104429341177652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,41913,0.00560771000425826,0.00345358588877807,-0.00116131833774676,0.0123767383462633,0.104455946341639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00517381473879963,0.00318715512639503,-0.0114206387865339,0.00107300930893463,0.104546886398185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0154520190525197,0.00952277814675327,-0.0341166642201562,0.00321262611511666,0.104690195419212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.0183767316229295,0.0113294077569554,-0.0405823708265621,0.00382890758070321,0.104823690237941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0129263555788309,0.00797323943077739,-0.0285539048631546,0.00270119370549279,0.104994807382007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42181,0.00980914420025434,0.00605975210567655,-0.00206796992687169,0.0216862583273804,0.105527109364875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.0119633364206649,0.00740371519886483,-0.0264746182104399,0.0025479453691102,0.106153759854933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.00675567194091852,0.00419006963653566,-0.0149682084285284,0.00145686454669137,0.106919325566757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0102788114714615,0.0063761656410938,-0.0227760961280054,0.00221847318508232,0.10697030202969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0109320861890822,0.00679813474819313,-0.0242564302955407,0.00239225791737638,0.107841101927032
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,39560,-0.00695541997018567,0.00432523957042044,-0.0154328895282097,0.00152204958783839,0.107841970559175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.00883117001163607,0.00549642892812097,-0.0196041707107532,0.00194183068748103,0.108141023436343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZN,Kazrin,39930,0.0182498932097932,0.0113614014538354,-0.00401845363972418,0.0405182400593107,0.108234446274161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,39575,-0.00726179775174217,0.0045226649400962,-0.0161262210343307,0.00160262553084638,0.108380537073336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,0.00968304864059521,0.00603071405796679,-0.0021371509130197,0.0215032481942101,0.108384794095505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.012266820159867,0.00764412765503499,-0.0272493103637356,0.00271567004400153,0.108579835296798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.00411222924219859,0.00256377536553712,-0.00913722895865134,0.000912770474254167,0.108742902578768
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0207242944948797,0.0129693639964344,-0.0461442479278911,0.0046956589381317,0.110079203997986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42113,-0.00414301158330813,0.0025929056191073,-0.00922510659675845,0.000939083430142183,0.110105124747214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.018839810235153,0.011799811892515,-0.0419674415444824,0.00428782107417647,0.110373799919136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,-0.0110408605947503,0.00691882806382211,-0.0246017635998416,0.00252004241034107,0.110563814077328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.0130664164021293,0.00819177096344905,-0.0291222874904894,0.00298945468623083,0.110725367341213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.00817014847868001,0.00512591943162856,-0.018216950564672,0.00187665360731196,0.110984680803294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,41839,-0.00912062172576532,0.0057261857935665,-0.0203439458811557,0.00210270242962501,0.111230780650391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00520449035184272,0.00327285562690231,-0.0116192873805713,0.00121030667688581,0.111813928971471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.00931695402091324,0.00586042190041258,-0.0208033809457219,0.00216947290389543,0.111901644607432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,39638,-0.00706761759035428,0.00444650525864072,-0.0157827678972901,0.00164753271658152,0.111981394794088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,0.00967499288207908,0.00609076939071041,-0.00226291512371331,0.0216129008878715,0.112209141584023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.00391706638910844,0.00246981529436312,-0.00875790436606016,0.000923771587843284,0.112772791157237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,39649,-0.0101277681699473,0.00638599584444065,-0.022644320025051,0.00238878368515634,0.112782890369482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,41913,-0.00525284461538792,0.00331797059691205,-0.0117560669853355,0.0012503777545597,0.113411069897893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0108473474914469,0.00685388958210587,-0.0242809710723744,0.00258627608948064,0.113527859704516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0104297372396632,0.00659507754309575,-0.0024966147448045,0.0233560892241308,0.11380062927219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0114505310316371,0.00724115424895562,-0.0256431933595901,0.0027421312963159,0.113829916512661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,41913,0.00466779036776129,0.00295436697881665,-0.00112276891071934,0.0104583496462419,0.114139108501122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.00538325836447476,0.00341118644053908,-0.0120691837879314,0.00130266705898183,0.114566914149481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0145259681553026,0.00920596895231665,-0.0325696673018433,0.003517730991238,0.114615720693241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.00519513783399231,0.00329356183078981,-0.0116505190223403,0.00126024335435572,0.114735772882148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0068105189037285,0.00432744647489123,-0.0152923139945153,0.0016712761870583,0.115563228419442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.00589472950026927,0.00375308882923694,-0.0132507836055737,0.00146132460503512,0.116295603126229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42119,0.00582586002236365,0.0037186546657604,-0.00146270312252674,0.013114423167254,0.117218061675198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.00693834843248951,0.00442940508172017,-0.015619982392661,0.00174328552768201,0.117271715922569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.0059814786848522,0.00382806044131094,-0.0134844771498216,0.00152151978011724,0.118185892923695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00658567225272475,0.00422006701784044,-0.014857003607692,0.00168565910224251,0.11865124806166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,41913,-0.0192220812591145,0.0123322551341349,-0.0433933013220189,0.00494913880378995,0.119095104584216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,0.00432515205990333,0.00277643089959943,-0.00111665250331154,0.00976695662311821,0.119306943496993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0138755051696863,0.00892506340478713,-0.0313686294430691,0.00361761910369644,0.120048664447428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0059200351438276,0.00380806947780869,-0.0133838513203326,0.00154378103267744,0.120063822828182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.0158956383228119,0.0102338327757146,-0.00416267391758872,0.0359539505632125,0.120392798201166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42137,-0.0122344834157023,0.00788184690528928,-0.0276829033500693,0.00321393651866469,0.120629236199808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,-0.0116222813763558,0.00748747823004145,-0.026297738707237,0.00305317595452547,0.120636042789417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0126662924047264,0.00818068437349023,-0.0287004337767673,0.00336784896731444,0.121573931801267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.00477906071469672,0.00308712414548984,-0.0108298240398568,0.00127170261046337,0.121630469428522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,-0.00656381312225264,0.0042419694934547,-0.0148780733294238,0.00175044708491856,0.121807611808698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.00948968631524483,0.00613476354469507,-0.0215138228628472,0.00253445023235751,0.121917802651538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.00937072180838656,0.00606164510263912,-0.0212515462095592,0.00251010259278611,0.122155670302875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,39757,-0.0055972309648191,0.00362245626171834,-0.0126972452377871,0.00150278330814885,0.122338836482895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,39657,-0.00652666923568882,0.00423027958620721,-0.014818017224655,0.00176467875327731,0.122896803258657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,41846,0.0093755191630502,0.00607738694622771,-0.00253615925155612,0.0212871975776565,0.122930093498321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTN,Titin,39575,0.0115633687228111,0.00750117940991934,-0.0031389429206308,0.026265680366253,0.123214226173246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0110123915280997,0.00715501898435235,-0.0250362287374303,0.00301144568123093,0.123800310918045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.00957638127898293,0.00622606817674317,-0.00262671234743368,0.0217794749053995,0.124045472943893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42070,-0.00318036138483528,0.00206774072111845,-0.00723313319822744,0.000872410428556879,0.124051274638305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00832216356864822,0.00541613541253848,-0.0189377889772236,0.00229346183992719,0.12443231121282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,39854,-0.00714592303740086,0.00466400106643176,-0.0162873651276071,0.00199551905280539,0.125514917821171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.0143190387700231,0.00935548760833646,-0.0326557944823625,0.00401771694231638,0.125909328355942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00706997569182065,0.00462205328209173,-0.0161292001247204,0.00198924874107914,0.126139928789244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,0.00666690512593951,0.0043597026800707,-0.00187811212699906,0.0152119223788781,0.12624080934616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42249,-0.00757567814729309,0.00495621192909848,-0.0172898535283261,0.00213849723373993,0.126406199751705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42082,0.0144826871772442,0.0094843711316675,-0.00410668024082408,0.0330720545953125,0.12678309448521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,39657,-0.0165450344163396,0.0108502163673569,-0.0378114584963591,0.00472138966367993,0.127323230701122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,39575,-0.0107805668970811,0.00707616567961189,-0.0246498516291204,0.00308871783495816,0.12766146657996
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0124398003228416,0.0081796533815988,-0.00359232030509201,0.0284719209507753,0.128327916684769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.00884726104978953,0.00582213207437729,-0.020258639915569,0.00256411781598996,0.128642635312229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00558557373200836,0.00368514436398009,-0.0128084566854093,0.0016373092213926,0.129623998252306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42262,-0.00721327391573048,0.00476081900005182,-0.016544479155832,0.00211793132437108,0.129761863685872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.00855971880431356,0.00565013615824551,-0.0196339856744748,0.00251454806584764,0.129810971119002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.00721133817233373,0.00476240756394333,-0.0165456569976627,0.0021229806529952,0.129998599825156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,41742,-0.0150058027094915,0.00991273891081158,-0.0344347709746822,0.00442316555569917,0.130103216944491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,39959,-0.00631463288127991,0.00417629200252767,-0.0145001652062341,0.00187089944367433,0.130556846643263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0106595801268374,0.00705377311572407,-0.0244849754336566,0.00316581517998175,0.130768920238624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00550083058605594,0.00364020384237815,-0.00163396894500523,0.0126356301171171,0.130782998988216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,39649,0.0136426376589375,0.00903421375373355,-0.00406442129838023,0.0313496966162553,0.131044486840268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0100211045476701,0.00663707522401668,-0.0230297719867428,0.00298756289140261,0.131105817860383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,0.00492495609724098,0.00326210057555738,-0.00146876103085149,0.0113186732253334,0.131135368479395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,39819,0.00988341513190508,0.00654703170262848,-0.00294876700524674,0.0227155972690569,0.13117305580988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.00814027830800911,0.00539581686231671,-0.0187160793581499,0.00243552274213165,0.131417311249632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0118547828575215,0.00788587973193988,-0.0273111071321236,0.0036015414170807,0.132786844554279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42119,-0.0051732201837603,0.0034423053604238,-0.011920138690191,0.00157369832267034,0.132904715348171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.0201167415428775,0.0134080442287785,-0.0463965082312833,0.0061630251455283,0.1335474395443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00996796553337611,0.00666668355683333,-0.0230346653047694,0.00309873423801723,0.134893342563574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.00759187976022624,0.00508127721260993,-0.0175511830969417,0.00236742357648923,0.135176216278704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.0109036715270957,0.00730359020867149,-0.0252187083360918,0.00341136528190045,0.135486120534273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,39915,-0.00397072101234704,0.00266117058161104,-0.00918661535230469,0.0012451733276106,0.135701954875024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,39560,-0.00849898300127052,0.00571311909994766,-0.0196966964371679,0.0026987304346269,0.136878391078964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.00915834709389311,0.00616560512947994,-0.0212429331476738,0.00292623895988758,0.137467556424518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,39586,-0.0156844016119604,0.0105708955231115,-0.036403356837259,0.00503455361333808,0.13790807685207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,39575,0.00903716478908262,0.00609111431211949,-0.00290141926267158,0.0209757488408368,0.137926894941578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.00509769552409176,0.00343767040103728,-0.0118355295101248,0.0016401384619413,0.138131669345805
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,39657,-0.00915313045062128,0.0061879939257738,-0.0212815985451379,0.00297533764389538,0.139121841235559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0133760963590555,0.00904944805211237,-0.0311130145411957,0.00436082182308479,0.13940103439016
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.0107395631944762,0.00727114337342909,-0.0249910042063972,0.00351187781744482,0.139701089804387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.00989208599855866,0.00669841716030492,-0.0230209836327563,0.00323681163563898,0.139762512134736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,41693,0.0143982209422038,0.00975104467242179,-0.00471382661574288,0.0335102685001505,0.139811662391894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00985943737320055,0.00667887546409365,-0.0229500332828241,0.00323115853642301,0.139915415162373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0095936233002078,0.00650076615882644,-0.0223351249715076,0.00314787837109201,0.140034846137224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.00596073701040178,0.00404355934827862,-0.0138861133330279,0.00196463931222432,0.140474041815679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.00830663815373907,0.0056349651428689,-0.0193511698337621,0.00273789352628398,0.140475979773092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42296,0.00781955429920741,0.0053113274181969,-0.00259064744045851,0.0182297560388733,0.140978771446952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0119684485669714,0.00813375404658599,-0.02791060649828,0.0039737093643371,0.14119696868324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLGN,Calmegin,39649,0.00728701523145259,0.00495258572396821,-0.0024200527875251,0.0169940832504303,0.141223426400962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,41900,-0.00434426446372433,0.00295370548711839,-0.0101335272184764,0.00144499829102772,0.141373042994488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0106728703503144,0.00725840105053015,-0.0248993364093535,0.00355359570872468,0.141472829527696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42199,-0.00510657164716366,0.00347413307134201,-0.011915872466994,0.00170272917266668,0.141616383312684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0126793888779258,0.00862940329359311,-0.0295930193333683,0.00423424157751675,0.141768699659453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0110447689274309,0.00751885317754335,-0.0257817211554159,0.00369218330055409,0.141876832794128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00331191366088867,0.00225519455207461,-0.00773209498295489,0.00110826766117756,0.141977804095845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.00760079782700786,0.00517649166118943,-0.0177467214829391,0.00254512582892343,0.142042375753676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,-0.00963309243367059,0.00656444617934582,-0.0224994069451884,0.00323322207784722,0.142278337031531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.00825540177508018,0.00563393434036666,-0.0192979130821988,0.00278710953203847,0.142862227847844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.00861923498517831,0.00588985165668212,-0.0201633442322753,0.00292487426191865,0.143384420574548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.0112570534132292,0.00770270249594515,-0.00384024347882333,0.0263543503052817,0.143921924209861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0136075671307751,0.00934760281214115,-0.0319288686425717,0.00471373438102159,0.145495560833752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.00641305009320658,0.00440544837065867,-0.0150477288996976,0.0022216287132844,0.145500834898374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.0104122170581046,0.00715330698540443,-0.0244326987494973,0.00360826463328809,0.145536900226511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.0153844902732286,0.010570147262925,-0.0361019789085615,0.00533299836210436,0.145563207735872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,0.00920782712245048,0.00633459439930856,-0.0032079779001943,0.0216236321450953,0.14609102456688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,39657,-0.0100456426990302,0.00691477297221898,-0.0235985977245794,0.00350731232651899,0.146313271223906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.0103662191314984,0.00714600123810835,-0.0243723815581908,0.00363994329519394,0.146910896943456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.00648553876943296,0.00447541026391262,-0.00228626534783577,0.0152573428867017,0.147319102178031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,-0.00961854893023591,0.00665745252342627,-0.0226671558761514,0.00343005801567957,0.148547596587766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,41843,-0.0253045865333992,0.0175171989234558,-0.0596382964233726,0.00902912335657411,0.148606109910125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42137,0.00994980813235829,0.00688836930328013,-0.00355139570207076,0.0234510119667873,0.148639533877406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0166420227021774,0.0115373772868952,-0.039255282184492,0.00597123678013712,0.149200162515301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,39806,0.0042045162171798,0.00291811100337929,-0.00151498134944361,0.00992401378380321,0.14965926696074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.0130755170769149,0.00907786278789001,-0.00471709398734951,0.0308681281411793,0.149785269953284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0081342301095061,0.0056493709401029,-0.0192069971521078,0.00293853693309558,0.149938330735235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00538091941106583,0.00374041377802809,-0.0127121304160009,0.00195029159386922,0.150295393675513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.00817554104988268,0.00569087838379948,-0.0193296626821297,0.0029785805823643,0.150858768284281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00451827792381516,0.00314683864571185,-0.0106860816694104,0.00164952582178006,0.15107863535793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,-0.00709815587981726,0.00494694453400742,-0.0167941671664718,0.00259785540683729,0.151350999902183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0174695190737449,0.0121824348165132,-0.0413470913141109,0.00640805316662104,0.151597734669686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,39919,0.0120507086863967,0.00841061737519815,-0.00443410136899172,0.028535518741785,0.151943430404784
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.00796766751926076,0.00557321611863229,-0.00295583607325853,0.01889117111178,0.152849238250934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00753611138430488,0.00528501908066325,-0.0178947487824049,0.00282252601379509,0.153910030545873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,-0.0141947767866737,0.00996024096337688,-0.0337168490748924,0.00532729550154499,0.154144013433855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,0.0100366164250834,0.00705329294179153,-0.00378783774082803,0.0238610705909948,0.154768628753113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00744892496571163,0.00523961138077163,-0.017718563272024,0.00282071334060076,0.155154553900479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,39586,-0.00945472546069735,0.00666278017674507,-0.0225137746071177,0.00360432368572298,0.155916867553505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,41839,-0.0104580894141389,0.00737287895862163,-0.0249089321730373,0.00399275334475953,0.15608180782097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00679111668158803,0.00478841984831246,-0.0161764195842804,0.00259418622110438,0.156144838589288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42129,-0.00474466804112753,0.00334664969952465,-0.0113041014521958,0.00181476536994077,0.156290686843188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.00848949426776101,0.00599733458842211,-0.0202442700610684,0.00326528152554633,0.156937062259489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,39492,-0.0108115252173052,0.00764166833454387,-0.0257891951530111,0.00416614471840083,0.157152167170929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.00678441052507316,0.00479732607936447,-0.0161871696406275,0.0026183485904812,0.157324229091367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.00511005217823323,0.00361396995310683,-0.0121934332863226,0.00197332892985615,0.157392921938741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,41843,-0.0135133486715844,0.00956137344677162,-0.0322536406272568,0.00522694328408796,0.157583058739625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,-0.00613626080557984,0.00434583971099091,-0.014654106639122,0.00238158502796235,0.157981751744251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0127072223683503,0.0090067901376141,-0.0303605310380739,0.00494608630137336,0.158317027422416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,39575,0.0100556078801069,0.00715709308806692,-0.00397229457250423,0.0240835103327181,0.160054064621587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0106576108915177,0.00758618606340385,-0.0255265355757892,0.00421131379275385,0.160082985278852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00956443937074762,0.00680880515638744,-0.022909697477267,0.00378081873577177,0.160133967227641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.00689363095485919,0.00490978985235662,-0.00272955715575978,0.0165168190654782,0.160329772126921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.0139121777027335,0.00991807867292004,-0.0333516119016567,0.00552725649618983,0.160731724721425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0136392945626498,0.00972466565088805,-0.0326996392383903,0.00542105011309082,0.160779553707393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,0.00579904763846272,0.00413928307451623,-0.00231394718758908,0.0139120424645145,0.161248700942397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00718411328790008,0.00513300360985203,-0.01724480036321,0.00287657378740989,0.161658815595244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.0129797522129982,0.00927528234469243,-0.0311593056085953,0.00519980118259901,0.161723885083323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,39736,-0.00700927599028588,0.00501466790668771,-0.0168380250873938,0.00281947310682202,0.162214562455474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPART,Spartin,39736,-0.0117761056717381,0.00842877874205827,-0.0282965120061723,0.00474430066269611,0.162402104019416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.00579267375585159,0.00414775192267944,-0.0139222675243033,0.00233692001260011,0.162562857456179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,39638,0.009007764186669,0.00645024965086389,-0.00363472512902422,0.0216502535023622,0.16259250111682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,41913,0.0106901748272314,0.00765551293918215,-0.00431463053356565,0.0256949801880284,0.16261670480979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0150855609251352,0.0108094083890253,-0.0362720013676247,0.00610087951735439,0.162864594042244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,-0.00504856328484538,0.00361815383612637,-0.0121401448036531,0.00204301823396231,0.162940896952512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,0.00645431787615782,0.00463267526279304,-0.00262572563891654,0.0155343613912322,0.163582661020018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.00601619561656333,0.00432058686347664,-0.0144845458689776,0.0024521546358509,0.163809947933598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.00954653094121979,0.0068654405942056,-0.0230027945058628,0.0039097326234232,0.16439369084559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42035,-0.0101986274234869,0.00734100815680653,-0.0245870034108277,0.00418974856385385,0.164774307486554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42123,-0.0193323701645972,0.0139213631525429,-0.0466182419435813,0.00795350161438687,0.164951822201507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.00697908651869062,0.00502903640557153,-0.0168359978736108,0.00287782483622958,0.16523351102671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,0.00551788026754621,0.00397991111370233,-0.00228274551531036,0.0133185060504028,0.165642687293931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,-0.00721987506789377,0.00520897497557195,-0.0174294660200148,0.00298971588422724,0.165761243671645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00728064426248476,0.00525552359957105,-0.017581470517644,0.00302018199267451,0.165979142916414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42296,0.00772621705088065,0.0055797345731511,-0.0032100627124955,0.0186624968142568,0.166169045998305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-0.00744670154494071,0.00538156861489108,-0.0179945760301272,0.00310117294024581,0.166465664681635
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,0.00493876900076137,0.0035710965138455,-0.00206058016637581,0.0119381181678986,0.16669234652556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,39757,-0.00620942382667601,0.00449540473559572,-0.0150204171084436,0.0026015694550916,0.167219783476968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,39560,-0.0116156681834208,0.00841309286662233,-0.0281053302020006,0.00487399383515892,0.167409947326452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.00623188018588017,0.00451745026249073,-0.015086082700362,0.00262232232860166,0.167760021130774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42262,-0.00473473357262887,0.00343289598380445,-0.0114632097008856,0.00199374255562785,0.167848183550533
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,-0.00548717626195378,0.0039810296923935,-0.013289994459045,0.00231564193513748,0.168124307577767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,39757,-0.0192480362833714,0.0139808087596596,-0.0466504214523041,0.00815434888556138,0.168618112314192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,39560,-0.0098849986017294,0.0071821240337088,-0.0239619617077986,0.00419196450433984,0.168746494095362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.00934343360439035,0.00678925116548387,-0.00396349867995803,0.0226503658887387,0.168779457524124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0142200574941493,0.0103455442356404,-0.0344973241960045,0.0060572092077059,0.169306086470474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00651033893162468,0.00474103022029158,-0.0158027581633962,0.00278208030014681,0.169720222663893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0119084382292814,0.00869003530227772,-0.0289409074217458,0.00512403096318291,0.170598864649109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,0.00925215480238102,0.00675514102805901,-0.00398792161261463,0.0224922312173767,0.170825358514122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.00978619199697685,0.00714974099227864,-0.023799684341843,0.00422730034788927,0.171100888546266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.00953702268329932,0.00696811433246819,-0.023194526774937,0.00412048140833834,0.171131440675947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,0.00638066696549161,0.00466701589952582,-0.002766684197579,0.0155280181285622,0.171591019048244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.00485362885873136,0.00355606418906342,-0.0118235146692957,0.00211625695183293,0.172316116942438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00738805504926349,0.00541427869981718,-0.0180000413009052,0.00322393120237818,0.172418644804202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00271141295100647,0.00198719548437202,-0.00660631610037562,0.00118349019836268,0.172455484105971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.00449247039264652,0.00329873630381495,-0.00197305276283077,0.0109579935481238,0.173259471071387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,39934,0.00691599586016059,0.00507961540805397,-0.00304005033962519,0.0168720420599464,0.173376612685939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.00988300067555505,0.00726628516962216,-0.0241249196080145,0.0043589182569044,0.173815420992319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.00913877788464111,0.00671969957719743,-0.0223093890559481,0.00403183328666586,0.173858535030085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,41900,0.020546808465902,0.0151766202251437,-0.00919936717537961,0.0502929841071835,0.175808479374589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.00557888649663693,0.00412104295843061,-0.0136561306951609,0.00249835770188707,0.175841916047922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0056509902951757,0.00417718845381723,-0.0138382796646575,0.00253629907430607,0.17613576198531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,0.009820925181058,0.00726959835179207,-0.00442748758845446,0.0240693379505705,0.176736599211465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,-0.00782062183490847,0.00581614658822258,-0.0192202691478247,0.0035790254780078,0.178764511748625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.00714412281497968,0.00531476441104377,-0.0175610610606255,0.00327281543066611,0.178905751181199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,39638,0.00457383205964381,0.00340355481278763,-0.00209713537341995,0.0112447994927076,0.179027852280099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,-0.00612116410183902,0.00455549044440203,-0.015049925372867,0.00280759716918895,0.179076447858918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.0053217507393578,0.00396290271970566,-0.0130890400699809,0.0024455385912653,0.179334687128401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,41839,-0.00559808562977279,0.00416884347864247,-0.013769018847912,0.00257284758836645,0.179347131788871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,39929,0.00388818603448097,0.00289819745019373,-0.00179228096789874,0.00956865303686069,0.17975660895477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,39586,-0.00625806409952069,0.0046663075531445,-0.0154040269036839,0.00288789870464254,0.179910213990437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00475598998219218,0.00355298877232223,-0.0117198479759438,0.00220786801155939,0.180732392975599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,39906,-0.00472342180955172,0.00353006020291035,-0.011642339807256,0.00219549618815257,0.180904762929053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,41843,0.00690332933581769,0.00517088290869286,-0.00323160116522031,0.0170382598368557,0.181886595237346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42181,0.00554942311143351,0.00415710260105893,-0.00259849798664198,0.013697344209509,0.181923041209706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.00514321897725795,0.0038546861245341,-0.00241196582682889,0.0126984037813448,0.182135571524376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.00828504835398251,0.00621226451372093,-0.0204610868008755,0.00389099009291051,0.182342846153465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.00566376346486243,0.00425383232253931,-0.0140012748170395,0.00267374788731463,0.183067848889942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,-0.00522784607163231,0.0039266119453546,-0.0129240054845273,0.00246831334126271,0.183088672223693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0123267960236044,0.0092587202452886,-0.0304738877043701,0.00582029565716122,0.183093623168292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCT,Secretin,39649,0.00693900002285357,0.00522065128843403,-0.00329347650247714,0.0171714765481843,0.18382774078065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.00645271533287757,0.00486277668192035,-0.0159837576294415,0.00307832696368632,0.184544054718595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00347226794299348,0.00261787767786587,-0.00860330819161058,0.00165877230562361,0.184744714804348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0054991155049779,0.00414807982555729,-0.0136293519630702,0.00263112095311439,0.184961475727704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0076583946944532,0.00577815227458591,-0.00366678376373519,0.0189835731526416,0.185059571471887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0127241226972064,0.00960668498827939,-0.031553225274234,0.00610497987982125,0.185361328573645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.00919039293765802,0.00695336048236558,-0.0228189794830945,0.00443819360777851,0.186288220720363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.00552133820918121,0.00417745203801104,-0.0137091442036828,0.00266646778532043,0.186295629667207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.00735358919967378,0.00556608256196032,-0.018263111021116,0.00355593262176845,0.1864765246294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,39930,0.0172592107724361,0.0130638151714993,-0.00834586696370255,0.0428642885085747,0.186479275433805
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0104239304500226,0.00790588737181477,-0.00507160879873432,0.0259194696987796,0.187362895080615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,39757,-0.00738062114778881,0.00560270387919882,-0.0183619207510185,0.00360067845544088,0.187754413161604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,39638,0.0105774618319558,0.00803073607693693,-0.00516278087884062,0.0263177045427522,0.187824963965208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,0.00678765784441989,0.00515929086324667,-0.00332455224754359,0.0168998679363834,0.188324224799453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,0.00390500938427699,0.00296822042352558,-0.00191270264583315,0.00972272141438714,0.188332852651952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.00856026407429389,0.00650758603742429,-0.0213151327076455,0.00419460455905772,0.188387960933612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00569305177286354,0.00433133206756832,-0.00279635907957036,0.0141824626252974,0.188742882298244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.0154688936228273,0.0118008868826596,-0.0385986319128401,0.00766084466718543,0.189943577056453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0095586242487931,0.00729394936727067,-0.0238547650086436,0.0047375165110574,0.190053556332897
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,39575,-0.00490794771488372,0.00375178056415827,-0.0122614376206339,0.0024455421908665,0.190844775203853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.00889454576427343,0.00680090703633177,-0.0222243235554837,0.00443523202693685,0.190947240757747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0377630548504079,0.028895555422017,-0.0943983434775612,0.0188722337767453,0.1912803264523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,39560,-0.00845657547260916,0.00649646780585974,-0.0211896523720943,0.00427650142687593,0.193039826477619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,-0.00575070333740739,0.00442300784417905,-0.0144197987119983,0.00291839203718355,0.193566636709195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,-0.00897082431060482,0.00690098052680616,-0.0224967461431449,0.00455509752193525,0.193645844043788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,0.0117728112425809,0.00905759746878552,-0.0059800797962387,0.0295257022814005,0.193701379689991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.0175889177389592,0.013535670527816,-0.0441188319734786,0.00894099649556027,0.193811829200519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0108843405240245,0.00837848681780973,-0.0273061746869315,0.00553749363888258,0.193942960570303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.00855308189884286,0.00658910113020358,-0.0214677201140419,0.00436155631635616,0.194287127325696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,39930,-0.0145264432952801,0.0111944740846548,-0.0364676125012036,0.00741472591064336,0.194436077809198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,-0.0106556167769535,0.00822267988365519,-0.0267720693489177,0.00546083579501067,0.19503888411779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,-0.0109971403418508,0.00848853589733813,-0.0276346707006336,0.00564039001693189,0.195164354220371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.00677912537029139,0.00523932107601129,-0.0170481946792735,0.00348994393869075,0.195728395322088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.00728495113588001,0.00563352502461595,-0.0183266601841273,0.00375675791236725,0.195983577814606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.00935437795683296,0.00724082249695547,-0.0235463900508657,0.00483763413719976,0.196420480687956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.00646876658795363,0.0050076012806281,-0.0162836650979847,0.00334613192207745,0.19645231693725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.00709790403678345,0.00549979373832959,-0.0178774997639094,0.00368169169034255,0.196877606820919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.00900676067233249,0.00698257239881427,-0.0226926025740085,0.00467908122934349,0.1971153152227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.00715057107253695,0.00554389420256911,-0.0180166037095724,0.00371546156449851,0.197139102572422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00391996570643596,0.00304032756079402,-0.00203907631272031,0.00987900772559224,0.197311974615044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00621676543140383,0.00483975003987318,-0.0157026755095553,0.00326914464674762,0.198986038332031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00575158452005122,0.00447884985834397,-0.0145301302424054,0.00302696120230297,0.199110956079897
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,41843,-0.00545831191955202,0.00425160763046191,-0.0137914628752574,0.00287483903615332,0.199226334428152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00971457817907673,0.0075752327127567,-0.0245620342960799,0.00513287793792641,0.199724651360333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0106807251760919,0.00835016042770797,-0.0270470396143996,0.00568558926221567,0.2008865647994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,0.0080339851420054,0.00628259796234583,-0.00427990686419243,0.0203478771482032,0.201004987834042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00475872203314551,0.00372553966642443,-0.0120607797793374,0.00254333571304638,0.201514828056641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,0.00500397744676837,0.00392355856072398,-0.00268619733225063,0.0126941522257874,0.202201449564157
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.0101244818930764,0.00794400900868813,-0.0256947395501051,0.00544577576395236,0.202519842044557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.00785461259485044,0.00616740078264864,-0.0199427181288418,0.00423349293914088,0.202838433620492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42070,0.00774411519563565,0.00608490047486321,-0.00418228973509625,0.0196705201263675,0.203154513918112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,0.00719365433833476,0.00565704450744984,-0.00389415289626693,0.0182814615729364,0.203531946705715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42310,0.00784307522338222,0.00616879692229188,-0.00424776674430987,0.0199339171910743,0.203604099966426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.00284221654095372,0.00223573428264841,-0.00153982265303717,0.0072242557349446,0.203655979994201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.00974956747393015,0.00769293840810543,-0.00532859180595649,0.0248277267538168,0.205060245356283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGRN,Neugrin,39929,-0.00307804526394745,0.00242907223296655,-0.00783902684056189,0.00168293631266699,0.20512088097915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.00823896217974498,0.00650428088289181,-0.0209873527102129,0.00450942835072298,0.205289182536361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.00946764520197924,0.00748318733766374,-0.0051994019798417,0.0241346923838002,0.205829659235285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.00882317066791506,0.00697436175592474,-0.00484657837369743,0.0224929197095275,0.205862600315586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00907659296578038,0.00717584595951411,-0.023141251046428,0.00498806511486728,0.205940320545619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42189,-0.00620691333519698,0.00490799917849544,-0.0158265917250481,0.00341276505465408,0.20601761969863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.0038010142515171,0.00300792271029984,-0.00969654276370478,0.00209451426067058,0.206371386779729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00449926132952034,0.00356875687872403,-0.0114940248118194,0.00249550215277875,0.207430673261948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42123,-0.00609485232391476,0.0048347064767495,-0.0155708770183438,0.00338117237051427,0.20745824665482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,-0.00695388153519448,0.00551965535384105,-0.0177724060287229,0.00386464295833398,0.207749364302824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.00842600562801196,0.00668878231764194,-0.0215360189705902,0.00468400771456624,0.207791416756545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.00703680564125269,0.005586539721132,-0.00391281221216603,0.0179864234946714,0.207840269033057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,0.00513990438736288,0.00408826647439875,-0.00287309790245866,0.0131529066771844,0.20869599050495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.00295397831414683,0.00235102826179671,-0.00165403707897473,0.00756199370726839,0.208974184300072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.00865201786596741,0.00688606978684241,-0.00484467891624372,0.0221487146481785,0.208974211217763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.0155104487161731,0.012380132562341,-0.00875461110601528,0.0397755085383614,0.210286569281447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0103374886106532,0.00828294800807111,-0.0265720667064726,0.00589708948516615,0.212040503398246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.012835838647668,0.0103025198620278,-0.00735710028190659,0.0330287775772425,0.212830266611934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,-0.00719777170527961,0.00577733105926943,-0.0185213405814477,0.00412579717088847,0.212839929343932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42196,-0.00472763922938126,0.0037989711311091,-0.0121736226463551,0.00271834418759258,0.213354512316919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,39575,-0.00785629787492819,0.00631450298123807,-0.0202327237181548,0.00452012796829842,0.213464581156959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENG,Endoglin,42310,-0.00232099847513849,0.00186845236737192,-0.00598316511518746,0.00134116816491047,0.214182656432219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.00565542613194908,0.00455994262630356,-0.0145929136795041,0.0032820614156059,0.214907988848687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00798347272578739,0.00644830746779437,-0.0206221553626644,0.00465520991108958,0.21571560284749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.00903087098969094,0.00731511387426981,-0.0233684941832598,0.00530675220387788,0.217019428705608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,-0.00745692083298432,0.00605350624344416,-0.0193217930701349,0.00440795140416623,0.218037093431598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0105964434692029,0.00860476025691143,-0.0274617735727493,0.00626888663434349,0.21817164212183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42166,0.0077517380369691,0.00631056109110357,-0.00461696170159389,0.0201204377755321,0.219327386063864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,-0.0102714989028327,0.00836196816782991,-0.0266609565117794,0.00611795870611388,0.21933865677027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.0083521202951122,0.00680300452514231,-0.00498176857416673,0.0216860091643911,0.219581832332468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.00743164275869492,0.00605776746542982,-0.0193048669909374,0.00444158147354752,0.219925529115775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00688163390542264,0.00561007916134992,-0.0178773890616685,0.0041141212508232,0.219979037640218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0104380868119357,0.00851686270556334,-0.0271311377148399,0.00625496409096842,0.220383304195101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,-0.00493345406195368,0.0040280319685059,-0.0128283967202252,0.00296148859631788,0.220683880606083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.0066256988100824,0.00542524108352254,-0.0172591713337866,0.00400777371362176,0.222008995006159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0135865731750249,0.0111504347006687,-0.0354414251883355,0.00826827883828571,0.223067951871764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELP,P-selectin,42217,-0.00733885341121556,0.00602489029928104,-0.0191476383978064,0.00446993157537528,0.223211207355444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,39649,-0.00641117950013474,0.00527456404606006,-0.0167493250304125,0.00392696603014298,0.224205256435182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,39990,0.00987832294211241,0.00812798147978899,-0.00605252075827401,0.0258091666424988,0.22425872784474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00311068222000668,0.00255951052145259,-0.0019059584020404,0.00812732284205376,0.224261437518849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42146,-0.0073825172479162,0.00609923999033103,-0.019337027628965,0.00457199313313262,0.226146739714132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,39575,-0.00514078908195039,0.00424933773681396,-0.0134694910461057,0.00318791288220497,0.226387096851271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,0.00515730691200787,0.00426550505801979,-0.00320308300171092,0.0135176968257266,0.226659958860676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.014549386076708,0.0120813491230003,-0.0382288303577886,0.00913005820437253,0.228501018320349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0108654618411417,0.00903500147602354,-0.0285740647341478,0.00684314105186444,0.22915760659418
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,-0.00372732562274679,0.00310158995118944,-0.00980644192707809,0.00235179068158451,0.229487569436314
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00439143505012726,0.00365593840922911,-0.00277420423196179,0.0115570743322163,0.229707694788412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.00552699055966317,0.00460228737012468,-0.0034934926857812,0.0145474738051075,0.229802622470486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,0.00715847441948184,0.00597423517460348,-0.00455102652274097,0.0188679753617047,0.230851114297628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00723939672578269,0.00604812267906555,-0.0190937171767512,0.00461492372518579,0.231345666571889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.00630427693349671,0.00527651169030051,-0.0166462398464857,0.0040376859794923,0.232193399255529
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,39757,-0.00725730481954899,0.0060917475364902,-0.0191971299910698,0.0046825203519718,0.233547907381902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.00252900478276324,0.00212287453450843,-0.00668983887039977,0.00163182930487329,0.233552013121704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.011580146023233,0.00973826489587146,-0.030667145219141,0.00750685317267508,0.234406119478652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00582406439310596,0.0049085933507228,-0.0154449073605227,0.00379677857431073,0.235448916498293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEP,Leptin,42145,0.00892185132819716,0.00752577839439852,-0.00582867432482393,0.0236723769812182,0.235838456885821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.00813579322960002,0.00686313392638541,-0.0215875357253154,0.00531594926611539,0.235867118900948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,39560,-0.00469042781553925,0.00395706993937511,-0.0124462848967145,0.00306542926563598,0.235913284601148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,39757,-0.00455011139669783,0.00384924487790543,-0.0120946313573925,0.00299440856399682,0.237199562911558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.00840756550437884,0.00712012799928688,-0.0223630163829811,0.00554788537422344,0.237696674076755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.00682996963722591,0.00580473150602793,-0.0182072433890407,0.00454730411458883,0.239371489002466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,0.0138486970124325,0.0117741933099389,-0.00922872187504786,0.0369261158999128,0.239543380641795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.00476468834132896,0.00405473973466736,-0.012711978221277,0.00318260153861906,0.239983012252372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,0.00631877571061019,0.00539238251438455,-0.00425029401758354,0.0168878454388039,0.241304149242349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.00386442841596755,0.0033061164385395,-0.010344416635505,0.00261555980356986,0.242479619457177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.00800215550769621,0.00684677027095973,-0.0214218252387773,0.00541751422338486,0.242525841207471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0078497437778882,0.00672138691395129,-0.0210236621292327,0.00532417457345632,0.242877499453509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00719129582662429,0.00615797432294504,-0.0192609254995966,0.00487833384634799,0.242907483086792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.00347011004503969,0.00297561922267667,-0.00930232372148596,0.00236210363140658,0.243561634098846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,41538,0.00357921785751849,0.00307023395485217,-0.00243844069399176,0.00959687640902874,0.243724827634258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,0.00854099475801519,0.00732721099836959,-0.00582033879878921,0.0229023283148196,0.243774861082717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.00603045674116321,0.00517772492203459,-0.016178797588351,0.00411788410602459,0.244168060485432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.00986886904575863,0.0084838066817283,-0.00675939205042884,0.0264971301419461,0.244744676948711
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0050823360259419,0.00436989211711201,-0.0136473245754814,0.00348265252359764,0.244835679435494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.00755912424876791,0.00650791359897796,-0.0203146349027647,0.00519638640522889,0.245451712122887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.00502290986519685,0.00432439559431396,-0.0134987252300522,0.00345290549965852,0.245451759284101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.0091323922275504,0.00786550602777669,-0.0245487840419927,0.00628399958689191,0.245638395869439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,39638,0.00873704867742713,0.00752905570482683,-0.00601990050403346,0.0234939978588877,0.245893116143041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.00472235909526168,0.0040740466242373,-0.0127074904787668,0.00326277228824343,0.246427474261188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.012281138605132,0.0106144828599355,-0.00852324780034168,0.0330855250106056,0.247285800633046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,39919,-0.00716766234906178,0.00620073967838623,-0.0193211121186988,0.00498578742057523,0.247731461718204
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,39560,-0.00766223325251003,0.00662956203116066,-0.0206561748335849,0.00533170832856487,0.24780140747171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.00618043189243391,0.00535339911710615,-0.016673094161962,0.00431223037709415,0.248324745997035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0160833597189206,0.0139674124538436,-0.0434594881284541,0.0112927686906128,0.249550326668595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00559920575544605,0.00486324619488239,-0.0151311682974155,0.00393275678652343,0.249616910245951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.00648334602907539,0.00563269781099357,-0.0175234337386228,0.00455674168047201,0.249744255621672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00629040483953867,0.00546755598021004,-0.004426004881673,0.0170068145607503,0.24996427180252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.00752381685939219,0.00655403095506807,-0.0203697175313256,0.00532208381254123,0.251002303029747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,0.00480606561172894,0.00418869151407715,-0.00340376975586227,0.0130159009793201,0.251244420326009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00828926046743564,0.00722953866320696,-0.0224591562473213,0.00588063531245002,0.251579301273983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.0102096341171829,0.00891103844173098,-0.00725600122860985,0.0276752694629756,0.251928052402613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.00295960446843387,0.00258816678328041,-0.00211320242679573,0.00803241136366348,0.252845726427565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.00931850795854514,0.00816198367721239,-0.0253159959658814,0.00667898004879115,0.253600168582051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.00499308745285632,0.00437352992872656,-0.0135652061131604,0.00357903120744775,0.253615283276906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00497432484455602,0.00436369870995713,-0.013527174316072,0.00357852462695995,0.254338621331593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0112188531077305,0.00984698136912855,-0.0305189365912225,0.00808123037576142,0.254594844340664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00939508530117575,0.00827325941481868,-0.0256106737542204,0.00682050315186886,0.256149823977097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,39757,-0.00285033836974346,0.00251108521680965,-0.00777206539469037,0.00207138865520345,0.256356881836869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,-0.00728763181663934,0.00642634179194655,-0.0198832617288546,0.0053079980955759,0.256808106251844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,39990,-0.00607189242943317,0.00535642249940463,-0.0165704805282662,0.00442669566939991,0.256997836363339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,0.00447623657217784,0.00394955314753478,-0.00326488759699033,0.012217360741346,0.257090975796237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,0.0108492822235734,0.0095747623377944,-0.00791725195850365,0.0296158164056504,0.257191020961858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.00453278268181938,0.00400584073254886,-0.0123842305176151,0.00331866515397639,0.257846475927955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.012233145159844,0.0108184828860364,-0.00897108129678741,0.0334373716164755,0.258178589110339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,0.00760559025000183,0.00672639052811724,-0.00557813518510795,0.0207893156851116,0.258201531852605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00679649166441856,0.00601468661315997,-0.0185852774262121,0.00499229409737499,0.258507817112424
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.00786716842448252,0.00697682147108289,-0.021541738507805,0.00580740165883994,0.259506434916703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00444823715586535,0.00394762817444245,-0.0121855883777725,0.00328911406604184,0.259846359453666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,0.0124143674803866,0.011019504973157,-0.00918386226700116,0.0340125972277745,0.259944221324187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.00561723818484403,0.00500105663349058,-0.00418483281679751,0.0154193091864856,0.261372769816651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,39586,-0.00913775171283444,0.00813566093478118,-0.0250836471450056,0.00680814371933668,0.261388726924062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,41913,-0.0058881596870422,0.00524837375922425,-0.0161749722551217,0.00439865288103733,0.261924452217692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.00937345566071135,0.0083558286910845,-0.025750879895237,0.00700396857381427,0.26197357514521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OCLN,Occludin,39934,-0.00538178144032452,0.00479767718215579,-0.0147852287173499,0.00402166583670083,0.26199366217886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00799118908306099,0.00712832429482683,-0.0219627047009216,0.00598032653479961,0.262291835037562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,39720,-0.00442577884941148,0.00395233925517671,-0.0121723637895578,0.00332080609073488,0.262828646855463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.00358844196913731,0.00320596318103672,-0.00269524586569466,0.00987212980396928,0.263035723378607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.00576637743959517,0.00516790762729048,-0.0158954763890845,0.00436272150989417,0.264529246836512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.0043295853612419,0.00388608007271817,-0.00328713158128571,0.0119463023037695,0.265249093105936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,39990,0.0088211330551624,0.00793688738801375,-0.00673516622534455,0.0243774323356694,0.266415529513681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.00875606532487922,0.00788159392917304,-0.0242039894260584,0.00669185877629994,0.266609488098059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.00496461141170859,0.00447102025454114,-0.0137278111106092,0.00379858828719204,0.266851799643778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00443530892910753,0.00399785827420601,-0.00340049328833625,0.0122711111465513,0.267268538381322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,0.00888561117896313,0.00802118847293076,-0.00683591822798116,0.0246071405859074,0.267982397472032
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.00744247219601895,0.00672622493179383,-0.0206258730623349,0.00574092867029696,0.26854023278683
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.00798473986759951,0.00722111814661166,-0.0221381314349584,0.00616865169975935,0.268858903094013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.00469627722947161,0.0042500742555332,-0.0130264227703167,0.00363386831137347,0.269184805893391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00448103777412275,0.00405606312632774,-0.0124309215017251,0.00346884595347963,0.269280480233794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0033707507805279,0.00305153752872659,-0.00261026277577622,0.00935176433683202,0.269353981261149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRTN,Neurturin,41913,-0.00590883476137685,0.00535166567815238,-0.0163980994905555,0.00458042996780181,0.269564798311687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,0.00997476244535788,0.00904212575219108,-0.00774780402893663,0.0276973289196524,0.269988273320948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,39908,-0.0102090737954462,0.00928442252633835,-0.0284065419470694,0.00798839435617692,0.271533475901265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.00438955606117868,0.00399473120960035,-0.0122192292319954,0.00344011710963801,0.271859322652603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,0.0053043654076546,0.00483091777271229,-0.0041642334268615,0.0147729642421707,0.272226799470993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,39586,-0.011020891349034,0.0100397909656601,-0.0306988816417279,0.00865709894365979,0.272350309702017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00373085688292305,0.00341096275861705,-0.0104163438898125,0.00295463012396636,0.274073517398496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00807759958424578,0.00739122500607922,-0.0225644005961611,0.0064092014276695,0.2744777501766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.00928155367071578,0.00850004390202591,-0.007378532377255,0.0259416397186866,0.274881922566092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00615459227705611,0.0056420643100803,-0.0172130383248135,0.00490385377070128,0.275367050867547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,41668,-0.00432407130756062,0.00396663738602911,-0.0120986805841777,0.00345053796905643,0.275684766933804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,39966,-0.0109491608561529,0.0100474726535916,-0.0306422072571924,0.00874388554488661,0.275849565637706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0072328573723609,0.00664011216386441,-0.0202474772135351,0.00578176246881333,0.276055833827079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,39586,-0.00494163771284151,0.0045372303797063,-0.0138346092570658,0.00395133383138283,0.276120064643192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.00679083135714949,0.00624044241725253,-0.00544043578066547,0.0190220984949644,0.276527651615376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,39919,0.00261424294458013,0.00240343359867111,-0.00209648690881525,0.00732497279797551,0.276745542966546
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,39919,0.00469386196212648,0.00431783949338803,-0.00376910344491406,0.013156827369167,0.277022044862023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.00615988049786283,0.00567517523109367,-0.00496346295508076,0.0172832239508064,0.277764114408682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.00515805118651451,0.0047558414180392,-0.0144795003658713,0.00416339799284233,0.278134478362986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,0.00926399806880667,0.00854330590735498,-0.0074808815096091,0.0260088776472224,0.27822999135801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00331379895803099,0.00305854920985235,-0.00268095749327962,0.0093085554093416,0.27863037077266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.00329431944623358,0.00304455561121232,-0.00267300955174257,0.00926164844420974,0.279255803915122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.00698307052358162,0.00646381646265243,-0.0196521507903804,0.00568600974321716,0.280013517176592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.00775059759652735,0.00717775396350946,-0.00631780017195119,0.0218189953650059,0.28024726346473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.0066641547924144,0.00617514302446315,-0.0187674351203622,0.00543912553553337,0.28052657116503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,0.0113087253402774,0.0105063253561744,-0.00928367235782439,0.0319011230383792,0.281783940161913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00454909802593615,0.00422809379118142,-0.00373796580477943,0.0128361618566517,0.281985941723127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,-0.0127778615393204,0.0118763353882088,-0.0360554789002096,0.0104997558215689,0.281986865257402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.00334081293226523,0.00310891999143086,-0.00943429611546972,0.00275267025093925,0.282577674572581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.011408360961565,0.0106188456940286,-0.0322212985218611,0.0094045765987311,0.282688551794245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,0.00904382717771052,0.00842215502987079,-0.00746359668083623,0.0255512510362573,0.282928957328509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,0.00970379599678339,0.00905132616672064,-0.00803680328998906,0.0274443952835558,0.283700615042936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.00375788067545223,0.00350820072855689,-0.0106339541034237,0.00311819275251927,0.284115592038133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,41913,-0.00456207404364179,0.00426011843533009,-0.0129119061768888,0.00378775808960518,0.284242970655729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.00878059336719887,0.0082001174986014,-0.0248528236644576,0.00729163693005987,0.284283957864846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,39649,-0.00556266656259441,0.00520159567331953,-0.0157577940823007,0.00463246095711187,0.28490588902041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0074919773662853,0.00700795947688527,-0.0212275779409804,0.00624362320840984,0.285058440713108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.00607663006463702,0.0056868263740825,-0.00506954962856467,0.0172228097578387,0.285293846343194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.00459124358384953,0.00429817841106506,-0.0130156732695371,0.00383318610183799,0.285456779616748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.022180965371233,0.0207854263479495,-0.018558470270748,0.062920401013214,0.285927606168343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.00365163959326464,0.00342975578365838,-0.0103739609292351,0.00307068174270578,0.287037822641741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0106491858329888,0.0100088719119536,-0.0302665747804179,0.00896820311444033,0.28735910181414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.00420235249531595,0.00395084483315036,-0.0119460083682907,0.00354130337765876,0.287505779690547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.00479204051633905,0.00451574500733183,-0.0136429007307094,0.00405881969803132,0.288628491626098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.00724872000773092,0.00684077883772696,-0.0206566465296758,0.00615920651421393,0.289334200479004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,41900,-0.00511695381699648,0.00483005486297476,-0.014583861348427,0.00434995371443406,0.289437482873922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,39930,0.00819399733532331,0.00773570577671303,-0.00696798598703424,0.0233559806576809,0.289511404880799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,41839,0.00592671496856265,0.00559652730631349,-0.0050424785518118,0.0168959084889371,0.289619706646305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.00771000902352601,0.00728771070919838,-0.0219939220135548,0.00657390396650281,0.290102271747165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.00664297741586194,0.00628108998180849,-0.0189539137802066,0.00566795894848271,0.290253372787019
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0128921148576319,0.012210740015545,-0.0368251652881,0.0110409355728362,0.291077883386559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,39657,-0.00492746874082996,0.00467295291128005,-0.0140864564469389,0.00423151896527894,0.291692779407297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.00530021186792783,0.0050325240785619,-0.0151639590619092,0.0045635353260535,0.292276393686966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00575911589190896,0.00547293298254304,-0.0164860645376933,0.0049678327538754,0.29268908107353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.00953744499439296,0.00908891520157794,-0.0273517187894857,0.00827682880069979,0.294036233471358
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.012205884296165,0.0116321060505631,-0.0350048121552687,0.0105930435629387,0.294049916765388
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.00693939076328858,0.00661803109426199,-0.0199107317080421,0.00603195018146492,0.29440446131602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0149522408490737,0.0142671721777178,-0.0429158983174006,0.0130114166192531,0.294653638285664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,-0.0062494777358023,0.0059639378305613,-0.0179387958837024,0.00543984041209784,0.294717988714578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0115635154672676,0.0110499433124364,-0.0332214043596429,0.0100943734251076,0.295363608780101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.00401223205418693,0.00383599581085408,-0.0115307838434609,0.00350631973508706,0.295609794715144
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0084194506973499,0.00805132168939389,-0.0242000412085619,0.00736113981386212,0.29571168573731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,0.00503185667884012,0.00482118573516184,-0.00441766736207709,0.0144813807197573,0.296648602602083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,39736,-0.00751159308607106,0.00720008753273288,-0.0216237646502275,0.00660057847808537,0.296848624006458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00311111556937835,0.0029839377647835,-0.00895963358835401,0.0027374024495973,0.297142904385409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.00346752336408585,0.00333049279793876,-0.00306024251987411,0.00999528924804581,0.297831737910749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.00288895053728505,0.00277546067018323,-0.00255095237627407,0.00832885345084417,0.297944969198058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0112116050489637,0.0107999266232867,-0.0323794612306055,0.00995625113267815,0.29923698412595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.0119737929392705,0.0115428490343665,-0.0106501911680878,0.0345977770466288,0.299598718049932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42262,0.00523009700804825,0.00505074037289169,-0.00466935412281945,0.015129548138916,0.300448679200564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.00697219760858479,0.00673450876716718,-0.0201718347922325,0.00622743957506289,0.300550465457621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.00551539522709574,0.00533866191773011,-0.0159791725858468,0.00494838213165528,0.301573515359616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.00598761912347619,0.00579931275020448,-0.0053790338669246,0.017354272113877,0.301870314120816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,39657,-0.00371418826679806,0.00360576811238612,-0.0107814937670749,0.00335311723347874,0.303000366985464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.00577393836665693,0.00560772571138499,-0.00521720402765765,0.0167650807609715,0.303197863316049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MB,Myoglobin,42310,-0.0062377661472719,0.00606585527878233,-0.0181268424936853,0.00565131019914146,0.303807712028691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.00729067866839446,0.00709501941627432,-0.0211969167242921,0.00661555938750321,0.304171348956797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,0.0137919372682994,0.0134603801526214,-0.0125904078308385,0.0401742823674373,0.305559406437824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,0.0117809231469757,0.0115086705411513,-0.0107760711136807,0.0343379174076322,0.306020036019472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,41913,0.00897362442542557,0.00877053485167539,-0.00821662388385819,0.0261638727347093,0.306252734123896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,-0.00762113013796149,0.00746069639369199,-0.0222440950695978,0.0070018347936748,0.307038147916521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.003914620669415,0.00383234009085374,-0.0114260072474883,0.00359676590865834,0.307054301260799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.00544471278566847,0.00533205791085439,-0.00500612071960614,0.0158955462909431,0.307212526946977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,-0.00445255329864059,0.00436688463015174,-0.013011647173738,0.00410654057645683,0.307932234926985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.00551216980506871,0.0054259916544572,-0.0161471134478048,0.00512277383766739,0.309703922174606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,39934,0.00666834600181339,0.00657368754312089,-0.00621608158270355,0.0195527735863303,0.310413769792894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.00292682136777378,0.00288708325889484,-0.00858550455520767,0.00273186181966011,0.310717707213757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42296,0.00495965317747486,0.00491415978567917,-0.00467210000245632,0.014591406357406,0.312868932126158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.00830214897228358,0.00823080015467108,-0.0244345172754389,0.00783021933087174,0.313155178574456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,39929,-0.00421558663681204,0.00419999843753188,-0.0124475835743745,0.00401641030075045,0.315539140440808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.00456753533367416,0.00455210425732354,-0.0134896596780283,0.00435458901067998,0.315694937948009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.00259978828612116,0.00259521433785999,-0.00248683181608441,0.00768640838832674,0.316476240410599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.00473651643493704,0.00473179671370123,-0.00453780512391738,0.0140108379937915,0.316849421508623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00687435686276593,0.00686993398924911,-0.0203394274816942,0.00659071375616233,0.317020747210915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.00314325331633587,0.00314653039719044,-0.00931045289482912,0.00302394626215739,0.317836145295796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,0.00832491100834078,0.00834736828201134,-0.00803593082440144,0.024685752841083,0.318635896802542
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,0.00272939653014911,0.00274616753087693,-0.00265309183036967,0.00811188489066789,0.320296217459023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,41997,-0.00676162577608651,0.00680650197187787,-0.0201023696409671,0.00657911808879412,0.320529659850766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,0.0088807664432776,0.00894072510300697,-0.00864305475861607,0.0264045876451713,0.320587978396688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42168,0.003460967734106,0.00348592452903242,-0.00337144434279754,0.0102933798110095,0.320805299752887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,0.00296213758074905,0.0029907324598074,-0.00289969804047346,0.00882397320197156,0.321980952821095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00856111428103545,0.00868615809202294,-0.0255859841414004,0.00846375557932953,0.324348727443318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00920318011299998,0.00934842549661427,-0.0275260940863639,0.00911973386036398,0.324909204931405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0037411476825282,0.00380352326570567,-0.00371375791825492,0.0111960532833113,0.325329315733567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,39930,0.00723787062999964,0.00736078234713605,-0.00718926277038703,0.0216650040303863,0.32547991454927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.0118430887231412,0.0120636154941402,-0.0354877750916559,0.0118015976453735,0.326255902337795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.00521865299747826,0.00531674459405553,-0.00520216640687058,0.0156394724018271,0.326342849395251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7,Complement component C7,39722,-0.00353612636833206,0.00361032670964526,-0.0106123667192368,0.00354011398257265,0.327380098045407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,39657,-0.00638172847999681,0.0065189591633355,-0.0191588884401344,0.00639543148014076,0.32762660305384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,0.00481656217488599,0.00492590112476607,-0.0048382040296555,0.0144713283794275,0.328193046685901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.00800244168826182,0.0081955042812112,-0.0240656300794358,0.00806074670291214,0.328862293866619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.00758122722018292,0.00776773760931496,-0.0228059929344402,0.00764353849407439,0.329087087265356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.00514925265004943,0.00527618998904421,-0.0154905850285761,0.00519207972847723,0.329114832830333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,-0.00339832283152218,0.00348656744067322,-0.0102319950152417,0.00343534935219733,0.329735167616434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,39657,-0.00346531593039363,0.00357333684200415,-0.0104690561407218,0.0035384242799345,0.332182213914214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42099,-0.00504474888520266,0.00520296957142443,-0.0152425692451945,0.00515307147478922,0.332268116051063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.00744032450181113,0.00768683393391645,-0.0225065190122874,0.00762587000866512,0.333096090439627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.00329109478022184,0.00340472341834559,-0.0099643526801792,0.00338216311973552,0.333751568681452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,39475,-0.00413095561116527,0.00429537412484474,-0.012549888895861,0.00428797767353042,0.336210672148137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,-0.0059996977632518,0.00629657408254587,-0.0183409829650417,0.00634158743853811,0.340686464782223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.00405382884028777,0.00426382358569,-0.0124109230682402,0.00430326538766464,0.341748384448962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,39919,0.00864741022419209,0.00909701052309077,-0.00918273040106582,0.02647755084945,0.341839374969304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.00263513529012842,0.00277224829438264,-0.00806874194711839,0.00279847136686155,0.341854392828285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.00734463018962858,0.00774841438516941,-0.0225315223845606,0.00784226200530347,0.343203209727068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,0.00978416793453484,0.0103309530707741,-0.0104645000841824,0.030032835953252,0.343618288315148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0120554338224115,0.0127333394423843,-0.0129019114846618,0.0370127791294847,0.343781216653235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.00590038161256848,0.00623342563252855,-0.0181178958523244,0.00631713262718747,0.34387408764969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.00490844777154216,0.00518701852403051,-0.015075004078642,0.00525810853555764,0.344018406262422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.00385153382646382,0.00408849895876899,-0.00416192413272341,0.011864991785651,0.346188459977368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.00461853830139306,0.00490446226933652,-0.0142312843492926,0.00499420774650651,0.346366182901399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00548128512896988,0.00582116653203728,-0.016890771531763,0.00592820127382319,0.346410990610583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00449657977083506,0.00477605632795309,-0.0138576501736231,0.004864490631953,0.346477067781261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.00168485151848273,0.00179017932872848,-0.00519360300279055,0.00182389996582509,0.346641035862472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0118860903005753,0.0126328424959916,-0.0366464615927188,0.0128742809915681,0.346779114551288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00491574184550537,0.0052337639390958,-0.0151739191661331,0.00534243547512239,0.347630094349119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.00469623584342408,0.00500141361043169,-0.0144990065198702,0.00510653483302203,0.347760177231058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.00236002879765923,0.00251538382416447,-0.00729018109302158,0.00257012349770313,0.348138830850803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.00316077246452645,0.00337037559175107,-0.00976670862435854,0.00344516369530564,0.348361979169849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.00962843996032548,0.0102680109858138,-0.0297537414925205,0.0104968615718696,0.348408968054997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,39586,-0.0034293559152006,0.00366455604243626,-0.0106118857583757,0.00375317392797448,0.349387695616246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.00753197752498771,0.00805031617188441,-0.00824664217190575,0.0233105972218812,0.349493135035253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,39575,-0.00399903557886378,0.00427588938545956,-0.0123797787743645,0.00438170761663695,0.349678844882966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00306724222206038,0.00328414737142293,-0.00950417107004932,0.00336968662592856,0.350348203646264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.00690687046603495,0.00741471845838737,-0.0214397186444742,0.00762597771240429,0.351607419489655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0106577217306969,0.011443376229578,-0.0330867391406698,0.0117712956792759,0.351695909796675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42310,0.00459737490781237,0.00494914077607633,-0.00510294101329725,0.014297690828922,0.35294490565601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0042856741161839,0.00462737130957139,-0.0133553218829438,0.00478397365057602,0.35438072744909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,39929,0.0137626760254772,0.0148723506130999,-0.0153871311761987,0.042912483227153,0.354784485584017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.00429607795303453,0.00464919324954593,-0.0134084967221446,0.00481634081607548,0.355477918645192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42145,-0.00546320243659101,0.00591537242758225,-0.0170573323946522,0.0061309275214702,0.355731804571082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.00730413020451079,0.00791128064071639,-0.0228102402603149,0.00820197985129333,0.355893988042027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.00582656115617045,0.00631187928302631,-0.018197844550902,0.00654472223856112,0.35596644223357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.00663695828586023,0.0071955746403446,-0.0207402845809356,0.00746636800921519,0.356357620012079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.00510964253548647,0.00555013069308204,-0.0159878986939273,0.00576861362295432,0.357261401414216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,39560,-0.00302970464876787,0.00329562848028067,-0.00948913647011799,0.00342972717258224,0.357953612114327
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.00803929764621101,0.00877794535129673,-0.0252440705347526,0.00916547524233058,0.359764582495006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00544287145296299,0.00595808898817939,-0.0171207258697946,0.00623498296386861,0.360985862077932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.00479983016320237,0.00526875786637427,-0.015126595581296,0.0055269352548912,0.362315532226858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00578857993101341,0.00637002400474058,-0.018273826980305,0.00669666711827813,0.363516779079307
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.00400292932096236,0.00440682645206426,-0.0126403091670083,0.00463445052508359,0.363714507459557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00641055207209629,0.00708632927149653,-0.0202997574442295,0.00747865330003691,0.36567752791626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.00944141261573203,0.0104429049428954,-0.029909506303807,0.011026681072343,0.365959513020614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,39657,-0.00561839309489242,0.00621984117139969,-0.0178092817908358,0.00657249560105098,0.366385473681057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,-0.00472990384671315,0.00523977240237304,-0.0149998577553643,0.005540050061938,0.366708868444225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.00564137537347477,0.00625053570512991,-0.0178924253555294,0.00660967460857985,0.366787868166469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00484797285095954,0.0053778594970112,-0.0153885774651015,0.00569263176318241,0.367358720471763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.00966985606744015,0.0107299930879705,-0.0307006425198624,0.0113609303849821,0.36749872401136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.00662630570672807,0.00736209201516936,-0.02105600605646,0.00780339464300388,0.368105561949607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.00672245246136992,0.00749055337117607,-0.021403937068875,0.00795903214613519,0.369494588124125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,39575,-0.00342613282565056,0.00382225577921143,-0.010917754152905,0.00406548850160385,0.370077999655017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.00546571688964917,0.00611831471039432,-0.0065261799427237,0.017457613722022,0.371692964390177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00285052759056815,0.00319928865348366,-0.00912113335139613,0.00342007817025982,0.372955029861915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.00346225154099316,0.00390009325436245,-0.0111064343195436,0.00418193123755725,0.374699040663457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00299863818371538,0.00338833166725656,-0.00963976825153825,0.00364249188410748,0.376178324715627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.00506662530996537,0.00575283548640687,-0.0163421828633228,0.0062089322433921,0.378489909561181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.00630617147854317,0.00717525634710999,-0.0077573309617924,0.0203696739188787,0.379486322317822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,39575,-0.00424783189509323,0.00484366811219732,-0.013741421395,0.00524575760481352,0.380513127177807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,-0.0055762158778074,0.00636358184079923,-0.0180488362857739,0.00689640453015909,0.380902473141337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0103008479533722,0.0117735112338994,-0.0333769299718149,0.0127752340650706,0.381638064575443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.00531070231171933,0.00608378971767429,-0.00661352553492228,0.0172349301583609,0.382721749762822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,0.00582339559000374,0.00667232214631321,-0.00725435581677015,0.0189011469967776,0.382808147442222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,39757,-0.00547359737629178,0.00627492026178837,-0.017772441089397,0.00682524633681343,0.383064862140393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGN,Cingulin,39649,0.00353077215885483,0.00405827972899623,-0.00442345610997778,0.0114850004276874,0.384310040520902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.0107428005351272,0.0123638252454851,-0.0134902969460237,0.034975898016278,0.384925785583512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.00434883297283469,0.00501195119665526,-0.014172257318279,0.00547459137260962,0.385577891859799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00329221512315966,0.00379608574774267,-0.0107325431887353,0.00414811294241597,0.385815364568519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.00491021601408233,0.00567786689707101,-0.0160388351323415,0.00621840310417685,0.387167516260196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,41997,-0.00648733977873824,0.00750499343038053,-0.0211971269022841,0.00822244734480759,0.387381952928814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,39638,-0.00278857168218272,0.00322991604047464,-0.00911920712151301,0.00354206375714758,0.387959792229438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,39586,-0.00600786542494418,0.00696374447848954,-0.0196568046027837,0.00764107375289533,0.388302069453843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.00622794457305255,0.00722757310529964,-0.0203939878594399,0.00793809871333475,0.388872456468411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.00519114043521962,0.00602848257418987,-0.0170069662806318,0.00662468541019252,0.389196810613652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00266604845223595,0.00310027266178571,-0.00874258286933594,0.00341048596486403,0.389837296083113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,-0.00161299744124299,0.00188163816132617,-0.00530100823744227,0.0020750133549563,0.39133277952052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.00441995971272378,0.00516052984598804,-0.0145345982108603,0.00569467878541279,0.391740450718156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42085,0.00772396200437703,0.00902120726887041,-0.00995760424260898,0.025405528251363,0.391902110010836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.00661297991289325,0.00772976464807638,-0.0217633186231229,0.00853735879733645,0.392277980200739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,39929,0.010040808796244,0.0117549403836407,-0.0129988743556918,0.0330804919481799,0.393024557912865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00928302049188768,0.0108989511568425,-0.0306449647592989,0.0120789237755235,0.394379364054446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.00286826740339372,0.00337068519453616,-0.00947481038468459,0.00373827557789714,0.394814885885384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,0.00437515463868562,0.00515102644788826,-0.00572085719917538,0.0144711664765466,0.395690894997225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.00526954748820147,0.00621598983212131,-0.0174528875591592,0.00691379258275631,0.396600587400404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,39560,-0.0042916532234947,0.00506360994321567,-0.0142163287121974,0.005633022265208,0.396708170126907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00685902991458585,0.00809462070221529,-0.0227244864909278,0.00900642666175612,0.396814889823266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,39560,-0.00428833007748227,0.00506867502561952,-0.0142229331276965,0.00564627297273198,0.397545791095936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,39946,0.00436677612880362,0.00516289157547957,-0.00575249135913634,0.0144860436167436,0.39768189909543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,-0.00369164724821613,0.00436495189492109,-0.0122469529622615,0.00486365846582921,0.39771202634458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,39560,-0.00669119981214521,0.00791291617767128,-0.0222005155203809,0.00881811589609051,0.397791713346702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.00629148484537319,0.0074408194809859,-0.0208754910281056,0.00829252133735917,0.397826229891614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.00634192694787335,0.00751115006586911,-0.0210637810769768,0.0083799271812301,0.398500614479783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLG,Plasminogen,39742,-0.00199367429947412,0.00236496476050499,-0.0066290052300639,0.00264165663111566,0.399244409985619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.00405773881054916,0.00482463214130955,-0.0135140178075159,0.00539854018641757,0.400340207905985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCLN,Nicalin,41913,-0.00465005454718412,0.00553075054401923,-0.0154903256134618,0.00619021651909358,0.400495400808655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.00497450693697507,0.00591757948494825,-0.0165729627274736,0.00662394885352349,0.400569198798572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,0.00372617049772667,0.00444550456763808,-0.00498701845484397,0.0124393594502973,0.401942873444086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00444502802238532,0.00531502647649377,-0.0148624799163131,0.00597242387154247,0.402993694066633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,39929,0.00344805950980447,0.00413035664720376,-0.00464743951871491,0.0115435585383238,0.40384277814457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.00599163109192532,0.00719827004173844,-0.0201002403737327,0.00811697818988202,0.405217114625695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,41913,-0.0054711910391706,0.00657952681125574,-0.0183670635892319,0.00742468151089066,0.405679151463171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPGN,Epigen,39919,-0.00416913552076478,0.00501861366167622,-0.0140056182976502,0.00566734725612062,0.406141153036189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00348673116704871,0.00419961118682109,-0.011717969093218,0.00474450675912062,0.406414974914234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,39657,-0.00329688510612073,0.00398170205036041,-0.0111010211248271,0.00450725091258568,0.407683277745121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.00527720170634025,0.00637474058991637,-0.00721728984989584,0.0177716932625763,0.407784746239246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42016,-0.011391457415157,0.0138267027926687,-0.0384917948887877,0.0157088800584737,0.410025945435556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.00295361895367624,0.00359380279277462,-0.00999747242751448,0.00409023452016201,0.411171737674742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00507436965163035,0.00621035158660362,-0.0172466587613735,0.00709791945811275,0.413899014394681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00395056093917658,0.00483959261791137,-0.0134361624702829,0.00553504059192971,0.414345984409673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.00350954918988809,0.00429958023400641,-0.00491762806876448,0.0119367264485407,0.414369109224925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42262,-0.00479868405312897,0.00589973633927041,-0.016362167278099,0.00676479917184104,0.416018622204364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.00436661032125374,0.00538976583614105,-0.00619733071758272,0.0149305513600902,0.417858773352381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00421458980979116,0.00521663045375234,-0.00601000587956342,0.0144391854991457,0.419156939048927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,0.00581934770259488,0.00720406105060345,-0.00830061195658788,0.0199393073617776,0.419230650293785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00311514709713794,0.00385947111086129,-0.00444941628015019,0.0106797104744261,0.419598235079504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00400470417997653,0.00496701997487763,-0.0137400633307367,0.00573065497078362,0.420110909603695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42185,-0.00413083543116603,0.00512521993739303,-0.0141762665084564,0.00591459564612431,0.420267288986876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.00593798266076512,0.00739679514544745,-0.0204357011458421,0.00855973582431188,0.422117608095195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00194433898871043,0.00242398998649535,-0.00669535936224133,0.00280668138482046,0.422498855665207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00543746774203079,0.00677910562470405,-0.0187245147664507,0.00784957928238915,0.422516864834582
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.00638711862269825,0.00797366710179616,-0.0220155061422187,0.00924126889682222,0.423133548217874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,0.00731388460790067,0.0091537165800042,-0.0106273998889076,0.0252551691047089,0.424300775533363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42145,-0.00990598665173286,0.0124053863766616,-0.0342205439499896,0.0144085706465239,0.424581037499512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00290922288173007,0.00365378274791911,-0.0100706370676515,0.00425219130419138,0.42591692473718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARC,SPARC,42181,-0.0060188720216354,0.00756112983612335,-0.0208386865004372,0.00880094245716637,0.426029600594326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42119,0.00744505635182027,0.00936106300698584,-0.010902627141872,0.0257927398455125,0.426440368875755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,39690,0.00732831688467323,0.00925756168995141,-0.0108165040276315,0.025473137796978,0.428608920938365
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,39638,0.0037909233267451,0.00481650666673748,-0.00564942974006035,0.0132312763935506,0.431258344631759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,39990,-0.00788146836578337,0.0100210286204168,-0.0275226844618002,0.0117597477302335,0.431595110141324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.00746487076126353,0.00949860677466376,-0.0260821400396045,0.0111523985170774,0.431948144250092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,39586,-0.00446837138772193,0.00569394072055524,-0.0156284952000102,0.00669175242456635,0.432611787916946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42310,0.00369308843316528,0.0047071325395081,-0.00553289134427059,0.0129190682106011,0.43271760423692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,41751,0.00635254080285313,0.00812408662102152,-0.00957066897434905,0.0222757505800553,0.434264455311492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,39979,0.00590950345986818,0.00756107572496081,-0.008910204961055,0.0207292118807914,0.434484089285045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42239,0.00170031030560421,0.00217933411339529,-0.00257118455665056,0.00597180516785898,0.435288367640291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,39560,-0.00779800327321306,0.0100300402847399,-0.0274568822313032,0.0118608756848771,0.436901374487655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.00210762312002715,0.00271313101259714,-0.00742535990471755,0.00321011366466325,0.437276615550565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.00573906521840928,0.00742721475448799,-0.0202964061372057,0.00881827570038718,0.43971182196285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,39929,-0.00707750272042777,0.00916020954686898,-0.025031513432291,0.0108765079914354,0.439754270582603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,39919,0.0052131993043903,0.00675217938348111,-0.00802107228723267,0.0184474708960133,0.44008521451333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0124808857257486,0.0162071314806638,-0.0192850919763524,0.0442468634278496,0.441262311516567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,-0.0050336672650656,0.00654447222429253,-0.017860832824679,0.00779349829454775,0.441819218737427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,-0.00195129554805135,0.00253896253819273,-0.0069276621229091,0.0030250710268064,0.442179374833507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.00509653200550394,0.00663279508897475,-0.00790374636888656,0.0180968103798944,0.442272649671057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,-0.00331537640078181,0.00431728324788639,-0.0117772515666391,0.00514649876507552,0.44254461890411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.00895511600562097,0.0116680083470064,-0.0318244123657535,0.0139141803545116,0.442804342630515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,-0.00219211334869735,0.00286122291969727,-0.007800110271304,0.0034158835739093,0.443606150692924
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,39966,-0.00232346691864399,0.00304455894917147,-0.00829080245902007,0.00364386862173209,0.445387480157141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.00201280959530819,0.00263828581556704,-0.00718384979381959,0.0031582306032032,0.445522498588209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,39657,0.00474704422715539,0.0062277784108567,-0.00745940145812375,0.0169534899124345,0.445934721010349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.00542640209358307,0.00712649974910611,-0.019394341601831,0.00854153741466491,0.44640785596566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,-0.00383192823069611,0.00504829260309083,-0.0137265817327541,0.00606272527136192,0.447836357812654
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.00687415941417395,0.00906501520576039,-0.0108932703891164,0.0246415892174643,0.448277255671779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.00357631170735612,0.00473219108766297,-0.0128514062391755,0.0056987828244633,0.449820495842981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00269386318332521,0.00360328144361485,-0.00975629481281031,0.0043685684461599,0.454709098142796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,0.00457156654556786,0.00613079844743521,-0.00744479841140514,0.0165879315025409,0.455881250551013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,41843,-0.00458891118350205,0.00616656642249993,-0.0166753813716019,0.00749755900459783,0.4567929744266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,0.00380749049867817,0.00511871981127469,-0.00622520033142022,0.0138401813287766,0.456988397836323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00241778706033307,0.00325317508872366,-0.00879401023423145,0.00395843611356532,0.457370921632477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,39930,0.00351769069485217,0.00473740495288727,-0.00576762301280688,0.0128030044025112,0.457778429571581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,0.00466305334304244,0.00628736980555572,-0.00766019147584676,0.0169862981619316,0.458309890993581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.00558472363307655,0.00755279363911552,-0.00921875189958987,0.020388199165743,0.459662068074099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00706113829408557,0.00955947348330843,-0.0257977063213701,0.011675429733199,0.460133149898371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.00237469139610191,0.00321793601084325,-0.00868184597735468,0.00393246318515087,0.460554649942081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS2,Podocin,39657,-0.00811163345580462,0.0110326746339384,-0.0297356757383239,0.0135124088267146,0.462210605403446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,39586,-0.00725731684622035,0.00988201575363165,-0.0266260677233384,0.0121114340308977,0.462722851095756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00247961858876366,0.00337677035992692,-0.00909808849422042,0.00413885131669309,0.462771390627151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBN,Nibrin,41913,-0.00430708856771442,0.00586929282846504,-0.0158109025115059,0.00719672537607706,0.463062637916681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,39560,0.00564020365893646,0.0077064793908729,-0.00946449594717443,0.0207449032650474,0.464258609830837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,-0.00208584090030804,0.00285094318975886,-0.00767368955223541,0.00350200775161932,0.464408932429437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.00342643778771936,0.00469637122145444,-0.0126313253817701,0.00577844980633134,0.465654269076053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42143,-0.008300050666349,0.0113855043263367,-0.0306156391459689,0.0140155378132709,0.466013301018447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,0.00226307039735101,0.00310598657810769,-0.00382466329574006,0.00835080409044207,0.46624961842522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42103,0.00522141558261857,0.00717152296674876,-0.008834769432209,0.0192776005974462,0.466579533447908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.00398520797197814,0.00547609419761559,-0.0147183525993047,0.00674793665534842,0.466784246892663
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,-0.00463613268375431,0.00637420094970901,-0.017129566545184,0.00785730117767534,0.467040769922993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.00523748933382123,0.00722296992228453,-0.0193945103814989,0.00891953171385645,0.468393404126349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.00270605139668199,0.00375076604929049,-0.0100575528532914,0.00464545005992737,0.470637907472589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,39934,0.00228851695681823,0.0031729715084911,-0.00393050719982432,0.00850754111346078,0.470768408672263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,-0.00526498813854742,0.00730221751050059,-0.0195773344591286,0.00904735818203374,0.470917244437354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.00277134026881783,0.003859268127199,-0.0103355057981279,0.00479282526049221,0.472708325642684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00351571663402533,0.00489590342193922,-0.00608025407297555,0.0131116873410262,0.472714647310923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.00470624207375918,0.0065664549941368,-0.0175764938622673,0.00816400971474895,0.473565870666532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,39575,-0.00312491281079037,0.004360124257839,-0.0116707563561548,0.00542093073457407,0.473572812886646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,-0.00389950658444798,0.00545378754111366,-0.0145889301650307,0.00678991699613479,0.474618778812104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,-0.00224987043989776,0.00314840394733108,-0.00842074217666667,0.00392100129687116,0.474867212384649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.0026718507409806,0.00374434530122321,-0.00466706604941689,0.0100107675313781,0.47550855853169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.00306268676912125,0.0043011382299034,-0.0114929176997319,0.00536754416148942,0.476439666554442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.00572996163032226,0.00805209747780378,-0.0215120726868177,0.0100521494261731,0.47672053363154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.00505937600052669,0.00712926843404851,-0.0190327421312618,0.00891399013020838,0.477927916817359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.00482124628960923,0.00679401957189784,-0.00849503207131054,0.018137524650529,0.477948122267333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.00491832615839922,0.00693569646374183,-0.0185122912273332,0.00867563891053477,0.478256993429677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,41839,-0.0038921159663974,0.00549263835654444,-0.0146576871452245,0.00687345521242971,0.478581548215433
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42119,-0.00522955511345703,0.00738197395438925,-0.01969822406406,0.0092391138371459,0.478695250319503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.00628712082498357,0.00888333216075911,-0.0236984518600714,0.0111242102101043,0.47911932622974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0055930700204398,0.00790887906027999,-0.0210944729785886,0.00990833293770898,0.479464139937825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,39560,-0.00382313498960746,0.00541000120734172,-0.0144267373559972,0.0067804673767823,0.479780919963302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.00309028498617723,0.00440004153556382,-0.0117143663958823,0.00553379642352786,0.48248481331456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00216264054251501,0.00308033554837276,-0.0038748171322956,0.00820009821732562,0.48264394203489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0038276464478375,0.0054588946857689,-0.0145270800319446,0.00687178713626955,0.483205187385537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,41839,-0.00541036683122715,0.0077232008668121,-0.0205478405301789,0.00972710686772457,0.483606025916339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00323034673273417,0.00461587256567948,-0.0122774569614659,0.00581676349599761,0.484045517975313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42145,-0.00267045059569854,0.00381703135866308,-0.0101518320586782,0.0048109308672811,0.484180080951409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.00446949523942192,0.00639462744411609,-0.0170029650298895,0.0080639745510456,0.484600884611335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.00379866602550882,0.00545092185981631,-0.0144824728707488,0.00688514081973114,0.485886962090925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,39919,0.00338839664001239,0.00486356088668357,-0.00614418269788741,0.0129209759779122,0.486010815492703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRL,Prolactin,42249,-0.00552105997387818,0.00796349044119147,-0.0211295012386135,0.0100873812908571,0.488135302161937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,-0.00244316453938401,0.00353299955235221,-0.00936784366199435,0.00448151458322632,0.489246552751403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0086442358460374,0.0125084972914411,-0.0158724188451871,0.0331608905372619,0.489534173017257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.00655765074104119,0.0095237520975277,-0.0252242048521955,0.0121089033701131,0.491115884904194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,39649,0.00445330700938791,0.00646777346364527,-0.00822352897935682,0.0171301429981326,0.491128582712169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.00202185443348963,0.00294094289592942,-0.00778610250951129,0.00374239364253203,0.49179115181906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.00299705006827794,0.00436140854656895,-0.0115454108195531,0.0055513106829972,0.491986667846912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.00437600943430436,0.00638364053103235,-0.0168879448751278,0.00813592600651905,0.493040582521361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00293871162378323,0.00428698093405621,-0.0113411942545334,0.00546377100696694,0.493044970738066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00268902067628907,0.00393309965172128,-0.0103978959936628,0.00501985464108463,0.49418530233519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.00314173581915742,0.00461019108855791,-0.0121777103527309,0.00589423871441609,0.495584557377147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42246,-0.00321567452336639,0.00473508987577927,-0.0124964506798938,0.00606510163316098,0.497075986669344
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,41960,-0.00296595813205719,0.00436921230174923,-0.0115296142434857,0.0055976979793713,0.497256508368265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.00581287290357359,0.00857932959825626,-0.0110026131090087,0.0226283589161559,0.498075106684668
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.00555255411086265,0.00819859394533019,-0.0216217982437098,0.0105166900219845,0.498257248672674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.00330828879572101,0.00489004770184573,-0.0128927822913386,0.00627620469989662,0.498715135223608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.00383361345893079,0.00567823151291599,-0.0149629472242461,0.00729572030638455,0.499597240652471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.00585928151656602,0.0087545290505791,-0.0230181584557011,0.011299595422569,0.503327191201473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.00329307640146172,0.00498603443331275,-0.0130657038907547,0.00647955108783127,0.508972324078068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,39638,0.0013052194654674,0.00197761050232324,-0.00257089711908615,0.00518133605002095,0.5092687251884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0041088489422661,0.00623664187183767,-0.0163326670110679,0.00811496912653573,0.510022456700853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.00604813024140167,0.0091993736469824,-0.0240789025894872,0.0119826421066838,0.51090517729258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.00285254837150621,0.00433927809676543,-0.0113575334411665,0.00565243669815403,0.510948961066563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.00190969366024245,0.00290573506649036,-0.00760493439056356,0.00378554707007865,0.511056163894043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,0.00518176928365271,0.00788908231201042,-0.0102808320478877,0.0206443706151931,0.511305347785258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42115,0.00656286099738664,0.0100010766963883,-0.0130392493275345,0.0261649713223077,0.511696684215333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.00466773296623934,0.0071263754906497,-0.0186354289279128,0.00929996299543407,0.512484935466561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,39575,0.00446589776916043,0.00683405620041581,-0.00892885238365456,0.0178606479219754,0.513462575452028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,0.00474931494205401,0.00728509854427211,-0.00952947820471933,0.0190281080888274,0.514465238510164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.00591139177438247,0.00909677431420356,-0.0237410694302214,0.0119182858814565,0.515812691051845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00324963760974763,0.00500345822371402,-0.0130564157282271,0.00655714050873185,0.516040523451723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.00387687458761303,0.00603811804440384,-0.0157115859546446,0.00795783677941849,0.520840756514935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,39649,0.00571985450573023,0.00890866665787617,-0.0117411321437071,0.0231808411551675,0.520850753910393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,0.00413458322977104,0.00644388176482272,-0.00849542502928149,0.0167645914888236,0.521124962244059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.00580366770649991,0.009076011684194,-0.0235926506075201,0.0119853151945203,0.522542714822085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00809384739711862,0.0126648435485221,-0.0329169407522219,0.0167292459579846,0.522784287578311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42137,-0.00235506474331844,0.00368928279626477,-0.00958605902399738,0.00487592953736051,0.523254716835966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.00307013176804213,0.00483374872809183,-0.0125442792751021,0.00640401573901785,0.525346630801676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MENT,Protein MENT,39736,0.00163461323684395,0.00257585832215652,-0.00341406907458283,0.00668329554827074,0.525709064449153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.0036962839464791,0.00583301131921029,-0.0151289861321313,0.00773641823917307,0.526300484706131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.00275783540698146,0.00436839114628021,-0.0113198820536907,0.00580421123972776,0.527846648207062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00562149043147064,0.00893393302553819,-0.0231319991615255,0.0118890182985842,0.529212217298439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,0.00427415259172461,0.00679535425229465,-0.0090447417427729,0.0175930469262221,0.529374230177593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42166,0.00591809430933509,0.00942237137176197,-0.0125497535793184,0.0243859421979886,0.529955759975198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.00364945123250655,0.00581376706470617,-0.00774553221431755,0.0150444346793306,0.530196667457016
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.00181248538460095,0.00289662200954925,-0.00748986452331749,0.00386489375411559,0.531506563066716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.00639068212238111,0.0102474520026502,-0.0264756880475755,0.0136943238028133,0.532876910844697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.00328138509274674,0.00526571537861897,-0.0136021872348399,0.00703941704934644,0.533189833058298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0105195214877377,0.0169328475965876,-0.0437079027770494,0.0226688598015741,0.534445944559823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMD,Dystrophin,39638,-0.00346006202216807,0.00557887081218319,-0.0143946488140471,0.00747452476971099,0.535133456758163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,39929,0.00468586549095785,0.00757466665922722,-0.0101604811611275,0.0195322121430432,0.536176968300869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.00384402312157285,0.00622604763673727,-0.0160470764895779,0.0083590302464322,0.536977224729641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,-0.00267681346253183,0.00433628741323138,-0.0111759367924653,0.00582230986740166,0.537046156300198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42070,-0.00683433532605296,0.0110780359712598,-0.0285472858297221,0.0148786151776162,0.537293552373159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.00482632816345198,0.00785198832027886,-0.0202162252711986,0.0105635689442946,0.538787520844667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.00561890755147326,0.00916295828425812,-0.0235783057886192,0.0123404906856727,0.539743316161069
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,0.00483316751875434,0.0079161855999676,-0.0106825562571822,0.0203488912946908,0.541513018604558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,38503,0.00704386159979743,0.0115492266408311,-0.0155926226162316,0.0296803458158264,0.541942719104994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NENF,Neudesin,39919,-0.00739795499768834,0.0121809353229379,-0.0312725882306467,0.01647667823527,0.543638257865297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0069615381687223,0.011477499271233,-0.029457436740339,0.0155343604028944,0.544170176555179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00220103969298829,0.0036333292281295,-0.00932236498012212,0.00492028559414553,0.544665369269187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,39919,-0.00279603564674878,0.00462625463996898,-0.011863494741088,0.00627142344759043,0.545600288853878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.00384165060400085,0.00635808623054598,-0.016303499615871,0.00862019840786927,0.545710773135007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42310,-0.0057481284054118,0.00951743339277248,-0.0244022978552459,0.0129060410444223,0.545881673008194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,-0.00438481369144285,0.00726439321603679,-0.018623024394875,0.00985339701198925,0.546119729316617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,0.00213163208871472,0.00354018895630554,-0.00480713826564414,0.00907040244307357,0.547101679052262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.00519234513092747,0.0086352281992881,-0.0221173924015322,0.0117327021396772,0.547651783673441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00381376288508007,0.00634306629533326,-0.0162461728239333,0.00861864705377312,0.547686492883811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,39657,0.00351643439017259,0.00586229868883037,-0.00797367103993494,0.0150065398202801,0.548625943744227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0061743444801166,0.0102986652193381,-0.0263597283100192,0.014011039349786,0.54883064776729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0075922447195172,0.0126975978237235,-0.017295047014981,0.0324795364540153,0.549898348022124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.00496882436455872,0.00835150715690828,-0.0213377783920989,0.0114001296629815,0.551881127655286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,0.00468411398917122,0.00788154606724687,-0.0107637163026326,0.0201319442809751,0.552313884371702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.0024642167451736,0.0041602800446277,-0.0106183656326439,0.00568993214229669,0.553648200042711
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,39934,-0.0100250769829263,0.0169294808170738,-0.0432068593843909,0.0231567054185383,0.553750691376616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,0.00375745015182644,0.00635960699785633,-0.00870737956397197,0.0162222798676249,0.554644043889984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.00315023481173488,0.00536857186062147,-0.013672635658553,0.00737216603508319,0.557353203511177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.00323303403695783,0.005510998196002,-0.0140345905011217,0.00756852242720608,0.55744983980448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,41900,-0.00339255801259745,0.00579075504672001,-0.0147424379041687,0.00795732187897377,0.557981135024923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.00426505219695971,0.00728393338791163,-0.0185415616372665,0.0100114572433471,0.558194897814333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,0.00357398894328216,0.00611021754046591,-0.00840203743603102,0.0155500153225953,0.558611420164561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00159946992570626,0.00275083222994305,-0.00379216124498211,0.00699110109639463,0.560949526105459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.00564519613459393,0.00972557999791323,-0.0247073329305039,0.013416940661316,0.561622124779167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,-0.00249533452681899,0.00430546040806443,-0.0109340369266253,0.00594336787298729,0.562211322244938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00377310498906776,0.00651704505860351,-0.0165465133039306,0.00900030332579511,0.5626263220022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,39649,-0.00406583355814671,0.00703153686750018,-0.0178476458184471,0.00971597870215365,0.563121784202819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.00257127041868923,0.00445181872244736,-0.0112968351146861,0.0061542942773076,0.563559006398143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.00153368791092366,0.00265866854711159,-0.00674467826326238,0.00367730244141507,0.564043649805648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.00659748797555531,0.0114466931527678,-0.0290330065549801,0.0158380306038695,0.564379256705893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,-0.00276080447645546,0.00479466741847068,-0.012158352616658,0.00663674366374708,0.564755026682913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.00447215095433515,0.00776979794688051,-0.019700954930221,0.0107566530215507,0.564909784048213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,39560,-0.00190742953931416,0.00331861708637299,-0.00841191902860522,0.0045970599499769,0.565461102495477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,39586,0.00243006661574814,0.00423102938887801,-0.00586275098645276,0.010722884217949,0.565746755785565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,39757,-0.0026923981743095,0.0046933778730679,-0.0118914188055226,0.00650662245690358,0.566210181932796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.00639074181050752,0.0112282772453461,-0.0156166815903709,0.028398165211386,0.569253616948662
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.004432496865201,0.00779433260919118,-0.0197093887792157,0.0108443950488137,0.569581479652564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42200,0.00246310584472871,0.00433164453185335,-0.00602691743770386,0.0109531291271613,0.569616209398837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.0028611588638987,0.00504987163963663,-0.00703658954978909,0.0127589072775865,0.571010803603433
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39398,-0.00431159529401984,0.00763453229442068,-0.0192752785910844,0.0106520880030447,0.572256159298678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.00533800731426262,0.00945671817167877,-0.0131971603022278,0.023873174930753,0.572447745794233
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.00397777892162421,0.00710415495860033,-0.0179019226404808,0.00994636479723243,0.575541317227788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.00451848219670944,0.00810806407931182,-0.0204102877921606,0.0113733233987417,0.577345414015154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,39958,0.00322218420759263,0.00579170139775232,-0.0081295505320019,0.0145739189471872,0.577985979107115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.00322602704080977,0.00580160332769667,-0.0145971695630952,0.00814511548147571,0.578180548183811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.00412658035905193,0.00742376534154203,-0.0104239997103704,0.0186771604284743,0.578317328904669
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,39929,0.00325250538426914,0.00587513147010428,-0.00826275229713525,0.0147677630656735,0.579859752769504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.00527021288466193,0.00960033189857777,-0.0240868634058744,0.0135464376365505,0.583042935925624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00259465707421516,0.00474506415775092,-0.011894982823407,0.00670566867497664,0.584519069887033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.00406523695284568,0.00744478668670783,-0.018657018858793,0.0105265449531017,0.585041571308238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.00246279354382581,0.00451522301952902,-0.0113126306621027,0.00638704357445107,0.585458354342845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42129,0.0017829824792073,0.00328924272792052,-0.00466393326751693,0.00822989822593152,0.587782840706528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,39759,-0.00143772001906012,0.00265389671322551,-0.00663935757698212,0.00376391753886187,0.588008961737218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.00396100166146823,0.00733739765824738,-0.0104202977486966,0.0183423010716331,0.589318081482698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,39657,-0.0028659032997031,0.00531490841032795,-0.0132831237839459,0.00755131718453967,0.58974612818082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,0.00280673031926018,0.00521654436599109,-0.00741769663808236,0.0130311572766027,0.59055724739074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,-0.00127291406052733,0.00237558825391245,-0.00592906703819574,0.00338323891714108,0.592086066073852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.00492583519039114,0.00919622898590928,-0.0229504440027733,0.0130987736219911,0.592218662968724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,39649,-0.00208773631068438,0.00389937075974084,-0.00973050299977641,0.00555503037840766,0.592381724530821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.00418125300598456,0.007827373964683,-0.0111603999647941,0.0195229059767632,0.593225164282614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00446025674560375,0.00835290161468038,-0.0119114304191698,0.0208319439103773,0.593368326404854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.00174000509686273,0.003262284662743,-0.00813408303583901,0.00465407284211354,0.593786246510403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.00245406151514691,0.00461927430474844,-0.0115078391524539,0.00659971612216003,0.595243606149643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42051,-0.00395913913478191,0.00746762940015414,-0.018595692759084,0.0106774144895202,0.596000401578143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.00272756094327927,0.00515601862278249,-0.0128333574439329,0.0073782355573744,0.596812503301111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.00144199569217218,0.00272721099540242,-0.00390333785881656,0.00678732924316092,0.596991848482189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00274624163949151,0.00520605486806986,-0.00745762590192542,0.0129501091809084,0.597850545335585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,0.00401680021010846,0.00762154440802381,-0.0109214268296182,0.0189550272498351,0.598181798693434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.00228195211630671,0.00436783905471713,-0.0108429166635523,0.00627901243093885,0.601369638283596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,0.00172161893828168,0.0032982571577875,-0.00474296509098181,0.00818620296754517,0.601694111775517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00352014640633756,0.00674533687247813,-0.0167410066763947,0.00970071386371956,0.60177569285507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.00362650896530593,0.00699848586043347,-0.0100905233211437,0.0173435412517555,0.604339787767681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.00481112097816542,0.00928867402399627,-0.0133946801088673,0.0230169220651981,0.604499599674705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,0.00506999860758395,0.00979668172844366,-0.0141314975801656,0.0242714947953335,0.604800439167733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,41740,0.00466422460799433,0.00902307696506055,-0.0130210062435243,0.022349455459513,0.605219493937389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.00419048054968513,0.00811532542113619,-0.0200965183751121,0.0117155572757418,0.605608852312686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00466748385291479,0.00910467270757529,-0.0225126423597624,0.0131776746539328,0.608206766060202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0027464480368783,0.00535963286143622,-0.0132513284452933,0.00775843237153668,0.608358858096679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.0017420565102226,0.0034162797639892,-0.00843796484764144,0.00495385182719624,0.610112188952432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,39757,0.0047523901235962,0.00937385709081851,-0.0136203697744081,0.0231251500216005,0.61217647190621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.00815943881501453,0.0161212281131206,-0.039757045916731,0.0234381682867019,0.612773748136112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42137,0.00487992443156809,0.00964698306860185,-0.0140281623828915,0.0237880112460277,0.612970333974278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.00465202498092808,0.00921207947556912,-0.0227077007530436,0.0134036507911874,0.613572971802098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,39914,-0.00532818082853533,0.0105654863619046,-0.0260365340978683,0.0153801724407976,0.61405999516203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.00246495243352034,0.00488913264502138,-0.0120476524177622,0.00711774755072156,0.614150533435976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,0.00495320931405897,0.00988069982057458,-0.0144129623342672,0.0243193809623851,0.616167061368679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,-0.00230163918339695,0.00459701465884242,-0.0113117879147281,0.00670850954793418,0.616605489287065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.00202584620998171,0.00406487997985683,-0.00594131855053769,0.0099930109705011,0.618227684478623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,41900,0.00304505620865733,0.00611205167364644,-0.00893456507168968,0.0150246774890044,0.618347623143319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,0.00121197596329714,0.00243292505545435,-0.00355655714539338,0.00598050907198767,0.618382231617157
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.00541063462499101,0.0108665158585218,-0.0267090057076937,0.0158877364577116,0.618551462349543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.00310942704422179,0.00625427015091624,-0.0153677965400176,0.00914894245157403,0.619078099860889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00219430956825055,0.0044166259641601,-0.0108508964580043,0.00646227732150324,0.619319248063919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42145,0.00245142148639933,0.00494656735059461,-0.00724385052076611,0.0121466934935648,0.620198572603044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00250093960473542,0.00505304846046797,-0.0124049145872526,0.0074030353777818,0.620652704227824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00211584002210588,0.00427782300064754,-0.0105003731033751,0.00626869305916329,0.620887654919796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,41756,-0.00392504607491298,0.00796745083972883,-0.0195412497207815,0.0116911575709555,0.622278651765961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.00347666646527999,0.00706839044868151,-0.0173307117446958,0.0103773788141358,0.62282706140033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00281975060905872,0.005753835739994,-0.014097268659447,0.00845776744132952,0.624097897198903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0048012280679511,0.00983890625417623,-0.0240854843261365,0.0144830281902343,0.625570905088239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.00239983920399559,0.00492845691239587,-0.0120596147522915,0.00725993634430032,0.626313690246933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.00907362250434753,0.0186400809155551,-0.0456081810988355,0.0274609360901404,0.626423512376611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0031092523560766,0.00639543378993043,-0.00942579787218703,0.0156443025843402,0.626856434259673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.00253123059868621,0.0052146133146177,-0.0127518726953369,0.00768941149796448,0.627394234877853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.00305090013277838,0.00632117835938139,-0.0154404097171659,0.00933860945160915,0.629355690897032
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00368566846734283,0.00768315976630611,-0.0187446616093028,0.0113733246746171,0.631445026787434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.00282436660738821,0.00589361856807777,-0.0143758590008206,0.00872712578604422,0.631788344489633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00358865559516708,0.00749441044225875,-0.0182777000619942,0.0111003888716601,0.632058886445411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.00170765823567952,0.00358381114492705,-0.00873192807973654,0.00531661160837751,0.63373137631719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,39649,-0.00177008985664852,0.00371578098484286,-0.00905302058694053,0.00551284087364348,0.633819596634735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0040866829785154,0.00861069155327349,-0.0127902724659006,0.0209636384229314,0.635077448563849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.00277558154983708,0.00586446071035,-0.0142699245421231,0.00871876144244891,0.636016823619691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00304030884991845,0.00644127245365645,-0.00958458515924819,0.0156652028590851,0.636933054785691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00334072426511696,0.00708739465801388,-0.0172320177948242,0.0105505692645902,0.637392045620269
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.00221279116552326,0.00469860316926758,-0.0069964710462412,0.0114220533772877,0.637686629452815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.00534079510009127,0.0113527587129355,-0.0275922021774449,0.0169106119772624,0.638049698096715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.00560434152730972,0.0119702425514801,-0.0290660169282108,0.0178573338735913,0.639656634495209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00272504045602515,0.00583421829285111,-0.0141601083100133,0.00871002739796302,0.640452527086657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00264258579522889,0.00566205649700864,-0.0137402165293658,0.00845504493890804,0.640710637978986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,0.00162053189047686,0.00348105829516972,-0.00520234236805579,0.00844340614900951,0.64156067862119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.00399946680950175,0.00861831237799522,-0.0208913590703724,0.0128924254513689,0.642609296934249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00262981807166607,0.00568679705706261,-0.0137759403035088,0.00851630416017663,0.643771448086646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00411741473334923,0.00891724810230169,-0.0215952210138605,0.0133603915471621,0.644279772732872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00209398033965458,0.00455423966634991,-0.0110202900857004,0.00683232940639126,0.645678051361187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.00191998242561535,0.00419765119537957,-0.00630741391732861,0.0101473787685593,0.647394796657422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42250,0.00249288202995505,0.00546563931804535,-0.00821977103341383,0.0132055350933239,0.648324808399272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.00244975111303809,0.00538428221358229,-0.0130029442516594,0.0081034420255832,0.649129552554351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.00227568667841899,0.00501524841601814,-0.00755420021697657,0.0121055735738145,0.65001520501863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00216799214776445,0.00477968675160048,-0.0115361781809014,0.00720019388537248,0.650136558814404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42296,-0.0012824730432755,0.0028316691761329,-0.00683254462849598,0.00426759854194499,0.65062536346919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42057,0.00272478247874153,0.00601631069939374,-0.00906718649207019,0.0145167514495532,0.650628607549151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42249,-0.0029790230825849,0.00658411207152315,-0.0158838827427703,0.00992583657760046,0.650947476475826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.00194713413312279,0.00431129919693567,-0.0103972805591167,0.00650301229287113,0.651540506355049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00146791966405407,0.00326061577549048,-0.00492288725590727,0.00785872658401542,0.65257694214898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.002718618939429,0.00604021803826426,-0.014557446294427,0.00912020841556895,0.652657170293353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,39919,0.00196426527563703,0.00438704017395821,-0.00663433346532107,0.0105628640165951,0.654347459477368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.00367304659476293,0.00820990334838115,-0.01976445715759,0.0124183639680641,0.65460047048726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,39757,-0.001335712335499,0.0029907034550926,-0.0071974911074805,0.0045260664364825,0.655157068658331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.00241649673672388,0.00542845679478995,-0.0130562720545122,0.00822327858106442,0.656217593673753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXN,Paxillin,41839,0.00247216552954208,0.00555460630466851,-0.00841486282760821,0.0133591938866924,0.656279449585605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRN1,Neuritin,39934,-0.0016740324210754,0.00376957226508628,-0.00906239406064451,0.0057143292184937,0.656985404880453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.00194799099753491,0.00440746365762843,-0.0105866197664866,0.0066906377714168,0.658515336711139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.00300956916981795,0.00682827327959163,-0.0163929847978175,0.0103738464581816,0.659400370351417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.00195591518330783,0.00448129333848749,-0.0107392501267433,0.00682741976012764,0.662509990551106
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.00276239064858568,0.00633865344285461,-0.0151861513965807,0.00966137009940936,0.662988121318566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,39657,0.00219611333617078,0.00504279322629774,-0.00768776138737278,0.0120799880597143,0.663211366052844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.00206373323229069,0.00474112043447748,-0.0113563292838665,0.00722886281928516,0.66336468570998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00198926712821573,0.0045762724811921,-0.0109587611913522,0.00698022693492078,0.663794715904921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,41839,0.00382517873413488,0.00886103481810409,-0.0135424495093491,0.0211928069776189,0.665977161120815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42296,0.00221870918468523,0.00514851837896884,-0.00787238683809369,0.0123098052074642,0.666517837162644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,0.00386279804501415,0.00898538741718278,-0.0137485612926641,0.0214741573826924,0.667276868251524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.00390755554345785,0.00910565612235121,-0.0139395304563505,0.0217546415432662,0.667831979151094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.0016720991858771,0.00390460813594563,-0.00932513113233054,0.00598093276057634,0.668485263408901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGN,Biglycan,41820,0.00545790158119546,0.0127551656685078,-0.0195422231290798,0.0304580262914707,0.668732827126853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.00410621013291901,0.00959961691211666,-0.0229214592806677,0.0147090390148296,0.668843445624294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00283263673636118,0.00666074192944206,-0.0158876909180676,0.0102224174453453,0.670645543736745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.00542161560757264,0.0128087898084722,-0.0305268436321781,0.0196836124170329,0.672104296785288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.00258676267105542,0.00617397656664159,-0.0146877567416729,0.0095142313995621,0.675238695882521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,39657,-0.0021267402949166,0.00507903730294466,-0.0120816534086881,0.00782817281885493,0.675422320066218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIT,Vitrin,39958,0.00173826765406668,0.00416434275404765,-0.00642384414386672,0.00990037945200008,0.676381278033586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.00239371427430194,0.00576338843223043,-0.0136899556014736,0.00890252705286972,0.677906289442281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00123071289936559,0.00296708744666226,-0.00704620429482362,0.00458477849609243,0.678304924282583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.00151618242496842,0.00366397699771557,-0.00566521249055411,0.00869757734049094,0.679022864259823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.00185165434379143,0.00450982341001024,-0.0106909082274115,0.00698759953982864,0.681386734806068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,41839,-0.00142694012154687,0.00349736038175413,-0.00828176646978497,0.00542788622669123,0.683276686237032
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00318749892927831,0.00784125561329445,-0.0185563599313354,0.0121813620727788,0.684380503173197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.00541056688072462,0.0133646189000904,-0.0316052199249019,0.0207840861634527,0.685601060278575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.00213287125106822,0.00527106755094543,-0.00819842114878482,0.0124641636509212,0.685750572818353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.00202398468723151,0.00500361412818003,-0.0118310683784644,0.00778309900400135,0.68584812266983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.00189327895925902,0.00468326211988272,-0.0110724727142291,0.0072859147957111,0.68602569282513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.00226760752401798,0.0056356564509416,-0.00877827911982756,0.0133134941678635,0.687419607904736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,-0.00148020899552619,0.00368529835360364,-0.00870339376858933,0.00574297577753696,0.687947615169769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00180528876405665,0.00451431194565992,-0.00704276264943679,0.0106533401775501,0.689235192933794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.00372555165445157,0.00933489203277502,-0.0220219400386906,0.0145708367297875,0.689827487494267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00227266506646577,0.00569704904862614,-0.013438881201773,0.00889355106884147,0.689960011712108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00180101252577422,0.00453170508963423,-0.0106831545014573,0.00708112944990887,0.691061820201299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,0.00370618371571972,0.00934035121036288,-0.0146009046565915,0.022013272088031,0.691527765132915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0025984060530765,0.00658084231515797,-0.0154968569907861,0.0103000448846331,0.692964226644418
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,39757,0.00123505302874386,0.00313311837105954,-0.00490585897853284,0.00737596503602056,0.693446158294535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00250234015122832,0.0063659884692197,-0.0149796775508989,0.0099749972484423,0.69426691486384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.00262268427630591,0.00667854688734926,-0.0157126361755105,0.0104672676228986,0.694546554301222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,39575,-0.00322456819426351,0.00821562571809234,-0.0193271946017245,0.0128780582131975,0.694702269131675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,-0.00326446776543604,0.00837118654858233,-0.0196719934006574,0.0131430578697853,0.696570121272748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00329942452929358,0.00847298757962949,-0.0133076311267802,0.0199064801853674,0.696984069766567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.00131386016866211,0.00337643219158362,-0.00530394692684179,0.007931667264166,0.697189927719566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00284366823916148,0.00742484642791712,-0.017396367237879,0.0117090307595561,0.701731848160057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.00151022583852622,0.00394867152816868,-0.00924962203373684,0.00622917035668441,0.702124365387841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EZR,Ezrin,42249,-0.00100549687304388,0.00262958673878452,-0.00615948688106154,0.00414849313497379,0.702186746986083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.00328381695713493,0.00879156234437713,-0.0139476452378442,0.0205152791521141,0.708769076005604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,0.00176532528576289,0.0047353643544601,-0.00751598884897889,0.0110466394205047,0.709307409800368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.005912218055669,0.0158839414712745,-0.037044743339367,0.025220307228029,0.709741063580139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,0.00104030904496785,0.00281138709770231,-0.00447000966652868,0.00655062775646437,0.711362923492771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,39958,-0.00215173899722739,0.00585653295542702,-0.0136305435898643,0.00932706559540956,0.713321303857381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.00116582087302806,0.00318016092468656,-0.00739893628541372,0.0050672945393576,0.713929394599873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42129,-0.00151199277169717,0.00412493955220201,-0.00959687429401311,0.00657288875061876,0.713961133312997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.00269869686866233,0.00737826249589582,-0.0117626976232935,0.0171600913606181,0.714547627377549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,39575,-0.00126159816992209,0.00346600453345119,-0.00805496705548644,0.00553177071564225,0.715870941670614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.00468995999036494,0.0129111408001613,-0.0299957959586811,0.0206158759779513,0.716424488721368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,41843,0.00387995833996894,0.0106959053392807,-0.0170840161250212,0.0248439328049591,0.716796129973707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00217614308672894,0.00600142152466566,-0.0139389292750736,0.00958664310161574,0.716907251450369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,39958,-0.00106612042845657,0.00294666817853785,-0.00684159005839076,0.00470934920147761,0.717504194797142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,-0.00124148930543644,0.00343609089810454,-0.00797622746572133,0.00549324885484846,0.717875695635289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.00244823456804014,0.00678251551418264,-0.0108454958397578,0.0157419649758381,0.71813410423806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0020857773718393,0.00579972906682392,-0.0134532463428142,0.00928169159913559,0.719126721069367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.00156404315983869,0.00437371355639883,-0.0101365217303804,0.00700843541070301,0.720649008475222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,0.00252758836722309,0.00715892219718347,-0.0115038991392565,0.0165590758737027,0.724043816209313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,39575,-0.00315307077292879,0.00893942624316147,-0.0206743462095253,0.0143682046636677,0.724308798504604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.00158145601846168,0.00450220717680898,-0.0104057820850073,0.00724287004808393,0.725397103325449
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.00308844647223235,0.00890435000110248,-0.0205409724743932,0.0143640795299285,0.728712922604213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,39929,0.000810498885167958,0.00236771003767273,-0.0038302127886706,0.00545121055900651,0.732121398675388
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.0011349970813463,0.00333803484645843,-0.00540755121771222,0.00767754538040482,0.73384717530929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,39649,-0.00269813956942642,0.00799431497624938,-0.0183669969228752,0.0129707177840224,0.735740930226876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.00162171036754528,0.00481771951911848,-0.0110644406250175,0.00782101988992694,0.736414462168464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.00244128515412728,0.00727050621940387,-0.0166914773441589,0.0118089070359043,0.737043711315909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.00215593622807305,0.00642512063537626,-0.0104373002172644,0.0147491726734105,0.737217047558253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.001758443373573,0.00529220238202385,-0.0121311600423398,0.00861427329519375,0.739691275915675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.00148354103033829,0.0044721854287946,-0.00728194241009913,0.0102490244707757,0.740102159494651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,41839,0.00268496671205273,0.00809679920981046,-0.0131847597391758,0.0185546931632812,0.740190217342394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.000955401076515825,0.00288452616768427,-0.006609072365177,0.00469827021214535,0.740487649511152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,39657,0.00440653605692638,0.0133104915706229,-0.0216820274214945,0.0304950995353473,0.740607440558539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.00270793685152421,0.00823641521415526,-0.0188513106712685,0.0134354369682201,0.742331175916137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,39930,0.00247246994276153,0.00755982051641953,-0.0123447782694207,0.0172897181549438,0.743633044359501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42084,-0.00283744741509755,0.00870401827936168,-0.0198973232426464,0.0142224284124514,0.74443485057569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00139316706850277,0.0042752711622414,-0.00977269854649591,0.00698636440949038,0.744531576840158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.00330902441557509,0.0102742505975606,-0.0234465555867938,0.0168285067556436,0.747404899481189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42084,0.00113009223051242,0.00353637344697137,-0.00580119972555147,0.00806138418657631,0.749304979567089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00189279260845993,0.00592420778623437,-0.0135042398694793,0.00971865465255944,0.749352379772496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.00162816577081164,0.005119007465891,-0.011661420403958,0.00840508886233472,0.750443265027069
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.00275823792308196,0.00871597152664784,-0.0198415421153117,0.0143250662691478,0.751660959894488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,39930,-0.00878511583934001,0.0281409422674324,-0.0639413626835074,0.0463711310048274,0.754907410277117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,-0.00137285881130228,0.0044069302513089,-0.0100104421038677,0.00726472448126316,0.75540916610059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.00188765009458588,0.00606978838512235,-0.0137844353294257,0.0100091351402539,0.755812228218425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,39649,-0.00201381115971759,0.0065142145915301,-0.0147816717591166,0.0107540494396814,0.757220060673793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.00133855283781761,0.00433010414097674,-0.0071484512784968,0.00982555695413201,0.757229494446014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,0.00393557993087645,0.0128696292766147,-0.0212888934512883,0.0291600533130412,0.759759746392758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00107110130402273,0.00351356074120022,-0.00795768035677515,0.0058154777487297,0.760487839644947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,-0.00143240254106416,0.00471861457726082,-0.0106808871124954,0.00781608203036704,0.761464565013199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.00113543110488497,0.00375025583902488,-0.00848593254937372,0.00621507033960379,0.762076641525249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00202799137114247,0.00675007869783544,-0.011202162876615,0.0152581456188999,0.763846594698824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,39638,0.000755017606321684,0.00252031422069171,-0.00418479826623407,0.00569483347887744,0.764508669267315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,39958,0.00295457688853839,0.0098807588226168,-0.0164117104037905,0.0223208641808673,0.764927755548435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.00279362525986209,0.00935477810639015,-0.0211289903483868,0.0155417398286626,0.765227402785838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.00155201727140527,0.00521990404389344,-0.0117830291974364,0.00867899465462587,0.76622156777115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.000836648144314962,0.00282314654282113,-0.00469671907961445,0.00637001536824437,0.766966076433211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00107228211516774,0.00363223659498257,-0.00819146584133358,0.0060469016109981,0.767837046940888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.00112378571971956,0.00382423740981997,-0.0086192910429667,0.00637171960352758,0.768870323415547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42296,0.00193742839777797,0.00661131858908958,-0.0110207560368376,0.0148956128323935,0.769490514170446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.0014707594365687,0.00502148903463872,-0.0083713590713232,0.0113128779444606,0.769609408496629
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42145,-0.00387335446665552,0.0132924868147959,-0.0299266286236554,0.0221799196903444,0.770754259876136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.00320385687137733,0.0109950021971515,-0.0183463474350396,0.0247540611777942,0.770755920037741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.000821731373651889,0.00282066374854367,-0.00635023232079749,0.00470676957349371,0.770807676522065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.00166651870120172,0.00572225924690925,-0.0128821468251438,0.00954910942274041,0.770877532100694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.00232280869471283,0.0079892053786566,-0.0179816512368798,0.0133360338474541,0.771252984260792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.00163826240760724,0.00568023782540213,-0.00949500373018093,0.0127715285453954,0.773033998712468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.00332754315026776,0.0115476714591131,-0.0193058929095939,0.0259609792101295,0.773231779344484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,39649,0.00241140920076299,0.00842525367235239,-0.0141020879970477,0.0189249063985737,0.774721074143215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,0.000973063693651676,0.0034020688959657,-0.00569499134244109,0.00764111872974444,0.774866369154343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.00106235253580598,0.00372767324411496,-0.00836859209427129,0.00624388702265933,0.775656489161403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,41839,-0.00181751947449195,0.00638109973398116,-0.014324474953095,0.0106894360041111,0.775779942445651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00282197814781939,0.0099085776957088,-0.0165988341357699,0.0222427904314086,0.775801576354688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.00118102912316143,0.00421565190302859,-0.00944370685309747,0.00708164860677461,0.779365113554845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAT,Catalase,39827,0.00157617668058493,0.00567548133723267,-0.0095477667403911,0.012700120101561,0.781234854511691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,41913,0.002299403695447,0.0083061162091768,-0.0139805840745395,0.0185793914654335,0.781912950327579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.000963530291304963,0.00348068472594411,-0.00585861177154549,0.00778567235415542,0.781920938702348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,41797,0.00207603638257631,0.00761297414054286,-0.0128453929328877,0.0169974656980403,0.78509028912755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.00115241461009097,0.00424651877992262,-0.00717076219855736,0.00947559141873931,0.786104749512266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSND,Barttin,39560,-0.000983712336345305,0.00363252284329001,-0.00810345710919373,0.00613603243650312,0.786544634068501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.00193862973830938,0.00716590930698633,-0.0159838119800026,0.0121065525033838,0.786753658585547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.00209308417575569,0.00776386889094049,-0.0131240988504877,0.0173102672019991,0.787478353065858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.000808818038808904,0.0030061719134118,-0.00670091498909604,0.00508327891147823,0.787893388100827
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.00253787831989448,0.00952284625965614,-0.0212026569888205,0.0161269003490315,0.78985580570989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.00101225406832654,0.00380724862309709,-0.00847446136959684,0.00644995323294375,0.790339211237044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.000832332756657764,0.00313756764340155,-0.00531729982440927,0.00698196533772479,0.790798892898095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,0.00178110945685587,0.00672202202130582,-0.0113940537049035,0.0149562726186153,0.791039507483765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.00261318570361162,0.00989460210107366,-0.022006605821716,0.0167802344144927,0.791706131652169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.00169656791190619,0.00646518213686301,-0.0143683249001577,0.0109751890763453,0.793004656372852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,39575,-0.00134943842373231,0.00515475800964782,-0.011452764122642,0.00875388727517742,0.793492102181355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.00234723196715517,0.00898778831360279,-0.0152688331275063,0.0199632970618166,0.793975568169738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.00236194197068006,0.00904988257004387,-0.020099711807966,0.0153758278666059,0.794103090936361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,39657,-0.00236507628374821,0.00909119910785795,-0.0201838265351498,0.0154536739676534,0.794752843944705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42007,-0.00137778233205591,0.00533135728693453,-0.0118272426144476,0.00907167795033577,0.796079081081803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.00148402738477346,0.00577515918283453,-0.0128033393831291,0.00983528461358222,0.797207898134138
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,0.00232718278009081,0.00924266852623433,-0.0157884475313285,0.0204428130915101,0.801210469312292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.00197931051698055,0.0079175931241468,-0.0174977930403083,0.0135391720063472,0.802600451573685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,39919,0.00190210621328936,0.00763012616325034,-0.0130529410666813,0.01685715349326,0.803141794064057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00113119212824244,0.00453915334906063,-0.0100279326924013,0.00776554843591639,0.803204724847737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,39757,0.00189644625253113,0.00762352210191174,-0.0130456570672159,0.0168385495722781,0.803549095503437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.00185578483185447,0.00750639749466676,-0.0165683239214013,0.0128567542576924,0.804737027754296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.00289003212559264,0.0117012456590263,-0.0200444093660989,0.0258244736172841,0.804924314275998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.00219036291999366,0.00888318834162732,-0.0196014120695832,0.0152206862295959,0.805242566836871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00113750071313728,0.00461921757060336,-0.0101911671515199,0.0079161657252453,0.80549020256065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.00177102533184401,0.00719958522835356,-0.015882212379417,0.012340161715729,0.805693855606665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.00178195821532,0.00724525711759531,-0.0124187457351668,0.0159826621658068,0.805726115349356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.0007547533826004,0.00309141486609676,-0.00681392652015005,0.00530441975494926,0.807122944313354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.00105455541514457,0.00433649208248536,-0.00955407989681587,0.00744496906652674,0.807869131465199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.000822550314521314,0.00339302401369476,-0.00747287738136305,0.00582777675232042,0.808456201202893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.00130578437079413,0.00540738083902923,-0.0119042508152914,0.00929268207370316,0.809186113638259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,0.000951385370449678,0.00397950808447979,-0.00684845047513071,0.00875122121603006,0.811054885964734
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.000453014567500687,0.00189947311682677,-0.00417598187648115,0.00326995274147978,0.811500912438505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00220018567281487,0.00931102231288494,-0.0204497894060694,0.0160494180604396,0.81320500553011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELN,Elastin,39958,0.000886348754337698,0.00376309068228293,-0.00648930898293685,0.00826200649161225,0.813795867958838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42262,0.00099621415903463,0.00423089457947592,-0.00729633921673817,0.00928876753480743,0.813853834409173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.00156371477720344,0.00666201298026951,-0.0146212602185317,0.0114938306641248,0.814428866315245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,39560,0.00131763836000586,0.0056529534468242,-0.00976215039576957,0.0123974271157813,0.815697048333884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,-0.000858334332862089,0.00368281942394794,-0.00807666040380005,0.00635999173807587,0.815715557838173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42081,0.00260010865878176,0.0112353209085777,-0.0194211203220305,0.024621337639594,0.816989919173742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.00120793597855409,0.00526155292375149,-0.011520579709107,0.00910470775199884,0.818423354988391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.00220156164884624,0.00962490045383347,-0.0210663665383598,0.0166632432406674,0.819077595478865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.000774920871435777,0.00340208486944464,-0.00744300721554728,0.00589316547267573,0.819822866122467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00115408709780576,0.00510909697241347,-0.00885974296812464,0.0111679171637362,0.821292188588737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.000910075231809307,0.00404695741839027,-0.00702196130823563,0.00884211177185425,0.822077659211947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.00065841546548024,0.00293372231245864,-0.00640851119789918,0.0050916802669387,0.822426743908419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.00271174953197263,0.0121348405551793,-0.0264960370201241,0.0210725379561788,0.823175381856242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.00094042246159566,0.0042356590087919,-0.00924231411882778,0.00736146919563646,0.824298479670264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.00228306327088258,0.0103825976997318,-0.0226329547623568,0.0180668282205917,0.825957673730855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.00126250863230729,0.00578078294912066,-0.0125928432125838,0.0100678259479692,0.827123334786513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAG,S-arrestin,39586,0.0012351393807675,0.00566601147326498,-0.00987024310683187,0.0123405218683669,0.82744018985563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.00103561956671961,0.00478853764539884,-0.0104211533517013,0.00834991421826212,0.828780155320139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.00099132392725529,0.0045968783808744,-0.0100012055537691,0.00801855769925854,0.829263358078756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,0.00205618213988296,0.00953822403931511,-0.0166387369771747,0.0207511012569406,0.829324703818832
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,41913,-0.00112212523143816,0.00520803672047747,-0.011329877203574,0.00908562674069768,0.829411750211395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.00144933410056642,0.00682471274481584,-0.0148257710804055,0.0119271028792726,0.831825654810308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,41900,-0.00111629454826167,0.00526912748141557,-0.0114437844118362,0.00921119531531284,0.832222879740173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,39929,-0.00162507083857567,0.00781665698110624,-0.0169457185215439,0.0136955768443926,0.83531199967179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,0.000512291736763191,0.00249098153617309,-0.00437003207413607,0.00539461554766245,0.837060736515191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,41913,-0.00104665928830253,0.00510137528698374,-0.0110453548507907,0.0089520362741856,0.837440894193487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.00155680409771089,0.00760354917765506,-0.013346152290493,0.0164597604859148,0.837773546888435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,0.000959847466555665,0.00472348900431323,-0.00829819098189826,0.0102178859150096,0.838976776418656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0018918324260528,0.0093769323031587,-0.0202706197402438,0.0164869548881383,0.840112763288233
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.00136388122378305,0.00676508162798145,-0.0146234412146267,0.0118956787670606,0.840228351788251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.00198775878678761,0.0100020074584568,-0.021591693405363,0.0176161758317878,0.842472956084849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.00132585235534169,0.00676794145881441,-0.0119393129039345,0.0145910176146179,0.844690579908038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42119,0.00109511953741944,0.00568470874290417,-0.0100469095986727,0.0122371486735116,0.847241433871552
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00111246971615174,0.00583761933420475,-0.012554203611193,0.0103292641788896,0.84886675035397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.000397048282658302,0.00209357318387753,-0.00450045172305826,0.00370635515774165,0.849585461767547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.00194261772798595,0.0102896217465654,-0.0182250408952822,0.0221102763512541,0.850257240498198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.000995610786906365,0.00529299200858504,-0.011369875123733,0.00937865354992032,0.85080188823747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.00112470660281405,0.00600354642552192,-0.0106422443912089,0.012891657596837,0.851397210729413
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,0.00277119971999371,0.0148208571787292,-0.0262776803503155,0.031820079790303,0.851679349919669
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42262,-0.00120689227754504,0.00649525470543103,-0.0139375915001899,0.0115238069450998,0.852595434030291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.00136598379671508,0.0073628001815808,-0.0157970721526134,0.0130651045591833,0.852819993768604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,0.000743963165629914,0.00401432113362266,-0.00712410625627051,0.00861203258753033,0.852975159902685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42015,-0.00101132526316003,0.00546670529767612,-0.0117260676466052,0.00970341712028516,0.853234015471271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,0.00135034640175259,0.0073467274119433,-0.0130492393256563,0.0157499321291615,0.854171790817948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,41843,-0.00264377182725451,0.014417745860379,-0.0309025537135973,0.0256150100590882,0.854511077258315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.000804086863692002,0.00439776417038177,-0.00942370463764027,0.00781553091025626,0.854926996191121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.00111740835234866,0.00612295983110751,-0.0131184096213194,0.0108835929166221,0.855197141481137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00126002584800262,0.00694966422201768,-0.0148813677231573,0.012361316027152,0.856129617036852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.000773201081432561,0.00426968151620604,-0.0091417768531964,0.00759537469033128,0.85629935404082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,39934,0.000499547688771094,0.00276394662203652,-0.00491778769042048,0.00591688306796267,0.856577170580129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.000588566417992669,0.00326638753308966,-0.00581355314686307,0.00699068598284841,0.857007663006119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.000729057088550753,0.00407209468746981,-0.00871036267599158,0.00725224849889007,0.857911092566057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.000957272977539814,0.00534884498004426,-0.0114410091384266,0.00952646318334693,0.857965979206172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.00148980239522631,0.00842483293317997,-0.018002474944259,0.0150228701538064,0.859640919030611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,39966,-0.000823157873545477,0.00470165601686139,-0.0100384036665938,0.00839208791950284,0.861021239113401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,0.000450200743362345,0.00258086971217424,-0.00460830389249917,0.00550870537922386,0.861524172386651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00105353468825861,0.00607927642693313,-0.0108618471085303,0.0129689164850475,0.862419330363473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.000609869710575934,0.00357592281604778,-0.00761867843002959,0.00639893900887772,0.864581577610544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,39897,-0.00169992571468945,0.0100372983819028,-0.0213730305432189,0.01797317911384,0.865515822351281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.00101444025615223,0.00607870911270729,-0.0129287101170585,0.0108998296047541,0.867464272340113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.00111889331008732,0.00674304358489387,-0.0143352587364793,0.0120974721163047,0.868212729701492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.000913826037616143,0.0055523975295812,-0.0117965251955953,0.009968873120363,0.869275819549699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,0.000942151898021774,0.00574650163562423,-0.0103209913078017,0.0122052951038453,0.869771732385563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.000850810899116974,0.0052166022374118,-0.0110753512844441,0.00937372948621016,0.870445166051406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000648193331119062,0.00397813882685021,-0.00844534543174548,0.00714895876950736,0.870569568329972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00102549235647182,0.00632974644632662,-0.013431795391272,0.0113808106783283,0.871299651962135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0010327611091985,0.00641151797564613,-0.0135993363414649,0.0115338141230679,0.872034119447237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0013493544482484,0.00838524449352623,-0.015085724759063,0.0177844336555598,0.872158738155188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.00102055563458992,0.00636916680477378,-0.0135041225719465,0.0114630113027667,0.872699369878349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,0.00156347610494555,0.00989932325180428,-0.0178391974685908,0.0209661496784819,0.874508257831709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.000981404892040307,0.00622946967342439,-0.0112283556678715,0.0131911654519521,0.874820366820521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,39930,0.00146903844214033,0.00947821824829507,-0.017108269324518,0.0200463462087987,0.876831180240766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,41839,-0.00123043790879986,0.00795004197164297,-0.0168125201732201,0.0143516443556204,0.877004019022242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.000629455214070702,0.00420265588164956,-0.00886666074210384,0.00760775031396244,0.880944414330735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00059570907912223,0.00405835764259655,-0.007358671900367,0.00855009005861146,0.883303824374662
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.00187400680272798,0.0127801360063263,-0.0231750597696715,0.0269230733751275,0.883423255537577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.000402621115264081,0.00275022412089065,-0.00579306039220975,0.00498781816168159,0.883611577665352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.000431142254319185,0.00295371824946227,-0.00622043002326524,0.00535814551462687,0.883950873875048
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.000743474268754014,0.0051324343519192,-0.0108030455985156,0.00931609706100761,0.884825633320712
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,39699,-0.000691443680420706,0.00481627951687516,-0.010131351533496,0.00874846417265461,0.885847486426685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.000478792629252009,0.00339423613973887,-0.00617391020463617,0.00713149546314019,0.887824286360718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,39560,-0.000653628736309345,0.0046431494161182,-0.00975420159190102,0.00844694411928233,0.888052087929571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.00161838419458813,0.0115731186777198,-0.024301696802919,0.0210649284137427,0.888788942383677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000601384390180754,0.00438656348496596,-0.00919904882071404,0.00799628004035253,0.890956676456226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,0.00186616971411943,0.0136423472551023,-0.0248728309058811,0.02860517033412,0.891196918571705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,0.00099367851820884,0.00731440377577123,-0.0133425528823028,0.0153299099187204,0.891940069934287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.00143317466840452,0.0105807622753047,-0.0221714687280017,0.0193051193911927,0.892257799681763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.00160551205785441,0.0119336049754865,-0.0217843536940992,0.024995377809808,0.892980307297724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.000929342695074301,0.00700465647378902,-0.0127997839935522,0.0146584693837008,0.894452383953406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.000626116335992129,0.00478340007499554,-0.00874934781099913,0.0100015804829834,0.895861896528714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,39966,-0.00120032149077293,0.00920997652852613,-0.0192518754866841,0.0168512325051383,0.896308919350932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.000525333250429088,0.00405033600100788,-0.00741332531154635,0.00846399181240452,0.896805229354618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.000759015761050559,0.0058655896846017,-0.0122555715428699,0.0107375400207688,0.897042362449995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.001795452227811,0.0139088053905925,-0.0254658063377503,0.0290567107933723,0.897290353981305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.000755746445254795,0.00585567711349748,-0.0107213806972003,0.0122328735877098,0.897310775184617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,39649,0.000637704550454978,0.00496773226996615,-0.00909905069867868,0.0103744597995886,0.897859023844539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.000458971183431376,0.00358653564903694,-0.00748858105554378,0.00657063868868103,0.898174498677537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.000703006009696946,0.00550881926472076,-0.0115002917685496,0.0100942797491558,0.898456263976009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000416370563387948,0.00327751177248916,-0.00684029363746671,0.00600755251069081,0.898912081305305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.00102485982022791,0.00820753041722296,-0.0171116194379849,0.0150618997975291,0.900630141807001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.000458882777764129,0.00368208821897446,-0.00767577568695406,0.0067580101314258,0.90082177242021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.000636511912446936,0.00511617097529484,-0.0106642070240248,0.00939118319913095,0.900991117894754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.00168373449043439,0.0136474293418679,-0.0284326960004955,0.0250652270196267,0.901813017613201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00084811877081812,0.00687438053204079,-0.0126256670719818,0.0143219046136181,0.901813328304781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.00077343895890012,0.00644171789214783,-0.0118523281097096,0.0133992060275099,0.904432051947156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,0.000506778395933222,0.00426702082647474,-0.00785658242395727,0.00887013921582371,0.905462659646026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.00131921332250246,0.0111217648902347,-0.0231178725073626,0.0204794458623576,0.905582114762645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,39586,-0.000625805135670178,0.00530668633513188,-0.0110269103525287,0.00977530008118831,0.906127127508324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42123,0.000453838685457767,0.00388115201811286,-0.00715321927004344,0.00806089664095898,0.906914080047711
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.000874887069299754,0.00748208834983011,-0.0155397802349668,0.0137900060963673,0.906916943171673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.000462973848508479,0.00404620205012801,-0.00839352986675937,0.00746758216974241,0.908905107955415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.000955632082067411,0.00838925509435064,-0.0173985720669947,0.0154873079028598,0.909309684476159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.00112454638419076,0.00989383790269998,-0.0182673759051012,0.0205164686734827,0.909507987062383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,0.00093579608460327,0.00839628393819044,-0.01552092043425,0.0173925126034565,0.911258681351971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.000402458972713346,0.0036282445154697,-0.00670890027760727,0.00751381822303396,0.911678670942925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.000667915600436571,0.00621589439902753,-0.0128510686225305,0.0115152374216574,0.914431691651783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.000912217821044291,0.00856739698952604,-0.0177043159205153,0.0158798802784267,0.915206711609977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00189460516076933,0.0179861782046889,-0.0371475144419597,0.033358304120421,0.91611048506557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00048444518482325,0.00462427751679451,-0.00857913874809399,0.00954802911774049,0.916567157444001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,39657,-0.000482905737639019,0.00461312169343317,-0.00952462425676803,0.00855881278148999,0.916630915786814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,41890,0.000631269775108796,0.00608875406016066,-0.0113026881828061,0.0125652277330237,0.917426459311102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.000655572029061302,0.00635249897853822,-0.0131064700269962,0.0117953259688736,0.917806503438771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,39649,0.000752277630476352,0.00743143952536374,-0.0138133438392366,0.0153178991001893,0.919370466208756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.000703740854363246,0.00702818945834934,-0.014478992192728,0.0130715104840015,0.920241954485944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.000728412007179122,0.00728043240010911,-0.0135412354970347,0.014998059511393,0.920305942746569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.000459828934169882,0.00461320775693273,-0.00858205826941826,0.00950171613775802,0.920602889507718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.000361769905523825,0.00366016902194571,-0.00753570118853742,0.00681216137748977,0.921267317713355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,41913,-0.00145307414140516,0.014919909435364,-0.0306960966347186,0.0277899483519083,0.922416865925201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.00101049931229542,0.0112652463214005,-0.0230903821022405,0.0210693834776496,0.928526470890486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0017700544320296,0.0207673834082547,-0.0424741259122087,0.0389340170481495,0.932077874496216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.000565287746916638,0.00665007747135597,-0.0124688640969411,0.0135994395907743,0.932258933748314
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.000273792344258109,0.00337756309944992,-0.00689381601917996,0.00634623133066374,0.935394049577909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.000384143437725279,0.00479869191398822,-0.00978957958914219,0.00902129271369163,0.936197587245375
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.000648044164799355,0.00811912143708152,-0.0165615221814791,0.0152654338518804,0.936384185208043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.000261493033356597,0.00347925667700198,-0.00708083612028047,0.00655785005356728,0.940090319941395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,0.000977448586991974,0.0130639098716773,-0.0246278147614956,0.0265827119354795,0.940358875139275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.000690314332917609,0.00923022049686385,-0.0174009178409355,0.0187815465067708,0.940384103541262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.00045005167672095,0.00602839258587366,-0.0122657011450333,0.0113655977915914,0.940490262905797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEB,Nebulin,39575,-0.000316209416500092,0.00431181425476896,-0.00876736535584726,0.00813494652284707,0.941540412412515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,41814,0.000267850419386835,0.00395845872868709,-0.00749072868883987,0.00802642952761354,0.946053071793979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,39934,0.000316413759738476,0.00480380921140187,-0.00909905229460918,0.00973187981408613,0.947484666845716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,41839,-0.000232182336904068,0.0036752054632986,-0.00743558504496933,0.00697122037116119,0.949627838976191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.00022601352175261,0.0036562432994811,-0.00739225038873556,0.00694022334523034,0.950710472144403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,39510,-0.000224100081218659,0.00372093570792138,-0.00751713406874457,0.00706893390630725,0.951976097731422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.00036693896652369,0.00618800102546939,-0.0117615430433963,0.0124954209764437,0.952715445183546
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIM,Vimentin,41900,-0.000736631041586775,0.0124277374624899,-0.0250949964680669,0.0236217343848933,0.952735443958874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.000398292613584447,0.00689056696451812,-0.01390380386404,0.0131072186368711,0.953906723278854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.000344511371967719,0.00605271713937607,-0.0122078369651448,0.0115188142212094,0.954610998968024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,0.000336764800106912,0.00595021180258364,-0.011325650332957,0.0119991799331709,0.954867164901101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42145,-0.000257935740127533,0.00463609877398136,-0.009344689337131,0.00882881785687593,0.955632305147198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.000285144389929606,0.00559097952471687,-0.0112434642583747,0.0106731754785155,0.959325811412252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.000366735141828018,0.00740841973702565,-0.0148872378263983,0.0141537675427423,0.960519587388223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.000251101575586515,0.0053079764283999,-0.0106547353752503,0.0101525322240773,0.962269840111729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.000187512724046762,0.00396467182381374,-0.00758324405062816,0.00795826949872169,0.962278250156674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.000369134969318723,0.00780949313504112,-0.0149374715753619,0.0156757415139993,0.962300760168236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.000147118200287009,0.00335611369612892,-0.00672510104469969,0.00643086464412567,0.965035871901039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,0.000315226895440499,0.00730670903841523,-0.0140059228198533,0.0146363766107343,0.965589011482946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.000145771255204267,0.00337986523387716,-0.00647876460319497,0.0067703071136035,0.965599177599867
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.000269423427391504,0.00624998111487948,-0.0119805395577723,0.0125193864125553,0.965616185380573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,41900,-0.000325294868046856,0.00760596579409834,-0.0152329878244796,0.0145823980883859,0.965886808606385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.000169158548198324,0.00402901966501779,-0.0080660370916332,0.00772771999523655,0.966511241856957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42016,0.000148798533765998,0.0035484554623276,-0.0068061741723961,0.0071037712399281,0.966552474793387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.000159590956631383,0.00399815314971556,-0.00799597113007388,0.00767678921681111,0.96816066000801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.000301945638936354,0.00790192455892319,-0.0157897177744258,0.0151858264965531,0.969519494476207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.000397307391722158,0.0109629866854857,-0.0210901465118297,0.0218847612952741,0.971091013925037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,39657,0.0001801189051896,0.0050353603520325,-0.0096891873847941,0.0100494251951733,0.971465756227875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.000125692735529287,0.00358196102064238,-0.00689495086492979,0.00714633633598836,0.972008118313432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.000134917500555146,0.00419987188950422,-0.00809683140287312,0.00836666640398341,0.974373477625039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.00025609231561946,0.00817012538687068,-0.016269538073886,0.0157573534426471,0.974994998442434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.000102841123343195,0.00338176411130326,-0.00673109878149758,0.00652541653481119,0.975740207610026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.000117883729122689,0.00390912052731724,-0.0075439925044191,0.00777975996266448,0.975943130339462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.000124024471437792,0.00425966196198702,-0.00822491297405676,0.00847296191693235,0.976772572123568
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,0.000168646448214194,0.00623865233655312,-0.0120591121314299,0.0123964050278583,0.978434209474212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.000200366321959347,0.00742394793653169,-0.0147513042775615,0.0143505716336428,0.978468757924545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,39657,-0.000115397184328131,0.00430698986198446,-0.00855709731381767,0.00832630294516141,0.978625319008915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.000168731934411394,0.0069853207296779,-0.0135224966957573,0.0138599605645801,0.980729235971909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.000124408789862729,0.00543715936612765,-0.0105324235677475,0.0107812411474729,0.981745430982587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42119,0.000168428721904049,0.00746483262333081,-0.0144626432198243,0.0147995006636324,0.981999222718336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.00024683366839126,0.012076914533923,-0.0239175861548804,0.0234239188180978,0.983693899145879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,8.93271514228712e-05,0.0045650438030106,-0.00885815870247791,0.00903681300532365,0.98438856372108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.000155626223845907,0.00836377287897806,-0.0165486210666429,0.0162373686189511,0.985154811335182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.000586947003019266,0.032357327599212,-0.0640073090974748,0.0628334150914363,0.985527803253589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,39575,-8.91326726305079e-05,0.00544793423528939,-0.0107670837737977,0.0105888184285367,0.986946833887482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLN,Promotilin,42119,-0.000156419989171893,0.00965052414797278,-0.0190714473191985,0.0187586073408548,0.987068337454392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-7.21382515067608e-05,0.00485319137539898,-0.00958439334728877,0.00944011684427525,0.988140874353436
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTTG1,Securin,39757,3.8200261862383e-05,0.00451514263298263,-0.00881147929878357,0.00888787982250834,0.993249747562862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,39560,-2.49998943281447e-05,0.0045339152170775,-0.00891147371980004,0.00886147393114375,0.995600607273016
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,39934,-2.04077396570499e-05,0.0039636495249166,-0.00778916080849358,0.00774834532917948,0.995892020930423
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,41843,3.81294292841764e-05,0.00846328620925171,-0.0165499115408492,0.0166261703994175,0.996405390891003
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,2.30095543583241e-05,0.0059995165525586,-0.0117360428886565,0.0117820619973732,0.996940002097007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,39649,-1.55039785182867e-05,0.00539982579144138,-0.0105991625297434,0.0105681545727068,0.99770916902215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-1.01167282808065e-05,0.00647025764099336,-0.0126918217046278,0.0126715882480662,0.998752471809267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,-3.60790075763683e-06,0.00381606865957875,-0.00748310247353199,0.00747588667201671,0.999245654678607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-3.13147286504349e-06,0.00908624083630803,-0.0178121635120288,0.0178059005662987,0.999725023045032
